<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id>
<journal-title>Frontiers in Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-453X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnins.2022.1032607</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The regulatory role of endoplasmic reticulum chaperone proteins in neurodevelopment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Sun</surname> <given-names>Hongji</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2078586/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Wu</surname> <given-names>Mengxue</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2049295/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Minxin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2062820/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zhang</surname> <given-names>Xiaomin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/827365/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zhu</surname> <given-names>Jia</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1418125/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>School of Basic Medicine, Kunming Medical University</institution>, <addr-line>Kunming, Yunnan</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Forensic and Pathology Laboratory, Department of Pathology, Institute of Forensic Science, Jiaxing University</institution>, <addr-line>Jiaxing</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Kazuhiko Sawada, Tsukuba International University, Japan</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Lilesh Pradhan, Siksha &#x2018;O&#x2019; Anusandhan University, India; Sophie Laguesse, University of Li&#x00E8;ge, Belgium; Livia La Barbera, Campus Bio-Medico University, Italy</p></fn>
<corresp id="c001">&#x002A;Correspondence: Xiaomin Zhang, <email>zhangxmtan@foxmail.com</email></corresp>
<corresp id="c002">Jia Zhu, <email>zhujia0322@163.com</email></corresp>
<fn fn-type="other" id="fn004"><p>This article was submitted to Neurodevelopment, a section of the journal Frontiers in Neuroscience</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>11</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>16</volume>
<elocation-id>1032607</elocation-id>
<history>
<date date-type="received">
<day>31</day>
<month>08</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>10</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2022 Sun, Wu, Wang, Zhang and Zhu.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Sun, Wu, Wang, Zhang and Zhu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>The endoplasmic reticulum (ER) is the largest tubular reticular organelle spanning the cell. As the main site of protein synthesis, Ca<sup>2+</sup> homeostasis maintenance and lipid metabolism, the ER plays a variety of essential roles in eukaryotic cells, with ER molecular chaperones participate in all these processes. In recent years, it has been reported that the abnormal expression of ER chaperones often leads to a variety of neurodevelopmental disorders (NDDs), including abnormal neuronal migration, neuronal morphogenesis, and synaptic function. Neuronal development is a complex and precisely regulated process. Currently, the mechanism by which neural development is regulated at the ER level remains under investigation. Therefore, in this work, we reviewed the recent advances in the roles of ER chaperones in neural development and developmental disorders caused by the deficiency of these molecular chaperones.</p>
</abstract>
<kwd-group>
<kwd>neurodevelopment</kwd>
<kwd>endoplasmic reticulum</kwd>
<kwd>molecular chaperone</kwd>
<kwd>neuronal migration</kwd>
<kwd>neuronal morphogenesis</kwd>
<kwd>synaptic function</kwd>
</kwd-group>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content></contract-sponsor>
<counts>
<fig-count count="1"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="285"/>
<page-count count="21"/>
<word-count count="18687"/>
</counts>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p>Neurodevelopment is a highly complex and precisely regulated process (<xref ref-type="bibr" rid="B12">Bagni and Zukin, 2019</xref>). The establishment of the human embryonic central nervous system begins on the 22nd day after fertilization when the neural tube begins to form (<xref ref-type="bibr" rid="B54">Devakumar et al., 2018</xref>). As development progresses, the anterior portion of the neural tube expands to form &#x201C;brain vesicles&#x201D;, and the brain develops from five small vesicle walls filled with fluid (<xref ref-type="bibr" rid="B101">Jiang and Xu, 2019</xref>). The initial vesicle wall has only two layers: the compartment layer and the marginal layer (<xref ref-type="bibr" rid="B24">Bostan et al., 2018</xref>; <xref ref-type="bibr" rid="B164">Moon and Xiong, 2022</xref>). Neural precursor cells (NPCs) are located in the inner layer of vesicles, and cells in the ventricular layer proliferate. Some of the newly generated cells remain in the ventricular layer where they to continue to divide and differentiate. Finally, these cells proliferate and form different brain regional structures, such as the cerebral cortex, thalamus, and hippocampus (<xref ref-type="bibr" rid="B249">Trujillo et al., 2005</xref>; <xref ref-type="bibr" rid="B253">Turrero Garc&#x00ED;a and Harwell, 2017</xref>). Another group of daughter cells located furthest from the ventricle side begin to migrate outward. After these cells reach various regions of the brain and occupy specific locations, they lose their ability to divide, undergo cell differentiation, and finally form the brain (<xref ref-type="bibr" rid="B44">Crelin, 1974</xref>; <xref ref-type="bibr" rid="B131">Li and Pleasure, 2014</xref>; <xref ref-type="bibr" rid="B18">Belmonte-Mateos and Pujades, 2022</xref>).</p>
<p>At the cellular level, NPCs proliferate and differentiate into immature neurons (<xref ref-type="bibr" rid="B207">Riquelme et al., 2008</xref>). Then, immature neurons undergo a series of morphological changes, including neuronal axon and dendrite development (<xref ref-type="bibr" rid="B184">Omotade et al., 2018</xref>; <xref ref-type="bibr" rid="B203">Prigge and Kay, 2018</xref>), axonal myelination, and dendritic spine formation (<xref ref-type="bibr" rid="B177">Nimchinsky et al., 2002</xref>), and gradually become mature neurons. Neurons are interconnected by synapses formed by both axonal endings and dendritic spines, forming complex neural networks (<xref ref-type="bibr" rid="B184">Omotade et al., 2018</xref>; <xref ref-type="bibr" rid="B106">Kadoyama et al., 2019</xref>). Abnormalities in any of these processes may impair neural development, resulting in brain dysfunction and subsequent leading to brain diseases (<xref ref-type="bibr" rid="B79">Guerrini and Dobyns, 2014</xref>).</p>
<p>The endoplasmic reticulum (ER) is the largest tubular reticular organelle in eukaryotic cells (<xref ref-type="bibr" rid="B204">Rapoport, 2007</xref>; <xref ref-type="bibr" rid="B200">Pobre et al., 2019</xref>) and plays several essential roles, including Ca<sup>2+</sup> storage and release, lipid synthesis, intracellular signaling, and protein synthesis (<xref ref-type="bibr" rid="B197">Phillips and Voeltz, 2016</xref>; <xref ref-type="bibr" rid="B225">Schwarz and Blower, 2016</xref>). ER molecular chaperones are a class of proteins ubiquitous in living organisms and are widely found in prokaryotes and eukaryotes (<xref ref-type="bibr" rid="B55">Doyle et al., 2013</xref>; <xref ref-type="bibr" rid="B23">Bose and Chakrabarti, 2017</xref>). These molecular chaperones are mainly responsible for assisting in correct protein folding, assembly, <italic>trans</italic>-location, degradation of misfolded proteins and inhibition of protein aggregation to maintain normal protein homeostasis (<xref ref-type="bibr" rid="B34">Carver et al., 2018</xref>; <xref ref-type="bibr" rid="B65">Freilich et al., 2018</xref>; <xref ref-type="bibr" rid="B242">Takeuchi, 2018</xref>; <xref ref-type="bibr" rid="B140">Ma et al., 2020</xref>).</p>
<p>Studies have found that abnormal expression of molecular chaperones often leads to abnormal neurodevelopment and even causes a variety of different neurodevelopmental diseases (<xref ref-type="bibr" rid="B59">Fatemi et al., 2005</xref>; <xref ref-type="bibr" rid="B125">Lammert et al., 2017</xref>). ER chaperones involved in neural development are mainly divided into the following categories: heat shock family proteins including heat shock protein 70 (HSP70) and heat shock protein 90 (HSP90) (<xref ref-type="bibr" rid="B159">Miller and Fort, 2018</xref>), glycan-binding lectin chaperones including calnexin (CNX) and calreticulin (CRT) (<xref ref-type="bibr" rid="B175">Ni and Lee, 2007</xref>), protein disulfide isomerase (PDI) (<xref ref-type="bibr" rid="B252">Turano et al., 2002</xref>), sigma-1 receptor (Sig-1R) (<xref ref-type="bibr" rid="B236">Su et al., 2010</xref>; <xref ref-type="bibr" rid="B284">Zhemkov et al., 2021</xref>; <xref ref-type="bibr" rid="B48">Dalwadi et al., 2022</xref>) and prefoldin (PFDN) (<xref ref-type="bibr" rid="B229">Siegert et al., 2000</xref>).</p>
<p>HSP70 and HSP90, members of the heat shock protein family, are highly conserved and ubiquitous molecular chaperones (<xref ref-type="bibr" rid="B251">Tsuboyama et al., 2018</xref>). The reversible interaction between HSP70 and peptides plays an important role in protein folding, transport, degradation of misfolded peptides and maintenance of cellular homeostasis (<xref ref-type="bibr" rid="B60">Fern&#x00E1;ndez-Fern&#x00E1;ndez and Valpuesta, 2018</xref>). HSP90 and its co-chaperones coordinate key physiological processes, such as cell survival, cell cycle control, hormone signaling, and apoptosis (<xref ref-type="bibr" rid="B93">Hoter et al., 2018</xref>). Binding immunoglobulin protein (Bip) and glucose-regulated protein 94 (GRP94) are the main HSP70 and HSP90 proteins in the ER. Bip cannot function alone, and the binding and separation between Bip and nascent proteins require the participation of other auxiliary proteins, such as the cochaperone SIL1, the main function of which is to serve as a nucleotide exchange factor (NEF) to assist Bip protein in binding nascent peptide chains and mediating their folding and assembly (<xref ref-type="bibr" rid="B187">Otero et al., 2010</xref>). However, GRP94 expression in the ER is mostly related to tumor cancer and other related diseases (<xref ref-type="bibr" rid="B71">Gewirth, 2016</xref>). CRT and CNX bind Ca<sup>2+</sup> and act as molecular chaperones in the transition of proteins from the ER to the extracellular membrane and regulate Ca<sup>2+</sup> balance in the ER (<xref ref-type="bibr" rid="B246">Tjoelker et al., 1994</xref>). In addition to assisting protein folding consistent with the Sig-1R and PFDN protein, PDI is also involved in the formation and isomerization of disulfide bonds to prevent intermolecular aggregation (<xref ref-type="bibr" rid="B266">Wilkinson and Gilbert, 2004</xref>).</p>
<p>In addition, in the ER, chaperones not only exert their respective functions individually but also interact with each other to maintain ER homeostasis and protein homeostasis. For example, glycan-binding lectin chaperones form the glycosylation-deglucosylation cycle. As a reticulin, CRT is involved in a quality control system for newly synthesized proteins and glycoproteins that relies on multiple additional chaperons, including CNX and protein disulfide isomerase family A member 3 (PDIA3) (<xref ref-type="bibr" rid="B67">Fucikova et al., 2021</xref>). This system is often referred to as the CNX/CRT cycle. The CNX/CRT cycle specifically recognizes glycoproteins linked by N2 glycosidic bonds and is an important monitoring mechanism for protein folding and assembly in eukaryotic cells as well as regulating Ca<sup>2+</sup> homeostasis and Ca<sup>2+</sup> signaling processes (Insert a) in the ER (<xref ref-type="bibr" rid="B88">Helenius and Aebi, 2001</xref>). As a highly conserved molecular chaperone, Bip assists in a wide range of folding processes through its two domains: the nucleotide binding domain (NBD) and the substrate binding domain (SBD) (<xref ref-type="bibr" rid="B149">Mayer and Gierasch, 2019</xref>). When adenosine diphosphate (ADP) binds the NBD, the SBD conformation changes, and the substrate binding affinity of Bip increases. The SBD lid closes on the bound substrate, limiting the conformational freedom of the substrate and protecting the bound substrate from premature folding or aggregation (<xref ref-type="bibr" rid="B89">Hendershot et al., 1996</xref>). The NEF of Bip can break the hydrogen bond contact and detach the bound ADP molecule (<xref ref-type="bibr" rid="B255">Tyson and Stirling, 2000</xref>) so that NBD can bind to the new adenosine triphosphate (ATP) molecule, and the substrate binding affinity is reduced. SBD docks on the NBD and opens the lid to release the bound polypeptide substrate (Insert b). At present, SIL1 and glucose-regulated protein (GRP170) are the two co-chaperones that can bind Bip to promote NEF activity (<xref ref-type="bibr" rid="B273">Yan et al., 2011</xref>). Bip is also a regulator of Ca<sup>2+</sup> homeostasis in the ER, maintaining Ca<sup>2+</sup> balance in the ER (<xref ref-type="bibr" rid="B134">Li&#x00E8;vremont et al., 1997</xref>). In addition, when unfolded/misfolded proteins in the ER exceed the capacity of the protein folding mechanism, Bip can initiate the unfolded protein response (UPR), assist in ER-associated degradation (ERAD), reduce the unfolded/misfolded protein load, and induce autophagy (<xref ref-type="bibr" rid="B259">Wang J. et al., 2017</xref>).</p>
<p>Recent studies have shown that many ER chaperone proteins participate in neural development. Therefore, in this work, we review the regulatory roles of ER chaperones in various stages of central nervous system development as well as recent research progress on related neurodevelopmental diseases.</p>
</sec>
<sec id="S2">
<title>The role of binding immunoglobulin protein in neurodevelopment</title>
<p>Heat shock proteins are a large family of evolutionarily conserved molecular chaperones that play key roles in cell survival and development, and their expression is induced by different factors, including heat shock, nutrient deficiency, hypoxia, and intoxication (<xref ref-type="bibr" rid="B251">Tsuboyama et al., 2018</xref>). HSP70 family plays an essential role in protein folding, transport, degradation of misfolded polypeptides, and maintenance of cellular homeostasis (<xref ref-type="bibr" rid="B60">Fern&#x00E1;ndez-Fern&#x00E1;ndez and Valpuesta, 2018</xref>). Among them, Bip [also known as glucose-regulated protein 78 (GRP78) or heat shock protein A5 (HSPA5)] with a molecular weight of 78 kDa, mainly exists in the ER and is responsible for binding the nascent peptide chain and mediating its folding and assembly (<xref ref-type="bibr" rid="B260">Wang et al., 2009</xref>). Bip cannot perform its functions alone, but other auxiliary proteins are required for its binding and separation from nascent proteins (<xref ref-type="bibr" rid="B187">Otero et al., 2010</xref>). The effects of Bip on neurodevelopmental processes are mainly reflected in embryonic development, cortical neuron migration, and coordination of developmental processes in conjunction with some ER cochaperone proteins.</p>
<sec id="S2.SS1">
<title>Binding immunoglobulin protein regulates the migration and localization of developing cortical neurons</title>
<p>Mutant mice with Bip deficiency die during the embryonic period (<xref ref-type="bibr" rid="B138">Luo et al., 2006</xref>; <xref ref-type="bibr" rid="B102">Jin et al., 2017</xref>), and the main cause of death is abnormal expression of the pulmonary surfactant protein surfactant protein-A (SP-A) and prominently surfactant protein-C (ProSP-C), which subsequently triggers respiratory insufficiency in neonatal or newborn mice and leads to death. In addition to respiratory failure, Bip mutant mice exhibit abnormal neuronal migration and dysplasia. Normal cortical neurogenesis in the ventricular zone (VZ), and newborn neurons migrate to different layers of the cerebral cortex through radial migration (<xref ref-type="bibr" rid="B170">Nadarajah and Parnavelas, 2002</xref>; <xref ref-type="bibr" rid="B143">Mar&#x00ED;n et al., 2010</xref>). Neurons generated earlier migrate to the deep cortex, whereas neurons generated later migration to shallow layers (<xref ref-type="bibr" rid="B72">Ghashghaei et al., 2007</xref>; <xref ref-type="bibr" rid="B121">Kwan et al., 2012</xref>). The subplate (SP), cortical plate (CP), and marginal zone (MZ) are formed in an inside-out migration pattern during development (<xref ref-type="bibr" rid="B36">Caviness, 1982</xref>). However, newborn neurons in Bip mutant mice are the first to migrate to the MZ and remain there, whereas later-born neurons fail to migrate to the upper layers. The mutant brain exhibits an outside-in pattern during neocortical layer formation. This phenotype is observed because loss of Bip affects the expression of reelin, a protein that plays an essential role in neuronal migration. In wild-type mice, reelin-secreting Cajal-Retzius (CR) cells are located in the superficial layer of the cortex. In contrast, CR cells in mutant Bip mice are scattered around the upper layer of the neocortical primordium, and CR cells in Bip mutants do not secrete reelin. Therefore, Bip mutant mice exhibit a phenotype similar to that of reelin knockout mice (<xref ref-type="bibr" rid="B160">Mimura et al., 2008</xref>).</p>
</sec>
<sec id="S2.SS2">
<title>Binding immunoglobulin protein regulates motor neuron development</title>
<p>Heterozygous mutant Bip mice exhibit no significant difference in lifespan compared with wild-type mice, but mutant Bip mice develop renal tubular-interstitial lesions as they age (<xref ref-type="bibr" rid="B115">Kimura et al., 2008</xref>). Some mutant Bip mice develop paralysis and tremors after 12 months. These mice exhibit motor nerve injury symptoms, such as loss of righting reflex, and suffer from paralysis (<xref ref-type="bibr" rid="B103">Jin et al., 2014</xref>). In addition, studies have shown that Bip deletion is associated with the neurodegenerative disease amyotrophic lateral sclerosis (ALS). ALS is a fatal neurodegenerative disease characterized by progressive degeneration of upper and lower motor neurons (<xref ref-type="bibr" rid="B17">Beghi et al., 2011</xref>; <xref ref-type="bibr" rid="B62">Filareti et al., 2017</xref>). In recent years, impaired protein homeostasis has been found to be a key factor in the pathogenesis of ALS (<xref ref-type="bibr" rid="B283">Zhao et al., 2008</xref>; <xref ref-type="bibr" rid="B216">Ruegsegger and Saxena, 2016</xref>), and Bip plays an important role in this process. Studies have found that Bip-deficient mice show more severe neurological decline and spinal motor neuron loss symptoms than normal mice. G&#x00F3;mez-Almer&#x00ED;a et al. created mutant superoxide dismutase 1 (mSOD1) and Bip double mutant (mSOD1/Bip+/-) mice to study the role of Bip in a mouse model of the neurodegenerative disease ALS (<xref ref-type="bibr" rid="B78">G&#x00F3;mez-Almer&#x00ED;a et al., 2021</xref>). They found that knockout of Bip show more intense neurological decline than mSOD1 single knockout mice. Then, to determine the relationship between the Bip protein and the pathogenesis of ALS, they also discussed the potential relationship between the Bip protein and the type-1 cannabinoid (CB1) receptor that mediates neuroprotection. CB1 receptor is mainly located in neurons of the central nervous system (<xref ref-type="bibr" rid="B40">Chiarlone et al., 2014</xref>). Numerous studies have reported that CB1 receptor-mediated neuroprotection is related to ALS (<xref ref-type="bibr" rid="B1">Abood et al., 2001</xref>; <xref ref-type="bibr" rid="B213">Rossi et al., 2010</xref>). They found that in mSOD1 mice with partial Bip gene deletion, the level of the CB1 receptor was significantly decreased, which indirectly indicated that Bip may play a neuroprotective role in ALS (<xref ref-type="bibr" rid="B78">G&#x00F3;mez-Almer&#x00ED;a et al., 2021</xref>). Similarly, Apolloni et al. found that increasing Bip and Hsp70 protein levels in the spinal cord and cortex of ALS model mice could rescue the loss of motor neuron dendritic spines (<xref ref-type="bibr" rid="B5">Apolloni et al., 2019</xref>). These studies suggest that Bip plays vital roles in motor neuron development.</p>
</sec>
<sec id="S2.SS3">
<title>Binding immunoglobulin protein regulates the plasticity of the central nervous system</title>
<p>Studies have shown that the interaction between Bip and N-methyl-D-aspartate (NMDA) receptors may affect synaptic transmission. NMDA receptors play essential roles in brain development, plasticity, and pathology. Functional NMDA receptors are tetramers mainly composed of two GluN1 subunits and two GluN2 regulatory subunits (<xref ref-type="bibr" rid="B46">Cull-Candy et al., 2001</xref>; <xref ref-type="bibr" rid="B274">Yashiro and Philpot, 2008</xref>). The number and composition of GluN2A and GluN2B containing NMDA receptors at synapses are dynamically regulated during development and neuronal activation, which is thought to control synaptic plasticity (<xref ref-type="bibr" rid="B171">Nase et al., 1999</xref>; <xref ref-type="bibr" rid="B137">Lopez de Armentia and Sah, 2003</xref>; <xref ref-type="bibr" rid="B135">Liu et al., 2004</xref>). Using immunoprecipitation, the authors examined the distribution of Bip in neurons and found that Bip is strongly expressed in both cortical and hippocampal neuronal cell bodies and neurites. Furthermore, Bip co-localizes with GluN2A in cultured cortical neuron dendrites, and preventing the binding of Bip to GluN2A reduces synaptic transmission and impairs memory formation (<xref ref-type="bibr" rid="B282">Zhang et al., 2015</xref>).</p>
</sec>
<sec id="S2.SS4">
<title>Binding immunoglobulin protein and SIL1 jointly regulate neural development</title>
<p>SIL1 is a 54-kDa ER protein composed of 461 amino acids and is a NEF for Bip (<xref ref-type="bibr" rid="B259">Wang J. et al., 2017</xref>). As an auxiliary protein of Bip, the synergistic effect of SIL1 and Bip has consistently been a research hotspot. The central nervous system of mice with SIL1 deficiency exhibits developmental defects, including abnormal neuronal morphological development, cortical neuron migration, and localization (<xref ref-type="bibr" rid="B95">Inaguma et al., 2014</xref>).</p>
<sec id="S2.SS4.SSS1">
<title>SIL1-binding immunoglobulin protein coordinately regulates neuronal migration</title>
<p>SIL1 plays a role in neuronal migration in the neocortex. Inaguma et al. constructed a SIL1 knockout plasmid, transfected it into the neural progenitor cells of the VZ of the embryonic mouse brain through <italic>in utero</italic> electroporation (<xref ref-type="bibr" rid="B240">Tabata and Nakajima, 2001</xref>; <xref ref-type="bibr" rid="B178">Nishimura et al., 2012</xref>) and observed the localization of the transfected cells at the post-natal day 0 (P0). In the control group, neurons normally migrated to the superficial layers (layers II-IV) of the CP, whereas the SIL1-deficient neurons remained in the middle or lower layers of the CP. Then, the authors performed immunostaining to assess the differentiation status of the abnormally localized cells and found that the abnormally localized cells remained in the immature neuronal state (NPCs or basal progenitor cells) (<xref ref-type="bibr" rid="B95">Inaguma et al., 2014</xref>).</p>
<p>Considering that SIL1 acts as a chaperone for Bip and regulates its function, Bip may also be involved in neuronal migration. Therefore, Inaguma et al. also examined the role of Bip in neuronal migration during cortical formation and compared it with SIL1. They found that a large fraction of Bip-deficient (through RNA interference) neural progenitor cells, which remain in the lower part of CP, intermediate zone (IZ), and subventricular zone (SVZ)/VZ at P0, exhibit a phenotype similar to that of SIL1-deficient cells. Bip-deficient neurons showed delayed migration at embryonic day 17 (E17) but localized in normal positions at post-natal day 7 (P7). However, after inhibiting the SIL1-Bip interaction, neuronal migration was significantly inhibited. In conclusion, the coordination function of SIL1 and Bip plays a key role in neuronal migration (<xref ref-type="bibr" rid="B95">Inaguma et al., 2014</xref>).</p>
</sec>
<sec id="S2.SS4.SSS2">
<title>SIL1 and binding immunoglobulin protein jointly regulate reelin protein and affect development</title>
<p>In addition to regulating neuronal migration during cortical development, Reelin is currently believed to be involved in neuronal dendrite development and changes in brain plasticity (<xref ref-type="bibr" rid="B179">Niu et al., 2004</xref>; <xref ref-type="bibr" rid="B104">Jossin and Goffinet, 2007</xref>). The distribution of cortical neurons in heterozygous reeler (Reelin knockout) mice did not appear disordered, but their dendritic development was affected. Dendritic spine density decreased on the dendrites of pyramidal neurons in the CA1 region of the mouse hippocampus at 21 and 32 days after birth, whereas more mature neurons showed a lower density of dendritic spines accompanied by decreased expression levels of post-synaptic density protein 95 (PSD95) and NMDA receptors (<xref ref-type="bibr" rid="B180">Niu et al., 2008</xref>). These findings indicate that Reelin promotes dendritic development and the generation and maintenance of dendritic spines during post-natal development. The loss of Bip is one of the reasons for the down-regulation of Reelin protein, indicating that Bip may affect the development of dendrites and dendritic spines by affecting Reelin protein expression. Loss of SIL1, Bip, or Reelin function leads to similar abnormal phenotypes of neuronal migration (<xref ref-type="bibr" rid="B129">Leemhuis and Bock, 2011</xref>; <xref ref-type="bibr" rid="B235">Stranahan et al., 2013</xref>), and the loss of function of the ER molecular chaperone Bip inhibits normal Reelin expression. Thus, the relationship among these three proteins during neural development and whether the role played by Reelin protein in development is co-regulated by the coordination of Bip and SIL1 represent questions that deserve to be explored.</p>
</sec>
</sec>
</sec>
<sec id="S3">
<title>The role of calnexin during neurodevelopment</title>
<p>Calnexin is a 90-kDa ER integral protein with a long amino-terminal domain (460 amino acids) located in the lumen of the ER, a hydrophobic <italic>trans</italic>-membrane domain and a short acidic cytoplasmic domain (91 amino acids). CNX binds to Ca<sup>2+</sup> and acts as a chaperone in the transition of proteins from the ER to the outer membrane (<xref ref-type="bibr" rid="B246">Tjoelker et al., 1994</xref>). CNX and CRT constitute the CNX/CRT cycle and are responsible for the folding and quality control of newly synthesized proteins (<xref ref-type="bibr" rid="B132">Li et al., 2011</xref>).</p>
<p>Many researchers have confirmed the role of CNX as a molecular chaperone in neurodevelopment. The <italic>CANX</italic> gene (coding CNX) is activated in neuronal tissue early in embryonic development (<xref ref-type="bibr" rid="B41">Coe et al., 2008</xref>). Immunohistochemical staining of mouse brain tissue sections showed that CNX exists in hippocampal neurons and is expressed at high levels in soma, dendrites, and synapses (<xref ref-type="bibr" rid="B100">Itakura et al., 2013</xref>). Additional studies have shown that in mice, CNX deficiency leads to a phenotype of peripheral axonal demyelination and reduced peripheral nerve conduction velocity, demonstrating that CNX may play an essential role in neuron growth and development (<xref ref-type="bibr" rid="B105">Jung et al., 2018</xref>).</p>
<sec id="S3.SS1">
<title>Calnexin regulates dendrite and synapse development</title>
<p>Denzel et al. found that approximately 50% of CNX knockout mice died within 48 h after birth, most of the remaining mice died within 4 weeks, and only a few mice survived to 3 months (<xref ref-type="bibr" rid="B52">Denzel et al., 2002</xref>). CNX gene knockout (<italic>cnx</italic><sup>&#x2013;/&#x2013;</sup>) mice exhibited significant movement impairment, including unsteady gait, inactive walking, and obvious trunk ataxia. The authors then examined the sciatic nerve in the gene-deficient mice through electron microscopy and found that most of the mice exhibited a reduced number of medullary nerve fibers and a reduced sciatic nerve diameter (<xref ref-type="bibr" rid="B52">Denzel et al., 2002</xref>). However, the cause of the short-lived death of <italic>cnx</italic><sup>&#x2013;/&#x2013;</sup> mice has not yet been discovered but might be related to the coordinating role of CNX proteins in development. This hypothesis deserves further exploration.</p>
<p>Recent studies assessing the localization of CNX and NMDA receptors on neurons based on specific immunostaining and biotin chemical reagent labeling revealed that a considerable portion of CNX was localized on the cell surface of cultured neurons, and this localization was regulated by NMDA receptors (<xref ref-type="bibr" rid="B100">Itakura et al., 2013</xref>). These results suggest that CNX may play an essential role in NMDA receptor-mediated neuronal function. Other studies demonstrated that &#x03B1;-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors interact with CNX and Bip in neuronal cell bodies and hippocampal pyramidal neuron dendrites (<xref ref-type="bibr" rid="B215">Rubio and Wenthold, 1999</xref>; <xref ref-type="bibr" rid="B70">Gerrow and Triller, 2010</xref>). In addition, the AMPA receptor is a tetramer composed of four subunits, GluA1, GluA2, GluA3, and GluA4. This receptor is expressed in both neurons and glial cells (<xref ref-type="bibr" rid="B198">Pick and Ziff, 2018</xref>). It is well known that NMDA receptors and AMPA receptors play essential roles in central nervous system development. NMDA receptors are involved in experience-dependent synapse and dendritic development (<xref ref-type="bibr" rid="B170">Nadarajah and Parnavelas, 2002</xref>; <xref ref-type="bibr" rid="B138">Luo et al., 2006</xref>), whereas AMPA receptor expression directly affects neuronal dendritic complexity, synaptic maturation, and neural network formation (<xref ref-type="bibr" rid="B30">Buffington et al., 2014</xref>). Defects in AMPA receptor expression are the underlying causes of developmental diseases, degenerative diseases, and cognitive dysfunction (<xref ref-type="bibr" rid="B113">Kessels and Malinow, 2009</xref>; <xref ref-type="bibr" rid="B90">Henley and Wilkinson, 2016</xref>; <xref ref-type="bibr" rid="B80">Guo and Ma, 2021</xref>). However, the specific effects of CNX loss on NMDA receptor or AMPA receptor membrane expression or function remain to be investigated. Moreover, studies have shown that CNX can be attached to membranes through NMDA receptor-mediated pathways (<xref ref-type="bibr" rid="B100">Itakura et al., 2013</xref>). Therefore, CNX may regulate central development by participating in receptor function at the cell membrane. In addition, CNX regulates calcium levels in the ER (<xref ref-type="bibr" rid="B210">Roderick et al., 2000</xref>), which subsequently regulates receptor transport to influence synaptic strength (<xref ref-type="bibr" rid="B254">Turrigiano, 2008</xref>). Therefore, CNX may directly affect synaptic strength and synaptic development through this mechanism. However, the direct correlation between CNX and synaptic development and function needs to be expanded.</p>
</sec>
<sec id="S3.SS2">
<title>Calnexin cooperates with the cytoskeleton-associated protein to regulate neural plasticity</title>
<p>Activity-regulated cytoskeleton-associated (Arc) protein is a master regulator of long-term synaptic plasticity and memory formation (<xref ref-type="bibr" rid="B28">Bramham et al., 2010</xref>; <xref ref-type="bibr" rid="B116">Korb and Finkbeiner, 2011</xref>; <xref ref-type="bibr" rid="B226">Shepherd and Bear, 2011</xref>; <xref ref-type="bibr" rid="B176">Nikolaienko et al., 2017</xref>). Arc proteins control synaptic strength by promoting AMPA receptor endocytosis (<xref ref-type="bibr" rid="B49">DaSilva et al., 2016</xref>) and activity-dependent long-term changes in synaptic strength (<xref ref-type="bibr" rid="B56">Ehlers, 2000</xref>; <xref ref-type="bibr" rid="B174">Newpher and Ehlers, 2008</xref>). Arc overexpression decreased the density of GluA1 subunits of AMPA receptors on the cell surface and AMPA receptor-mediated miniature excitatory post-synaptic currents (mEPSCs). Arc mutations that prevent clathrin-adaptor protein 2 (AP-2) interaction reduce Arc-mediated endocytosis of GluA1 and abrogate AMPA receptor-mediated mEPSCs reduction (<xref ref-type="bibr" rid="B49">DaSilva et al., 2016</xref>). Endocytosis is the process by which cells internalize substances through the plasma membrane. Endocytosis plays an important role in different stages of the development of the nervous system, such as the formation of continuous synaptic transmission (<xref ref-type="bibr" rid="B238">Sudhof, 2004</xref>), the entry of drugs into the central nervous system (<xref ref-type="bibr" rid="B230">Smith et al., 2008</xref>), and the internalization of receptor-ligand complexes to nerve endings for intracellular signaling (<xref ref-type="bibr" rid="B76">Gloor et al., 2001</xref>). CNX is also involved in clathrin-mediated endocytosis of neurons (<xref ref-type="bibr" rid="B132">Li et al., 2011</xref>). Kraus et al. performed an electron microscopy analysis of the cerebellum of 7-day-old wild-type and CNX-null mice to assess whether CNX is involved in neuronal endocytosis. The results showed that the number of synaptic vesicles was significantly increased in the cerebellum of CNX-deficient mice compared with wild-type mice, demonstrating that CNX deficiency leads to increased endocytic activity in the mouse neuronal system (<xref ref-type="bibr" rid="B118">Kraus et al., 2010</xref>). Recent studies have found a direct interaction between Arc and CNX in neurons, and the interaction between recombinantly expressed glutathione S-transferase (GST)-tagged Arc and endogenous CNX has also been found in HEK293, SH-SY5Y neuroblastoma, and PC12 cells (<xref ref-type="bibr" rid="B169">Myrum et al., 2017</xref>). Given that both Arc and CNX mediate clathrin-dependent endocytosis and that both are expressed in excitatory synapses, it is possible that Arc and CNX cooperate in regulating endocytosis. Therefore, whether CNX is involved in the synaptic effect is also a mechanism that needs further exploration.</p>
</sec>
</sec>
<sec id="S4">
<title>Calreticulin regulates neurodevelopment</title>
<p>Calreticulin is a multifunctional protein with a molecular weight of 46 kDa. CRT is expressed in almost all eukaryotic cells and is preferentially located in the ER. Depending on the sublocalization of CRT in cells, CRT has different physiological functions, including chaperone function and lectin binding. CRT was initially considered to be a high-affinity calcium-binding protein (<xref ref-type="bibr" rid="B205">Rauch et al., 2000</xref>), and early studies focused on its role as a calcium storage molecule in the ER (<xref ref-type="bibr" rid="B157">Michalak et al., 1992</xref>), including regulating calcium channel activation and maintaining intracellular calcium homeostasis (<xref ref-type="bibr" rid="B39">Chen et al., 2015</xref>). Later, CRT was considered a multifunctional protein that interacts with other proteins and participates in various processes (<xref ref-type="bibr" rid="B156">Michalak et al., 1999</xref>). In recent years, the focus of CRT research has been refocused to its role as an ER chaperone that aids in glycoprotein folding (<xref ref-type="bibr" rid="B189">Pacheco et al., 2020</xref>). The role of CRT in neurodevelopment mainly involves regulating embryonic development, neural differentiation, and axonal growth in the peripheral nervous system.</p>
<sec id="S4.SS1">
<title>Calreticulin regulates embryonic development of the central nervous system</title>
<p>To study the role of CRT during development <italic>in vivo</italic>, Rauch et al. generated CRT-deficient mice by targeted inactivation of the CRT gene. The results demonstrated that CRT heterozygous mice were viable and fertile, whereas <italic>crt</italic><sup>&#x2013;/&#x2013;</sup> mice were embryonic lethal and exhibited multiple disease phenotypes, including cardiomyopathy, anencephaly, and omphalocele (<xref ref-type="bibr" rid="B205">Rauch et al., 2000</xref>). In addition, CRT is also important for cranial neural tube closure and is highly expressed in the developing brain during neurogenesis (<xref ref-type="bibr" rid="B155">Mesaeli et al., 1999</xref>). Neural tube formation is a complex process that requires the interaction of neuroepithelial cells and the underlying mesenchyme (<xref ref-type="bibr" rid="B139">Lynch et al., 2012</xref>; <xref ref-type="bibr" rid="B42">Correll et al., 2019</xref>). Disruption of neural tube closure was found in several CRT knockout mice, in which proteins involved in neuronal migration and calcium signaling were inactivated (<xref ref-type="bibr" rid="B233">Solheim et al., 1997</xref>; <xref ref-type="bibr" rid="B205">Rauch et al., 2000</xref>). These results demonstrate that CRT is important for embryonic brain development, especially the neural tube development. However, it is currently unclear which proteins interact with CRT to regulate embryonic neural development.</p>
</sec>
<sec id="S4.SS2">
<title>Calreticulin regulates neuronal differentiation</title>
<p>Neurotrophic factors, including nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophic factor-3 (NT-3), and neurotrophic factor-4/5 (NT-4/5), are key tissue factors that control nervous system development (<xref ref-type="bibr" rid="B37">Chao, 2003</xref>). The NGF/tyrosine receptor kinase A (TrkA) signaling pathway is necessary for neural development, and abnormalities in this pathway can lead to abnormal neuronal differentiation. Shih et al. found that in NGF-stimulated PC12 cell differentiation, CRT levels were increased by activation of mitogen-activated protein kinase (MAPK) mediated by extracellular signal-regulated kinase (ERK). CRT deficiency significantly reduced NGF-induced neuronal differentiation. Furthermore, CRT overexpression enhanced neuronal differentiation through simultaneous activation of the ERK-dependent MAPK pathway (<xref ref-type="bibr" rid="B227">Shih et al., 2012</xref>). The Ca<sup>2+</sup> regulation ability of CRT is also essential for NGF-triggered neuronal differentiation (<xref ref-type="bibr" rid="B199">Pilquil et al., 2020</xref>). In addition, studies have shown that CRT is a novel oncogenic N-MYC (MYCN) inhibitor that can down-regulate MYCN promoter activity and protein expression to regulate neuronal differentiation. This study also found that CRT-mediated MYCN inhibition resulted in increased neurite length (<xref ref-type="bibr" rid="B127">Lee et al., 2019</xref>).</p>
</sec>
<sec id="S4.SS3">
<title>Calreticulin regulates axonal growth in the peripheral nervous system</title>
<p>Calreticulin localizes to axons of cultured dorsal root ganglion neurons <italic>in vitro</italic> and peripheral nervous system axons <italic>in vivo</italic> (<xref ref-type="bibr" rid="B268">Willis et al., 2005</xref>; <xref ref-type="bibr" rid="B258">Vuppalanchi et al., 2010</xref>), and automatic axonal regeneration occurs after injury to adult peripheral neurons (<xref ref-type="bibr" rid="B27">Bradke et al., 2012</xref>). The intrinsic growth capacity of peripheral nervous system axons after injury is greater than that of central nervous system axons. Pacheco et al. constructed <italic>in vitro</italic> and <italic>in vivo</italic> neuronal axonal injury models to study the relationship between CRT and axonal regeneration after axonal injury. Intra-axonal CRT levels were elevated after peripheral nerve injury <italic>in vivo</italic>. Unilateral sciatic nerve crush injury was performed in the mid-thigh of male SD rats, and then sciatic nerve sections were collected and stained 1 h, 6 h, 18 h, and 7 days after the crush injury. Compared with the control sciatic nerve, axonal CRT levels were significantly increased 6 h after injury and reached a maximum at 18 h after injury. The authors then performed axotomy on dorsal root ganglion neurons to study the effect of CRT deletion on the post-operative axonal growth process. The results showed that the shRNA-mediated CRT deletion group exhibited exacerbated post-axotomy contractions. In contrast, axon-targeted expression of unrestricted CRT mRNA reduces contraction and promotes axon regeneration after axotomy <italic>in vitro</italic> (<xref ref-type="bibr" rid="B189">Pacheco et al., 2020</xref>). In conclusion, the overexpression of axon-targeted CRT promotes axon regeneration after axonal injury, indicating that CRT plays an important role in axonal growth.</p>
</sec>
</sec>
<sec id="S5">
<title>The role of protein disulfide isomerase in neurodevelopment</title>
<p>Protein disulfide isomerase is a class of multifunctional proteins present in the ER lumen, including endoplasmic reticulum protein 57 (ERp57, also known as PDIA3), endoplasmic reticulum protein 29 (ERp29), protein disulfide isomerase-1 (PDI-1), endoplasmic reticulum protein 72 (ERp72), protein disulfide isomerase A1 (PDIA1), and protein disulfide isomerase p (PDI p) (<xref ref-type="bibr" rid="B252">Turano et al., 2002</xref>). As a molecular chaperone, PDI binds to the stretched or partially folded peptide chain through its polypeptide binding site to form an intermediate to prevent incorrect protein folding (<xref ref-type="bibr" rid="B266">Wilkinson and Gilbert, 2004</xref>).</p>
<sec id="S5.SS1">
<title>Protein disulfide isomerase-1 regulates neuronal migration</title>
<p>Protein disulfide isomerase-1 controls neuronal migration by regulating Wnt secretion. PDI is a family of protein chaperones that reside in the ER and are capable of catalyzing the formation (oxidation), cleavage (reduction), and rearrangement (isomerization) of disulfide bonds (<xref ref-type="bibr" rid="B266">Wilkinson and Gilbert, 2004</xref>). The formation of a proper Wnt protein structure requires the formation of disulfide bonds, which are critical for Wnt secretion and signaling (<xref ref-type="bibr" rid="B279">Zhang X. et al., 2012</xref>; <xref ref-type="bibr" rid="B141">MacDonald et al., 2014</xref>). Wnt proteins play essential roles in neuronal migration and axon-dendritic guidance in vertebrates (<xref ref-type="bibr" rid="B275">Yoshikawa et al., 2003</xref>; <xref ref-type="bibr" rid="B22">Bocchi et al., 2017</xref>), and they also control neural developmental processes in <italic>C. elegans</italic>, including neuronal migration, polarity, and axon guidance (<xref ref-type="bibr" rid="B43">Coudreuse et al., 2006</xref>; <xref ref-type="bibr" rid="B91">Hilliard and Bargmann, 2006</xref>; <xref ref-type="bibr" rid="B190">Pan et al., 2006</xref>). Therefore, abnormal Wnt expression or function significantly impairs neural development.</p>
<p>PDI-1 controls the secretion of EGL-20, the Wnt homolog in <italic>C. elegans</italic>, and therefore affects neuron migration (<xref ref-type="bibr" rid="B247">Torpe et al., 2019</xref>). EGL-20/Wnt is expressed and secreted in subcutaneous (epidermal) and muscle cell subsets of <italic>C. elegans</italic> (<xref ref-type="bibr" rid="B265">Whangbo and Kenyon, 1999</xref>). EGL-20 function is critical for the migration of hermaphroditism-specific neuron (HSN) (<xref ref-type="bibr" rid="B53">Desai et al., 1988</xref>). Torpe et al. used HSN development as a readout of EGL-20 function to identify molecules that control Wnt maturation and secretion. They hypothesized that PDI is important for EGL-20-directed HSN development. The expression of five PDI-encoding genes (pdi-1, pdi-2, pdi-3, pdi-6, and C14B9.2) in <italic>C. elegans</italic> was reduced using RNA interference, and the development of HSN was analyzed. This study found a specific requirement for PDI-1 during HSN development with approximately 20% of PDI-1-silenced animals exhibiting a phenotype deficient in HSN migration. Subsequently, to determine whether PDI-1 also controls EGL-20-dependent post-embryonic neuron development, the authors performed post-embryonic neuronal migration assays in PDI-1-deficient animals and found that PDI-1 knockout animals exhibited migration defects (<xref ref-type="bibr" rid="B247">Torpe et al., 2019</xref>). PDI inhibitors reduce Wnt3a secretion in human cells. Most mammalian genomes contain 19 Wnts and greater than 20 PDI proteins, which exhibit distinct expression domains and biological functions (<xref ref-type="bibr" rid="B57">Ellgaard and Ruddock, 2005</xref>; <xref ref-type="bibr" rid="B69">Galligan and Petersen, 2012</xref>; <xref ref-type="bibr" rid="B267">Willert and Nusse, 2012</xref>). Mammalian Wnt3a secretion was abolished when a single cysteine residue was replaced by alanine (<xref ref-type="bibr" rid="B141">MacDonald et al., 2014</xref>), suggesting that Wnt secretion is influenced by disulfide coordination. These results suggest that PDI can affect neuronal migration by regulating the secretion of Wnt and its homolog EGL-20.</p>
<p>The role of the Wnt signaling pathway in early cortical development is not limited to the migratory localization of neurons. It is also involved in neurogenesis, neuronal differentiation, and axon-dendritic guidance (<xref ref-type="bibr" rid="B64">Freese et al., 2010</xref>; <xref ref-type="bibr" rid="B168">Munji et al., 2011</xref>). In addition, the atypical Wnt signaling pathway is involved in the assembly of neural circuits (<xref ref-type="bibr" rid="B92">Hinata et al., 2007</xref>; <xref ref-type="bibr" rid="B262">Wang et al., 2011</xref>), especially dendrite development and synaptogenesis in cultured pyramidal neurons (<xref ref-type="bibr" rid="B222">Salinas and Zou, 2008</xref>). Wnt pathway dys-regulation is closely related to human neurological diseases (<xref ref-type="bibr" rid="B35">Castelo-Branco et al., 2003</xref>). However, the mechanism by which PDI further affects other developmental processes by affecting the Wnt signaling pathway is unclear and deserves further exploration.</p>
</sec>
</sec>
<sec id="S6">
<title>The role of sigma-1 receptor in neurodevelopment</title>
<p>Sigma-1 receptor is a 223-amino acid long <italic>trans</italic>-membrane ER chaperone with a molecular weight of 25.3 kDa (<xref ref-type="bibr" rid="B83">Hanner et al., 1996</xref>; <xref ref-type="bibr" rid="B48">Dalwadi et al., 2022</xref>). Most Sig-1R proteins are located in the ER, especially in the mitochondria-associated ER membrane, and are critical for regulating energy balance and calcium homeostasis (<xref ref-type="bibr" rid="B86">Hayashi and Su, 2007</xref>). Sig-1R is highly expressed in the central nervous system, especially in the cortex, basal ganglia, spinal cord, and brainstem. It is also vital to maintain the proper functioning of motor neurons (<xref ref-type="bibr" rid="B236">Su et al., 2010</xref>). Sig-1R has recently attracted extensive attention as a potential drug target for neurological diseases and cancer (<xref ref-type="bibr" rid="B154">Merlos et al., 2017</xref>; <xref ref-type="bibr" rid="B193">Penke et al., 2018</xref>).</p>
<p>Recently, Sig-1R was shown to be important in neurodevelopmental research as an ER chaperone and is known to be involved in learning and memory. Within the nervous system, Sig-1R is predominantly localized in the gray matter of neurons and multiple glial cell types (<xref ref-type="bibr" rid="B195">Peviani et al., 2014</xref>; <xref ref-type="bibr" rid="B209">Robson et al., 2014</xref>). In addition to its role in regulating intercellular signaling (<xref ref-type="bibr" rid="B236">Su et al., 2010</xref>), neuroprotection (<xref ref-type="bibr" rid="B218">Ruscher et al., 2011</xref>), neural recovery (<xref ref-type="bibr" rid="B217">Ruscher et al., 2012</xref>), neuroplasticity (<xref ref-type="bibr" rid="B117">Kourrich et al., 2012</xref>), and neurotransmitter release (<xref ref-type="bibr" rid="B285">Zheng, 2009</xref>), Sig-1R also regulates various neural developmental processes, such as hippocampal neuronal dendritic morphogenesis, dendritic spine maturation, and neuroplasticity.</p>
<sec id="S6.SS1">
<title>Sigma-1 receptor regulates neuronal morphogenesis</title>
<p>Sigma-1 receptor regulates neurite outgrowth (<xref ref-type="bibr" rid="B98">Ishima et al., 2014</xref>) as well as primary neuron morphogenesis (<xref ref-type="bibr" rid="B97">Ishima and Hashimoto, 2012</xref>). Dendritic spines in hippocampal neurons play important roles in neuroplasticity and memory formation. siRNAs were used to silence the expression of Sig-1R to study their role in the morphogenesis of primary hippocampal neurons <italic>in vitro</italic>. The results showed impaired dendrite extension and branching after Sig-1R gene silencing. Moreover, Sig-1Rs also have a major impact on the formation and maturation of dendritic spines in later stages (<xref ref-type="bibr" rid="B250">Tsai et al., 2009</xref>). In rat hippocampal primary neurons, reducing the expression of Sig-1Rs by siRNA resulted in defects in dendritic spine formation. Tsai et al. observed and analyzed the dendritic spine morphology and maturity of cultured hippocampal neurons. On DIV 16, the control group neurons formed filamentous protrusions on the dendrites. On DIV 22, control neurons formed clusters of short, thick mushroom-like spine heads without filopodia, indicating spine maturation. In contrast, Sig-1R-siRNA-transfected (siSig-1R-tf) neurons formed elongated protrusions with a few spine heads at the tips. The longer the culture time, the more pronounced the abnormal phenotype. This finding suggests that Sig-1Rs are endogenous regulators of hippocampal dendritic spine formation (<xref ref-type="bibr" rid="B250">Tsai et al., 2009</xref>).</p>
</sec>
<sec id="S6.SS2">
<title>Sigma-1 receptor regulates synaptic function</title>
<p>Sigma-1 receptor also plays an important role in the development of synaptic function (<xref ref-type="bibr" rid="B220">Ryskamp et al., 2019</xref>). Active synapses express specific proteins and receptors for proper function. Studies have shown that Sig-1R knockdown inhibits functional synapse formation. GluA2, GluA3, and PSD-95 staining revealed a strong immune response on dendritic spines in control neurons. However, this response was not observed in filopodia protrusions of siSig-1R-tf neurons, whereas these proteins were still present in dendritic shafts. The axonal terminals of siSig-1R-tf neurons also showed significantly reduced immune responses to synaptophysin. Neurons labeled with FM4-64, a membrane-selective red fluorescent dye, were depolarized with KCl to measure synaptic activity. The results showed that siSig-1R-tf neurons did not form functional synapses. These results suggest that Sig-1Rs have essential effects on synapse formation and synaptic function (<xref ref-type="bibr" rid="B220">Ryskamp et al., 2019</xref>).</p>
<p>Earlier, we mentioned that the NMDA receptor is associated with learning and memory. A study found that changes in Sig-1R can cause changes in NMDA receptor expression. Sig-1R was overexpressed by intraperitoneal injection of the Sig-1R activation agonist SKF10,047 in SD rats, and subsequent immunofluorescence staining revealed increased GluN2A, GluN2B, and PSD95 expression (<xref ref-type="bibr" rid="B50">de Montigny et al., 1992</xref>; <xref ref-type="bibr" rid="B162">Monnet et al., 1994</xref>, <xref ref-type="bibr" rid="B161">1996</xref>). This effect was abolished after the addition of the Sig-1R antagonist BD1063 (<xref ref-type="bibr" rid="B145">Matsumoto et al., 1995</xref>; <xref ref-type="bibr" rid="B151">McCracken et al., 1999</xref>). In addition, they found increased interactions between Sig-1R and GluN2 subunits as well as increased surface levels of NMDA receptor upon Sig-1R activation, which suggests that Sig-1R regulates the expression of NMDA receptor and related neural function (<xref ref-type="bibr" rid="B188">Pabba et al., 2014</xref>).</p>
</sec>
<sec id="S6.SS3">
<title>Sigma-1 receptor regulates mitochondrion-associated endoplasmic reticulum membrane conduction and affects neural development</title>
<p>The membrane of the ER of a cell forms contacts directly with mitochondria, and the contact is referred to as the mitochondrion-associated ER membrane (MAM) (<xref ref-type="bibr" rid="B165">Mori et al., 2013</xref>). The MAM is a subdomain of the ER that engages in a direct physical association with mitochondria (<xref ref-type="bibr" rid="B208">Rizzuto et al., 2004</xref>; <xref ref-type="bibr" rid="B45">Csord&#x00E1;s et al., 2006</xref>; <xref ref-type="bibr" rid="B239">Szabadkai et al., 2006</xref>). The MAM integrates many signaling pathways and is important for cellular survival because it serves as the &#x201C;tunnel&#x201D; for lipid transport and Ca<sup>2+</sup> signaling between the ER and mitochondria (<xref ref-type="bibr" rid="B33">C&#x00E1;rdenas et al., 2010</xref>). Sig-1Rs are ER chaperones that localize specifically at the MAM and regulate a variety of cellular functions including Ca<sup>2+</sup> signaling between ER and mitochondria, neuronal differentiation, ion channel activities, and notably cellular survival (<xref ref-type="bibr" rid="B10">Aydar et al., 2002</xref>; <xref ref-type="bibr" rid="B63">Fontanilla et al., 2009</xref>; <xref ref-type="bibr" rid="B68">Fukunaga and Moriguchi, 2017</xref>). However, exactly how Sig-1R regulates the neuronal differentiation process at the MAM is not fully clarified. Neurons are highly differentiated cells and require great amounts of ATP for the maintenance of cell membrane ionic gradients and neurotransmission (<xref ref-type="bibr" rid="B271">Xavier et al., 2016</xref>). Mitochondria, the main intracellular energy transducers, play a key role in neural development by producing ATP and biosynthetic substrates, regulating Ca<sup>2+</sup> homeostasis, and initiating apoptosis (<xref ref-type="bibr" rid="B107">Kann and Kov&#x00E1;cs, 2007</xref>). Given the vital role of Sig-1R in the MAM and the importance of energy transport for neural development, exploring the energy transduction mechanism of Sig-1R in the MAM may be key to studying the developmental process.</p>
</sec>
</sec>
<sec id="S7">
<title>The function of prefoldin during neurodevelopment</title>
<p>Prefoldin is a heterohexameric protein complex (<xref ref-type="bibr" rid="B77">Glover and Clark, 2015</xref>) consisting of two &#x03B1; subunits (PFDN3 and PFDN5) and four &#x03B2; subunits (PFDN1, PFDN2, PFDN4, and PFDN6). PFDN interacts with nascent polypeptide chains and can act as a substitute for Hsp70 <italic>in vitro</italic> to facilitate protein folding and prevent intermolecular aggregation (<xref ref-type="bibr" rid="B229">Siegert et al., 2000</xref>). In recent years, studies have found that PFDN regulates the toxicity of misfolded proteins, including those that lead to neurodegenerative diseases. For example, PFDN can protect neuronal cells from polyglutamine toxicity by preventing aggregate formation or maintaining proteostasis by unfolding misfolded proteins in physiopathological conditions (<xref ref-type="bibr" rid="B244">Tashiro et al., 2013</xref>; <xref ref-type="bibr" rid="B241">Tahmaz et al., 2022</xref>). PFDN-deficient mice exhibit phenotypic features of defective cytoskeletal function, including ciliary dyskinesia, neuronal loss, and defects in B- and T-cell development and function. As ubiquitous components of the cytoskeleton, actin and tubulin play essential roles in multiple stages of neural development, including dendritic axon growth, neuronal polarization, neuronal migration, and synaptic signal transduction (<xref ref-type="bibr" rid="B31">Cao et al., 2008</xref>; <xref ref-type="bibr" rid="B20">Bertling and Hotulainen, 2017</xref>), whereas efficient synthesis of actin and tubulin requires the participation of the protein complex formed by PFDN and t-complex protein 1 ring complex (TRiC)/chaperonin-containing t-complex protein 1 (CCT). As an ER chaperone, PFDN promotes the post-translational folding of actin and other cytoskeletal proteins through the t-complex protein 1 (TCP1)-containing loop complex chaperone TRiC (<xref ref-type="bibr" rid="B31">Cao et al., 2008</xref>). PFDN and TCP1 play essential roles in metazoan development. In <italic>C. elegans</italic>, RNA interference screens revealed that knockdown of a single PFDN or TCP1 subunit resulted in morphological abnormalities and distinct penetrating embryonic lethal phenotypes (<xref ref-type="bibr" rid="B51">Delgehyr et al., 2012</xref>), suggesting that these proteins are essential in multiple tissue development and early embryonic development (<xref ref-type="bibr" rid="B163">Monzo et al., 2010</xref>). In contrast, PFDN1-deficient mice develop defective cytoskeletal function, loss of neural tracts, hydrocephalus, neuromuscular defects, abnormal lymphocyte development and function, and shortened lifespan (<xref ref-type="bibr" rid="B128">Lee et al., 2011</xref>). Furthermore, abnormal actin and/or tubulin cytoskeleton assembly and microtubule formation may underlie the <italic>Pfdn5<sup>nmf</sup></italic><sup>5<italic>a</italic></sup> (encoding PNDF5) disease phenotype, including photoreceptor degeneration (<xref ref-type="bibr" rid="B122">Kwon et al., 2019</xref>), central nervous system abnormalities, and male sterility (<xref ref-type="bibr" rid="B128">Lee et al., 2011</xref>). Although PFDN5 is expressed in various tissues, defects in PFDN5 homozygotes appear to be limited to neuronal cells. Genetic disruption of the mouse <italic>Pfdn5</italic> gene results in reduced formation of microtubules and microfilaments, leading to progressive neurodegeneration, hydrocephalus, and reproductive abnormalities. These results suggest that PFDN5 is required for normal sensory and neuronal development (<xref ref-type="bibr" rid="B128">Lee et al., 2011</xref>).</p>
</sec>
<sec id="S8">
<title>Endoplasmic reticulum molecular chaperones and neurodevelopmental disorders</title>
<p>Neurodevelopmental disorders (NDDs) refer to the abnormal development of the nervous system caused by inherited or acquired diseases, resulting in brain dysfunction. NDDs include intellectual disability (ID), autism spectrum disorder (ASD), attention-deficit hyperactivity disorder (ADHD), and bipolar disorder (BD) (<xref ref-type="bibr" rid="B219">Rutter et al., 2006</xref>; <xref ref-type="bibr" rid="B245">Thapar et al., 2017</xref>; <xref ref-type="bibr" rid="B99">Ismail and Shapiro, 2019</xref>; <xref ref-type="bibr" rid="B166">Morris-Rosendahl and Crocq, 2020</xref>). At present, the global prevalence of unexplained ID is 2&#x2013;3% (<xref ref-type="bibr" rid="B183">Olusanya et al., 2020</xref>), the prevalence of ASD is 1&#x2013;2% (<xref ref-type="bibr" rid="B16">Baxter et al., 2015</xref>; <xref ref-type="bibr" rid="B276">Zablotsky et al., 2015</xref>), the prevalence of ADHD is 5&#x2013;7.2% (<xref ref-type="bibr" rid="B202">Polanczyk et al., 2007</xref>, <xref ref-type="bibr" rid="B201">2014</xref>; <xref ref-type="bibr" rid="B232">Sokolova et al., 2017</xref>; <xref ref-type="bibr" rid="B261">Wang T. et al., 2017</xref>), and the prevalence of BD is 1&#x2013;4% (<xref ref-type="bibr" rid="B153">Merikangas et al., 2011</xref>). Numerous studies have shown that children with NDDs have a high incidence of mental health problems compared with normal children (<xref ref-type="bibr" rid="B6">Arim et al., 2015</xref>; <xref ref-type="bibr" rid="B58">Eyre et al., 2019</xref>). NDDs bring heavy economic and mental burdens to families and society, seriously affect the quality of life of patients and their families and represent a public health problem of high concern worldwide. The pathogenesis of NDDs is complex. Environmental risk factors, such as the inflammatory response, immune disorders and metabolic disorders, and genetic factors, such as neuronal dysfunction and chromosome deletion, are involved in the occurrence of NDDs (<xref ref-type="bibr" rid="B11">B&#x0103;descu et al., 2016</xref>). The abnormal expression of ER chaperone proteins can lead to the dys-regulation of neurodevelopmental processes and participate in the occurrence of many neurodevelopmental diseases.</p>
<sec id="S8.SS1">
<title>Endoplasmic reticulum molecular chaperones and autism spectrum disorder</title>
<p>Autism spectrum disorder is a brain developmental disorder characterized by language disorders, social difficulties, and repetitive and stereotyped behaviors (<xref ref-type="bibr" rid="B123">Lai et al., 2014</xref>).</p>
<sec id="S8.SS1.SSS1">
<title>Calreticulin and autism spectrum disorder</title>
<p>Current studies have reported copy number variations (CNVs) in specific genes, and the ASD-related literature has cited the involvement of ER chaperone proteins. However, the molecular mechanisms are not well understood. For example, when studying the relationship among CD47 overexpression, brain overgrowth and 16p11.2 deletion syndrome, Li et al. found that ER chaperone CRT-mediated phagocytosis was related to the pathogenesis of ASD (<xref ref-type="bibr" rid="B133">Li et al., 2021</xref>). CNV at 16p11.2 has been implicated in neuropsychiatric disorders, such as ASD and schizophrenia (<xref ref-type="bibr" rid="B120">Kumar et al., 2008</xref>; <xref ref-type="bibr" rid="B264">Weiss et al., 2008</xref>; <xref ref-type="bibr" rid="B150">McCarthy et al., 2009</xref>; <xref ref-type="bibr" rid="B277">Zarrei et al., 2019</xref>). Carriers with 16p11.2 deletions tend to have macrocephaly (or enlarged brain), whereas carriers with 16p11.2 duplications often have microcephaly (<xref ref-type="bibr" rid="B15">Bartholomeusz et al., 2002</xref>; <xref ref-type="bibr" rid="B87">Hazlett et al., 2011</xref>; <xref ref-type="bibr" rid="B142">Maillard et al., 2015</xref>; <xref ref-type="bibr" rid="B221">Sacco et al., 2015</xref>). Human induced pluripotent stem cells (hiPSCs) from controls and subjects with 16p11.2 deletions and duplications were employed to understand the underlying mechanisms regulating brain overgrowth. CD47 (the &#x201C;do not eat me&#x201D; signal) was found to be overexpressed in cells with the 16p11.2 deletion vector, and CRT was also highly expressed. Cells with high CRT expression should be eliminated by immunophagocytosis, whereas cells escape immunophagocytosis due to high expression of CD47 (<xref ref-type="bibr" rid="B182">Oldenborg et al., 2000</xref>). The phagocytosis and CRT expression of hiPSCs with 16p11.2 deletion were restored to the control level when anti-CD47, a CD47 blocking agent, was applied (<xref ref-type="bibr" rid="B133">Li et al., 2021</xref>). This finding indicates that the normal phagocytosis mediated by CRT is affected in 16p11.2 null cells, and this mechanism may be involved in the pathogenesis of ASD.</p>
</sec>
<sec id="S8.SS1.SSS2">
<title>Protein disulfide isomerase A1 and autism spectrum disorder</title>
<p>Lammert et al. found that increased PDIA1 was associated with ASD (<xref ref-type="bibr" rid="B125">Lammert et al., 2017</xref>). Studies have shown that RELN gene mutation can lead to ASD complications (<xref ref-type="bibr" rid="B59">Fatemi et al., 2005</xref>). In the ASD mouse model based on the RELN R2290C (Reelin mutant gene) (<xref ref-type="bibr" rid="B96">Iossifov et al., 2014</xref>; <xref ref-type="bibr" rid="B263">Wang et al., 2014</xref>; <xref ref-type="bibr" rid="B124">Lammert and Howell, 2016</xref>) mutation, PDIA1 expression was increased in the neurospheres of RELN R2290C heterozygous (+/-) as well as in the cerebellum of RELN Orleans (Orl) +/- mice. Reelin protein is highly expressed in the developing cerebral cortex and cerebellum and plays an important role in neuronal migration. As an ER-resident chaperone, PDIA1 can ensure the formation of correct disulfide bonds in nascent proteins (<xref ref-type="bibr" rid="B192">Parakh and Atkin, 2015</xref>), but its overexpression may cause neuropathological diseases (<xref ref-type="bibr" rid="B194">Perri et al., 2016</xref>; <xref ref-type="bibr" rid="B278">Zeeshan et al., 2016</xref>). This finding indicates that the increased expression of PDIA1 may be associated with the risk of ASD.</p>
</sec>
<sec id="S8.SS1.SSS3">
<title>Sigma-1 receptor and autism spectrum disorder</title>
<p>Fragile X syndrome (FXS) is a disorder of synaptic development and dysfunction (<xref ref-type="bibr" rid="B81">Hagerman et al., 2009</xref>) and is the most prevalent genetic form of ID, ASD, and ADHD (<xref ref-type="bibr" rid="B26">Boyle and Kaufmann, 2010</xref>; <xref ref-type="bibr" rid="B29">Budimirovic and Kaufmann, 2011</xref>; <xref ref-type="bibr" rid="B110">Kaufmann et al., 2017</xref>). FXS mouse models recapitulate anxiety phenotypes similar to those observed in the clinic. Blarcamesine is a Sig-1R agonist (<xref ref-type="bibr" rid="B257">Villard et al., 2011</xref>), and the important role of Sig-1R in calcium homeostasis and synaptic function (<xref ref-type="bibr" rid="B237">Su et al., 2016</xref>; <xref ref-type="bibr" rid="B224">Schmidt and Kruse, 2019</xref>) makes blarcamesine a potential candidate for FXS. Blarcamesine has shown preliminary efficacy in patients with Alzheimer&#x2019;s disease, Rett syndrome (RTT), synaptic neurodegeneration and NDDs (<xref ref-type="bibr" rid="B82">Hampel et al., 2020</xref>). Reyes et al. conducted research on the role of blarcamesine in FXS (<xref ref-type="bibr" rid="B206">Reyes et al., 2021</xref>). These researchers used the Fmr1 knockout FXS mouse model (<xref ref-type="bibr" rid="B13">Bakker et al., 1994</xref>; <xref ref-type="bibr" rid="B158">Mientjes et al., 2006</xref>; <xref ref-type="bibr" rid="B47">Dahlhaus, 2018</xref>) to evaluate the effect of blarcamesine on key cognitive and behavioral aspects that represent the FXS phenotype. When FXS mice were administered blarcamesine, two key neurobehavioral phenotypes, the open field test (hyperactivity) and contextual fear conditioning (associative learning), returned to normal.</p>
<p>Kaufmann et al. conducted further studies on the role of blarcamesine in RTT (<xref ref-type="bibr" rid="B111">Kaufmann et al., 2019</xref>). RTT is a progressive, non-inherited, X-linked neurodevelopmental disorder with an incidence of approximately 1 in 10,000 female births (<xref ref-type="bibr" rid="B126">Laurvick et al., 2006</xref>; <xref ref-type="bibr" rid="B172">Neul et al., 2010</xref>). Most patients carry a mutation in the methyl-CpG-binding protein 2 (<italic>MECP2</italic>) gene, which encodes a rich transcriptional regulator in the brain (<xref ref-type="bibr" rid="B4">Amir et al., 1999</xref>; <xref ref-type="bibr" rid="B173">Neul et al., 2014</xref>). The disorder is characterized by a variety of neurological impairments, particularly affecting cognition (i.e., developmental delay, ID, communication deficits), behavior, and motor and autonomic dysfunction (<xref ref-type="bibr" rid="B172">Neul et al., 2010</xref>; <xref ref-type="bibr" rid="B112">Kaufmann et al., 2016</xref>). No specific effective treatment is available for RTT, and treatment is mainly symptomatic. Using female Mecp2 mutant mice (<xref ref-type="bibr" rid="B223">Samaco et al., 2013</xref>; <xref ref-type="bibr" rid="B136">Lombardi et al., 2015</xref>; <xref ref-type="bibr" rid="B243">Tan and Zoghbi, 2019</xref>) as the research object, the authors and others administered the Sig-1R agonist blarcamesine and found that motor defects, acoustic starvation defects and visual defects were significantly improved. These data suggest that Sig-1Rs play an important role in FXS and in neurological disorders that are genetically characterized as FXS.</p>
</sec>
</sec>
<sec id="S8.SS2">
<title>Endoplasmic reticulum molecular chaperones and intellectual disability</title>
<p>Intellectual disability (ID) is a common disorder of nervous system development that leads to intellectual disabilities. Various factors can cause ID, including loss of important synaptic function, abnormal neuronal morphological development, and neuronal migration and localization disorders (<xref ref-type="bibr" rid="B108">Kaufman et al., 2010</xref>; <xref ref-type="bibr" rid="B212">Ropers, 2010</xref>; <xref ref-type="bibr" rid="B152">Mehregan et al., 2016</xref>).</p>
<sec id="S8.SS2.SSS1">
<title>SIL1 and intellectual disability</title>
<p>Studies have shown that <italic>SIL1</italic> gene mutations causes Marinesco-Sj&#x00F6;gren syndrome (MSS), and it is the only gene that has been found to cause MSS. MSS is a rare autosomal recessive genetic disease. Clinical studies have found that approximately 90% of patients with MSS caused by <italic>SIL1</italic> mutation present with moderate to severe ID, motor delay, congenital cataract, cerebellar atrophy, and other NDDs (<xref ref-type="bibr" rid="B211">Roos et al., 2014</xref>; <xref ref-type="bibr" rid="B186">Osborn et al., 2017</xref>). It has been well established that the decreased interaction between Bip and SIL1 or the loss of SIL1 function alone leads to the abnormal migration and localization of cortical neurons, representing a possible cause of ID (<xref ref-type="bibr" rid="B119">Krieger et al., 2013</xref>; <xref ref-type="bibr" rid="B95">Inaguma et al., 2014</xref>).</p>
</sec>
<sec id="S8.SS2.SSS2">
<title>Calnexin and intellectual disability</title>
<p>In a study of mucopolysaccharidosis type II (MPS II), Osaki et al. demonstrated that CNX expression directly affects intellectual deficits caused by iduronate 2-sulfatase (IDS) mutations (<xref ref-type="bibr" rid="B185">Osaki et al., 2019</xref>). MPS II is one of the most common mucopolysaccharidoses (<xref ref-type="bibr" rid="B270">Wraith et al., 1987</xref>; <xref ref-type="bibr" rid="B234">Stapleton et al., 2018</xref>) and is caused by mutations in the gene encoding IDS (<xref ref-type="bibr" rid="B269">Wilson et al., 1990</xref>). The loss of IDS function leads to the accumulation of heparan sulfate and dermatan sulfate of glycosaminoglycans throughout the body, resulting in skeletal deformities, retardation, rigid joints, and thick skin (<xref ref-type="bibr" rid="B61">Ficicioglu et al., 2018</xref>). It was found that mutant IDS retained in the ER requires binding to CNX to achieve folding. Thus, CNX knockdown reduces the transport of mutant IDS from the ER to lysosome and its enzymatic activity. These studies indicate that proper folding by interaction with CNX ensures its functional activity. These findings reveal the existence of a role between IDS and CNX for the treatment of ID caused by MPSII and IDS mutations (<xref ref-type="bibr" rid="B185">Osaki et al., 2019</xref>).</p>
</sec>
<sec id="S8.SS2.SSS3">
<title>Sigma-1 receptor and intellectual disability</title>
<p>&#x03B1;-thalassemia X-linked intellectual disability (ATR-X) syndrome is caused by mutations in <italic>ATRX</italic> (<xref ref-type="bibr" rid="B74">Gibbons et al., 1992</xref>, <xref ref-type="bibr" rid="B73">1995</xref>). ATR-X syndrome is characterized by a variety of clinical manifestations, including severe ID, facial dysmorphism, genital abnormalities, and seizures (<xref ref-type="bibr" rid="B75">Gibbons et al., 2008</xref>). Similarly, ATR-X model mice lacking <italic>Atrx exon</italic> 2 (<xref ref-type="bibr" rid="B181">Nogami et al., 2011</xref>) show phenotypes similar to the symptoms of ID noted in humans, cognitive deficits (<xref ref-type="bibr" rid="B109">Kaufmann and Moser, 2000</xref>; <xref ref-type="bibr" rid="B130">Levenga and Willemsen, 2012</xref>), and abnormal dendritic formation (<xref ref-type="bibr" rid="B228">Shioda et al., 2011</xref>). Yamaguchi et al. investigated whether Sig-1R promotes the increased activity of neurotrophic factors, such as BDNF, to induce neuroprotection and nerve regeneration (<xref ref-type="bibr" rid="B272">Yamaguchi et al., 2018</xref>). They found that treatment with the Sig-1R activator SA4503 (<xref ref-type="bibr" rid="B147">Matsuno et al., 1996</xref>) reversed axonal development and dendritic spine abnormalities in primary cultured cortical neurons of ATR-X model mice. In addition, SA4503 treatment rescued the cognitive deficits noted in ATR-X model mice.</p>
</sec>
<sec id="S8.SS2.SSS4">
<title>Protein disulfide isomerase family A member 3 and intellectual disability</title>
<p>Recessive gene mutations underlie many developmental disorders and often lead to disabling neurological problems (<xref ref-type="bibr" rid="B144">Martin et al., 2018</xref>). Bilches et al. conducted clinical and genetic studies on large close relatives with ID (<xref ref-type="bibr" rid="B21">Bilches Medinas et al., 2022</xref>). These researchers isolated a homozygous mutant of PDIA3, c.170G &#x003E; A (p. Cys57Tyr or C57Y), from the genes of clinical patients with ID and determined that this disease was associated with PDIA3. PDIA3 is an oxidoreductase containing a thioredoxin-like domain that catalyzes the formation and isomerization of disulfide bonds in the ER and is associated with syndromic ID (<xref ref-type="bibr" rid="B57">Ellgaard and Ruddock, 2005</xref>). Experiments in zebrafish embryos demonstrated that the PDIA3<italic><sup>C</sup></italic><sup>57<italic>Y</italic></sup> mutation is pathogenic and causes developmental defects, such as axonal disorganization and skeletal abnormalities. Abnormal PDIA3<italic><sup>C</sup></italic><sup>57<italic>Y</italic></sup> expression in the hippocampus leads to impaired synaptic plasticity and memory consolidation (<xref ref-type="bibr" rid="B21">Bilches Medinas et al., 2022</xref>).</p>
</sec>
</sec>
<sec id="S8.SS3">
<title>Endoplasmic reticulum molecular chaperones and bipolar disorder</title>
<p>Bipolar disorder is a common mental disorder characterized by recurrent episodes of mania, hypomania, and depression. BD is characterized by mood swings between elevated and depressed moods (<xref ref-type="bibr" rid="B214">Rosso et al., 2007</xref>). The exact mechanism of these mood swings remains unclear and needs to be further elucidated.</p>
<sec id="S8.SS3.SSS1">
<title>Binding immunoglobulin protein and bipolar disorder</title>
<p>There is increasing evidence from previous <italic>in vitro</italic> studies that the ER, as a protein folding factory, plays a major role in BD (<xref ref-type="bibr" rid="B231">So et al., 2007</xref>; <xref ref-type="bibr" rid="B84">Hayashi et al., 2009</xref>; <xref ref-type="bibr" rid="B196">Pfaffenseller et al., 2014</xref>). The role of the ER molecular chaperone Bip in BD diseases is more reflected in ER stress. ER stress activates the UPR (<xref ref-type="bibr" rid="B281">Zhang and Kaufman, 2008</xref>; <xref ref-type="bibr" rid="B256">van Schadewijk et al., 2012</xref>), which is partially impaired in BD (<xref ref-type="bibr" rid="B196">Pfaffenseller et al., 2014</xref>). Therefore, Bengesser et al. analyzed <italic>Bip</italic> and C/EBP homologous protein (<italic>CHOP</italic>) gene expression and X-box binding protein 1 (<italic>XBP1</italic>) splicing in the peripheral blood of BD patients and control study participants (<xref ref-type="bibr" rid="B19">Bengesser et al., 2018</xref>). They isolated RNA from fasting blood of BD patients and control study participants, reverse transcribed it into cDNA, and analyzed <italic>Bip</italic> and <italic>CHOP</italic> gene expression. The results significantly increased <italic>Bip</italic> gene expression in BD samples. In addition, valproate, an atypical antipsychotic drug, has been shown to play a neuroprotective role by increasing the expression of chaperone proteins that assist ER protein folding, such as CRT and Bip (<xref ref-type="bibr" rid="B38">Chen et al., 2000</xref>; <xref ref-type="bibr" rid="B25">Bown et al., 2002</xref>; <xref ref-type="bibr" rid="B114">Kim et al., 2005</xref>). This neuroprotective effect has been suggested to be potentially related to the pathophysiology of neuropsychiatric disorders, such as schizophrenia and BD (<xref ref-type="bibr" rid="B2">Aghajani et al., 2006</xref>). However, the role of the specific pathophysiology of this neurological disorder remains to be elucidated.</p>
</sec>
</sec>
<sec id="S8.SS4">
<title>Endoplasmic reticulum molecular chaperones and attention-deficit hyperactivity disorder</title>
<p>Attention-deficit hyperactivity disorder is a syndrome characterized by inattention, hyperactivity, emotional impulsivity, and learning difficulties (<xref ref-type="bibr" rid="B248">Tripp and Wickens, 2009</xref>).</p>
<p>At present, there are few studies on the role of molecular chaperones in ADHD, and more relevant studies exist at the level of drug treatment targets. Methylphenidate (MPH) is a commonly used stimulant drug for ADHD (<xref ref-type="bibr" rid="B32">Capp et al., 2005</xref>; <xref ref-type="bibr" rid="B7">Arnsten, 2006</xref>). The symptoms of ADHD patients are mostly consistent with dysfunction in the pre-frontal cortex (PFC) (<xref ref-type="bibr" rid="B14">Barkley et al., 1992</xref>), a highly functional region that directs and organizes attention, thoughts, and emotions (<xref ref-type="bibr" rid="B9">Arnsten and Li, 2005</xref>). It has been demonstrated that low-dose MPH injection into the PFC can improve working memory performance (<xref ref-type="bibr" rid="B8">Arnsten and Dudley, 2005</xref>). High MPH doses can cause behavioral sensitization and a high risk of addiction (<xref ref-type="bibr" rid="B3">Amini et al., 2004</xref>). Sig-1R receptor proteins are highly distributed in the PFC, striatum and hippocampus. At the cellular level, Sig-1R is post-synaptic (<xref ref-type="bibr" rid="B85">Hayashi and Su, 2004</xref>) and is an excitatory target for the treatment of ADHD (e.g., cocaine) (<xref ref-type="bibr" rid="B146">Matsumoto et al., 2001</xref>; <xref ref-type="bibr" rid="B148">Maurice et al., 2002</xref>). MPH was found to increase NMDA receptor-mediated synaptic transmission, which was mediated by Sig-1R. Under the same dose of MPH stimulation, the NMDA-induced post-synaptic strength in the hippocampus of mice supplemented with the Sig-1R agonist PRE-084 was significantly higher than that of the control group (<xref ref-type="bibr" rid="B167">Motawe et al., 2020</xref>). Similarly, pretreatment with the Sig-1R antagonist BD1063 effectively prevented hyperactivity caused by MPH hyperactivity (<xref ref-type="bibr" rid="B145">Matsumoto et al., 1995</xref>), confirming the importance of Sig-1R receptors in excitatory synaptic transmission (<xref ref-type="bibr" rid="B280">Zhang C. L. et al., 2012</xref>). Therefore, the active use of Sig-1R receptor ligands in the treatment of ADHD and prevention of MPH-induced addiction may have unexpected effects.</p>
</sec>
</sec>
<sec id="S9" sec-type="conclusion">
<title>Conclusion</title>
<p>A considerable amount of evidence indicates that ER chaperones play key roles in neural development through various processes, such as neuronal migration and localization, neuronal morphogenesis, and synaptic modification. There are two main mechanisms by which ER chaperones participate in the regulation of neural development: 1. ER chaperones directly act on specific developmental periods to regulate developmental stages. 2. ER chaperones indirectly regulate development by regulating the spatial and temporal expression of secreted proteins or central development-related receptor proteins. Of these methods, the indirect regulation mode mainly affects the secretory protein Reelin and membrane receptor proteins AMPA receptor, NMDA receptor and Wnt receptor. Bip protein maintains protein homeostasis under ER stress. In addition, the key effects of these partners in neurodevelopmental diseases also deserve our attention (<xref ref-type="table" rid="T1">Table 1</xref>). Bip, SIL1, and PDI-1 regulate neuronal migration. Bip, CNX, CRT and PFDN regulate early embryonic development. CNX, CRT and Sig-1R regulate neuronal morphogenesis and dendritic axon growth. Bip, CNX, and Sig-1R regulate synaptic function (<xref ref-type="fig" rid="F1">Figure 1</xref>). These direct effects occur through membrane receptor-independent mechanism and are related to the regulation of ER calcium levels by ER chaperones. However, the direct mechanisms of action remain unclear and need to be further studied.</p>
<table-wrap position="float" id="T1">
<label>TABLE 1</label>
<caption><p>The role of Endoplasmic reticulum (ER) chaperones in neural development.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left">Protein</td>
<td valign="top" align="left">Localization</td>
<td valign="top" align="left">Development stage</td>
<td valign="top" align="left">Neurodevelopmental disorders</td>
<td valign="top" align="left">References</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">GRP78/Bip</td>
<td valign="top" align="left">ER lumen<break/> ER <italic>trans</italic>-membrane<break/> Cell surface<break/> Nucleus</td>
<td valign="top" align="left">Embryonic neurodevelopment<break/> Neuronal migration<break/> Synapse formation and plasticity</td>
<td valign="top" align="left">BD</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B38">Chen et al., 2000</xref>; <xref ref-type="bibr" rid="B1">Abood et al., 2001</xref>; <xref ref-type="bibr" rid="B25">Bown et al., 2002</xref>; <xref ref-type="bibr" rid="B170">Nadarajah and Parnavelas, 2002</xref>; <xref ref-type="bibr" rid="B114">Kim et al., 2005</xref>; <xref ref-type="bibr" rid="B2">Aghajani et al., 2006</xref>; <xref ref-type="bibr" rid="B138">Luo et al., 2006</xref>; <xref ref-type="bibr" rid="B231">So et al., 2007</xref>; <xref ref-type="bibr" rid="B160">Mimura et al., 2008</xref>; <xref ref-type="bibr" rid="B281">Zhang and Kaufman, 2008</xref>; <xref ref-type="bibr" rid="B84">Hayashi et al., 2009</xref>; <xref ref-type="bibr" rid="B213">Rossi et al., 2010</xref>; <xref ref-type="bibr" rid="B256">van Schadewijk et al., 2012</xref>; <xref ref-type="bibr" rid="B40">Chiarlone et al., 2014</xref>; <xref ref-type="bibr" rid="B103">Jin et al., 2014</xref>, <xref ref-type="bibr" rid="B102">2017</xref>; <xref ref-type="bibr" rid="B196">Pfaffenseller et al., 2014</xref>; <xref ref-type="bibr" rid="B259">Wang J. et al., 2017</xref>; <xref ref-type="bibr" rid="B19">Bengesser et al., 2018</xref>; <xref ref-type="bibr" rid="B78">G&#x00F3;mez-Almer&#x00ED;a et al., 2021</xref></td>
</tr>
<tr>
<td valign="top" align="left">SIL1</td>
<td valign="top" align="left">ER lumen</td>
<td valign="top" align="left">Neuronal migration</td>
<td valign="top" align="left">ID</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B119">Krieger et al., 2013</xref>; <xref ref-type="bibr" rid="B95">Inaguma et al., 2014</xref>; <xref ref-type="bibr" rid="B211">Roos et al., 2014</xref>; <xref ref-type="bibr" rid="B186">Osborn et al., 2017</xref>; <xref ref-type="bibr" rid="B259">Wang J. et al., 2017</xref></td>
</tr>
<tr>
<td valign="top" align="left">Calnexin</td>
<td valign="top" align="left">ER <italic>trans</italic>-membrane<break/> Cell surface</td>
<td valign="top" align="left">Embryonic neurodevelopment<break/> Axon/dendrite initiation<break/> Synapse formation and plasticity</td>
<td valign="top" align="left">ID</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B270">Wraith et al., 1987</xref>; <xref ref-type="bibr" rid="B269">Wilson et al., 1990</xref>; <xref ref-type="bibr" rid="B246">Tjoelker et al., 1994</xref>; <xref ref-type="bibr" rid="B76">Gloor et al., 2001</xref>; <xref ref-type="bibr" rid="B52">Denzel et al., 2002</xref>; <xref ref-type="bibr" rid="B41">Coe et al., 2008</xref>; <xref ref-type="bibr" rid="B230">Smith et al., 2008</xref>; <xref ref-type="bibr" rid="B118">Kraus et al., 2010</xref>; <xref ref-type="bibr" rid="B100">Itakura et al., 2013</xref>; <xref ref-type="bibr" rid="B61">Ficicioglu et al., 2018</xref>; <xref ref-type="bibr" rid="B105">Jung et al., 2018</xref>; <xref ref-type="bibr" rid="B234">Stapleton et al., 2018</xref>; <xref ref-type="bibr" rid="B185">Osaki et al., 2019</xref></td>
</tr>
<tr>
<td valign="top" align="left">Calreticulin</td>
<td valign="top" align="left">ER lumen<break/> Cytosol<break/> Cell surface</td>
<td valign="top" align="left">Embryonic neurodevelopment<break/> Axon/dendrite initiation<break/> Neuronal differentiation</td>
<td valign="top" align="left">ASD</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B233">Solheim et al., 1997</xref>; <xref ref-type="bibr" rid="B155">Mesaeli et al., 1999</xref>; <xref ref-type="bibr" rid="B182">Oldenborg et al., 2000</xref>; <xref ref-type="bibr" rid="B205">Rauch et al., 2000</xref>; <xref ref-type="bibr" rid="B15">Bartholomeusz et al., 2002</xref>; <xref ref-type="bibr" rid="B37">Chao, 2003</xref>; <xref ref-type="bibr" rid="B268">Willis et al., 2005</xref>; <xref ref-type="bibr" rid="B120">Kumar et al., 2008</xref>; <xref ref-type="bibr" rid="B264">Weiss et al., 2008</xref>; <xref ref-type="bibr" rid="B150">McCarthy et al., 2009</xref>; <xref ref-type="bibr" rid="B258">Vuppalanchi et al., 2010</xref>; <xref ref-type="bibr" rid="B87">Hazlett et al., 2011</xref>; <xref ref-type="bibr" rid="B227">Shih et al., 2012</xref>; <xref ref-type="bibr" rid="B142">Maillard et al., 2015</xref>; <xref ref-type="bibr" rid="B221">Sacco et al., 2015</xref>; <xref ref-type="bibr" rid="B127">Lee et al., 2019</xref>; <xref ref-type="bibr" rid="B277">Zarrei et al., 2019</xref>; <xref ref-type="bibr" rid="B189">Pacheco et al., 2020</xref>; <xref ref-type="bibr" rid="B199">Pilquil et al., 2020</xref>; <xref ref-type="bibr" rid="B133">Li et al., 2021</xref></td>
</tr>
<tr>
<td valign="top" align="left">PDI</td>
<td valign="top" align="left">ER lumen<break/> Cell surface</td>
<td valign="top" align="left">Neuronal migration</td>
<td valign="top" align="left">ASD, ID</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B53">Desai et al., 1988</xref>; <xref ref-type="bibr" rid="B265">Whangbo and Kenyon, 1999</xref>; <xref ref-type="bibr" rid="B252">Turano et al., 2002</xref>; <xref ref-type="bibr" rid="B266">Wilkinson and Gilbert, 2004</xref>; <xref ref-type="bibr" rid="B57">Ellgaard and Ruddock, 2005</xref>; <xref ref-type="bibr" rid="B59">Fatemi et al., 2005</xref>; <xref ref-type="bibr" rid="B96">Iossifov et al., 2014</xref>; <xref ref-type="bibr" rid="B263">Wang et al., 2014</xref>; <xref ref-type="bibr" rid="B192">Parakh and Atkin, 2015</xref>; <xref ref-type="bibr" rid="B124">Lammert and Howell, 2016</xref>; <xref ref-type="bibr" rid="B194">Perri et al., 2016</xref>; <xref ref-type="bibr" rid="B278">Zeeshan et al., 2016</xref>; <xref ref-type="bibr" rid="B125">Lammert et al., 2017</xref>; <xref ref-type="bibr" rid="B144">Martin et al., 2018</xref>; <xref ref-type="bibr" rid="B247">Torpe et al., 2019</xref>; <xref ref-type="bibr" rid="B21">Bilches Medinas et al., 2022</xref></td>
</tr>
<tr>
<td valign="top" align="left">Sigma-1 Receptor</td>
<td valign="top" align="left">ER <italic>trans</italic>-membrane</td>
<td valign="top" align="left">Axon/dendrite initiation<break/> Spine maturation<break/> Synapse formation and plasticity</td>
<td valign="top" align="left">ASD, ID, ADHD</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B14">Barkley et al., 1992</xref>; <xref ref-type="bibr" rid="B74">Gibbons et al., 1992</xref>, <xref ref-type="bibr" rid="B73">1995</xref>, <xref ref-type="bibr" rid="B75">2008</xref>; <xref ref-type="bibr" rid="B13">Bakker et al., 1994</xref>; <xref ref-type="bibr" rid="B147">Matsuno et al., 1996</xref>; <xref ref-type="bibr" rid="B4">Amir et al., 1999</xref>; <xref ref-type="bibr" rid="B109">Kaufmann and Moser, 2000</xref>; <xref ref-type="bibr" rid="B146">Matsumoto et al., 2001</xref>; <xref ref-type="bibr" rid="B10">Aydar et al., 2002</xref>; <xref ref-type="bibr" rid="B148">Maurice et al., 2002</xref>; <xref ref-type="bibr" rid="B3">Amini et al., 2004</xref>; <xref ref-type="bibr" rid="B85">Hayashi and Su, 2004</xref>; <xref ref-type="bibr" rid="B208">Rizzuto et al., 2004</xref>; <xref ref-type="bibr" rid="B8">Arnsten and Dudley, 2005</xref>; <xref ref-type="bibr" rid="B9">Arnsten and Li, 2005</xref>; <xref ref-type="bibr" rid="B32">Capp et al., 2005</xref>; <xref ref-type="bibr" rid="B7">Arnsten, 2006</xref>; <xref ref-type="bibr" rid="B45">Csord&#x00E1;s et al., 2006</xref>; <xref ref-type="bibr" rid="B126">Laurvick et al., 2006</xref>; <xref ref-type="bibr" rid="B158">Mientjes et al., 2006</xref>; <xref ref-type="bibr" rid="B239">Szabadkai et al., 2006</xref>; <xref ref-type="bibr" rid="B107">Kann and Kov&#x00E1;cs, 2007</xref>; <xref ref-type="bibr" rid="B63">Fontanilla et al., 2009</xref>; <xref ref-type="bibr" rid="B81">Hagerman et al., 2009</xref>; <xref ref-type="bibr" rid="B250">Tsai et al., 2009</xref>; <xref ref-type="bibr" rid="B285">Zheng, 2009</xref>; <xref ref-type="bibr" rid="B26">Boyle and Kaufmann, 2010</xref>; <xref ref-type="bibr" rid="B33">C&#x00E1;rdenas et al., 2010</xref>; <xref ref-type="bibr" rid="B172">Neul et al., 2010</xref>, <xref ref-type="bibr" rid="B173">2014</xref>; <xref ref-type="bibr" rid="B236">Su et al., 2010</xref>, <xref ref-type="bibr" rid="B237">2016</xref>; <xref ref-type="bibr" rid="B29">Budimirovic and Kaufmann, 2011</xref>; <xref ref-type="bibr" rid="B181">Nogami et al., 2011</xref>; <xref ref-type="bibr" rid="B218">Ruscher et al., 2011</xref>, <xref ref-type="bibr" rid="B217">2012</xref>; <xref ref-type="bibr" rid="B228">Shioda et al., 2011</xref>; <xref ref-type="bibr" rid="B257">Villard et al., 2011</xref>; <xref ref-type="bibr" rid="B97">Ishima and Hashimoto, 2012</xref>; <xref ref-type="bibr" rid="B117">Kourrich et al., 2012</xref>; <xref ref-type="bibr" rid="B130">Levenga and Willemsen, 2012</xref>; <xref ref-type="bibr" rid="B280">Zhang C. L. et al., 2012</xref>; <xref ref-type="bibr" rid="B165">Mori et al., 2013</xref>; <xref ref-type="bibr" rid="B223">Samaco et al., 2013</xref>; <xref ref-type="bibr" rid="B98">Ishima et al., 2014</xref>; <xref ref-type="bibr" rid="B195">Peviani et al., 2014</xref>; <xref ref-type="bibr" rid="B209">Robson et al., 2014</xref>; <xref ref-type="bibr" rid="B136">Lombardi et al., 2015</xref>; <xref ref-type="bibr" rid="B112">Kaufmann et al., 2016</xref>, <xref ref-type="bibr" rid="B110">2017</xref>, <xref ref-type="bibr" rid="B111">2019</xref>; <xref ref-type="bibr" rid="B271">Xavier et al., 2016</xref>; <xref ref-type="bibr" rid="B68">Fukunaga and Moriguchi, 2017</xref>; <xref ref-type="bibr" rid="B47">Dahlhaus, 2018</xref>; <xref ref-type="bibr" rid="B272">Yamaguchi et al., 2018</xref>; <xref ref-type="bibr" rid="B220">Ryskamp et al., 2019</xref>; <xref ref-type="bibr" rid="B224">Schmidt and Kruse, 2019</xref>; <xref ref-type="bibr" rid="B243">Tan and Zoghbi, 2019</xref>; <xref ref-type="bibr" rid="B82">Hampel et al., 2020</xref>; <xref ref-type="bibr" rid="B167">Motawe et al., 2020</xref>; <xref ref-type="bibr" rid="B206">Reyes et al., 2021</xref>; <xref ref-type="bibr" rid="B48">Dalwadi et al., 2022</xref></td>
</tr>
<tr>
<td valign="top" align="left">Prefoldin</td>
<td valign="top" align="left">ER lumen<break/> Nucleus<break/> Cytosol</td>
<td valign="top" align="left">Embryonic neurodevelopment</td>
<td valign="top" align="left">N.D.</td>
<td valign="top" align="left"><xref ref-type="bibr" rid="B31">Cao et al., 2008</xref>; <xref ref-type="bibr" rid="B163">Monzo et al., 2010</xref>; <xref ref-type="bibr" rid="B128">Lee et al., 2011</xref>; <xref ref-type="bibr" rid="B51">Delgehyr et al., 2012</xref>; <xref ref-type="bibr" rid="B77">Glover and Clark, 2015</xref>; <xref ref-type="bibr" rid="B20">Bertling and Hotulainen, 2017</xref></td>
</tr>
</tbody>
</table></table-wrap>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p>Endoplasmic reticulum (ER) molecular chaperones involved in neurodevelopment. ER molecular chaperones regulate central nervous development through two mechanisms: 1. ER chaperones directly act on specific developmental periods and regulate developmental stages. 2. ER chaperones indirectly act on secretory proteins or receptor proteins and regulate ER stress by ensuring protein homeostasis. CRT and Sig-1R regulate neuronal morphogenesis and dendritic axon growth <bold>(A)</bold>; Bip, SIL1, and PDI-1 regulate cortical neuron migration <bold>(C)</bold>; CRT regulates Ca<sup>2+</sup> to guide NGF differentiation into mature neurons <bold>(D)</bold>; Bip, CNX, and Sig-1R regulate synaptic function <bold>(B)</bold>. Indirect regulation mainly affects the secreted protein Reelin and AMPA and NMDA membrane receptors <bold>(C)</bold>, which act on the post-synaptic membrane and nerve migration. Bip proteins are involved in endoplasmic quality control and transport misfolded proteins for degradation, thereby maintaining protein homeostasis under ER stress conditions. Insert (a) CRT cooperates with CNX and PDIA3 to form the CNX/CRT cycle that controls protein folding within the ER. The CNX/CRT cycle can specifically recognize glycoproteins linked by N2 glycosidic bonds and regulate Ca<sup>2+</sup> homeostasis and Ca<sup>2+</sup> signaling processes in the ER. Insert (b) Bip is involved in a variety of ER functions dependent on ATP-induced conformational changes. The adenosine triphosphatase (ATPase) cycle of Bip is regulated by its co-chaperones of two families, namely, the ER-localized DnaJ-like proteins (ERdjs) and the nucleotide exchange factors (NEFs). ERdjs enables Bip to stably associate with its target protein. The NEF SIL1 then mediates the release of the target protein from the upper Bip and further folds to form the mature protein. Modified from <xref ref-type="bibr" rid="B67">Fucikova et al. (2021)</xref>, <xref ref-type="bibr" rid="B94">Ichhaporia and Hendershot (2021)</xref>.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnins-16-1032607-g001.tif"/>
</fig>
<p>In summary, considerable research on the function of ER molecular chaperones has been performed, and some progress has been made. However, some limitations remain. 1. ER molecular chaperones have specific expression sites in the early stage of neural development, and specific spatial and temporal patterns coincide with different stages of neural development. For example, Bip is involved in early embryonic development and is closely related to cortical neuronal migration. Sig-1R regulates neuronal morphogenesis and dendritic axon growth and are mainly localized in the hippocampus. Do these findings suggest that the functions of these molecular chaperones are focused at specific developmental sites at specific developmental times? 2. The mechanism by which ER chaperones affect central nervous system development is still not well defined. For example, Bip and SIL1 coregulate the coordination mechanism during central development. CNX regulates the specific regulatory processes of the NMDA receptor and AMPA receptor. Whether PDI-mediated Wnt protein-dependent disulfide bond formation affects other developmental processes in addition to migration remains unclear. As well characterized molecular ER chaperone, the role of GRP94 in protein folding and assembly as well as in cancer and related diseases has been widely studied (<xref ref-type="bibr" rid="B66">Fu and Lee, 2006</xref>; <xref ref-type="bibr" rid="B191">Pan et al., 2009</xref>). However, there are few studies on GRP94 in neural development, and further exploration is needed. 3. At present, studies on the role of molecular chaperones in developmental function are insufficient, and further studies on the functions of these molecular chaperones in different brain regions are needed. Finally, studies on the key role and induction mechanism of molecular chaperones in neurodevelopmental diseases are limited.</p>
<p>At present, neurodevelopmental diseases have become a problem of great concern. The complex etiology and specific pathogenesis have affected the health of numerous individuals. Determining whether it is possible to repair developmental defects by controlling the expression of chaperone proteins and subsequently treat developmental diseases is the focus of our research.</p>
</sec>
<sec id="S10">
<title>Author contributions</title>
<p>XZ and JZ: conceptualization and funding acquisition. HS, MWu, MWa, and XZ: writing&#x2014;original draft preparation. HS, MWu, and XZ: writing&#x2014;review and editing. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<sec id="S11" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by the National Natural Science Foundation of China (Grant No. 31960168) which covered the open access publication fees and Sci-Tech Planning Project of Jiaxing, China (Grant No. 2021AY10049) which covered other expenses of the work.</p>
</sec>
<sec id="S12" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="S13" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abood</surname> <given-names>M. E.</given-names></name> <name><surname>Rizvi</surname> <given-names>G.</given-names></name> <name><surname>Sallapudi</surname> <given-names>N.</given-names></name> <name><surname>McAllister</surname> <given-names>S. D.</given-names></name></person-group> (<year>2001</year>). <article-title>Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity.</article-title> <source><italic>Neurosci. Lett.</italic></source> <volume>309</volume> <fpage>197</fpage>&#x2013;<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1016/s0304-3940(01)02065-1</pub-id></citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aghajani</surname> <given-names>A.</given-names></name> <name><surname>Rahimi</surname> <given-names>A.</given-names></name> <name><surname>Fadai</surname> <given-names>F.</given-names></name> <name><surname>Ebrahimi</surname> <given-names>A.</given-names></name> <name><surname>Najmabadi</surname> <given-names>H.</given-names></name> <name><surname>Ohadi</surname> <given-names>M.</given-names></name></person-group> (<year>2006</year>). <article-title>A point mutation at the calreticulin gene core promoter conserved sequence in a case of schizophrenia.</article-title> <source><italic>Am. J. Med. Genet. B Neuropsychiatr. Genet.</italic></source> <volume>141B</volume> <fpage>294</fpage>&#x2013;<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.30300</pub-id> <pub-id pub-id-type="pmid">16511840</pub-id></citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amini</surname> <given-names>B.</given-names></name> <name><surname>Yang</surname> <given-names>P. B.</given-names></name> <name><surname>Swann</surname> <given-names>A. C.</given-names></name> <name><surname>Dafny</surname> <given-names>N.</given-names></name></person-group> (<year>2004</year>). <article-title>Differential locomotor responses in male rats from three strains to acute methylphenidate.</article-title> <source><italic>Int. J. Neurosci.</italic></source> <volume>114</volume> <fpage>1063</fpage>&#x2013;<lpage>1084</lpage>. <pub-id pub-id-type="doi">10.1080/00207450490475526</pub-id> <pub-id pub-id-type="pmid">15370174</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amir</surname> <given-names>R. E.</given-names></name> <name><surname>Van den Veyver</surname> <given-names>I. B.</given-names></name> <name><surname>Wan</surname> <given-names>M.</given-names></name> <name><surname>Tran</surname> <given-names>C. Q.</given-names></name> <name><surname>Francke</surname> <given-names>U.</given-names></name> <name><surname>Zoghbi</surname> <given-names>H. Y.</given-names></name></person-group> (<year>1999</year>). <article-title>Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.</article-title> <source><italic>Nat. Genet.</italic></source> <volume>23</volume> <fpage>185</fpage>&#x2013;<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1038/13810</pub-id> <pub-id pub-id-type="pmid">10508514</pub-id></citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Apolloni</surname> <given-names>S.</given-names></name> <name><surname>Caputi</surname> <given-names>F.</given-names></name> <name><surname>Pignataro</surname> <given-names>A.</given-names></name> <name><surname>Amadio</surname> <given-names>S.</given-names></name> <name><surname>Fabbrizio</surname> <given-names>P.</given-names></name> <name><surname>Ammassari-Teule</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Histamine is an inducer of the heat shock response in SOD1-G93A models of ALS.</article-title> <source><italic>Int. J. Mol. Sci.</italic></source> <volume>20</volume>:<issue>3793</issue>. <pub-id pub-id-type="doi">10.3390/ijms20153793</pub-id> <pub-id pub-id-type="pmid">31382568</pub-id></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arim</surname> <given-names>R. G.</given-names></name> <name><surname>Kohen</surname> <given-names>D. E.</given-names></name> <name><surname>Garner</surname> <given-names>R. E.</given-names></name> <name><surname>Lach</surname> <given-names>L. M.</given-names></name> <name><surname>Brehaut</surname> <given-names>J. C.</given-names></name> <name><surname>MacKenzie</surname> <given-names>M. J.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Psychosocial functioning in children with neurodevelopmental disorders and externalizing behavior problems.</article-title> <source><italic>Disabil. Rehabil.</italic></source> <volume>37</volume> <fpage>345</fpage>&#x2013;<lpage>354</lpage>. <pub-id pub-id-type="doi">10.3109/09638288.2014.919361</pub-id> <pub-id pub-id-type="pmid">24840026</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arnsten</surname> <given-names>A. F.</given-names></name></person-group> (<year>2006</year>). <article-title>Stimulants: Therapeutic actions in ADHD.</article-title> <source><italic>Neuropsychopharmacology</italic></source> <volume>31</volume> <fpage>2376</fpage>&#x2013;<lpage>2383</lpage>. <pub-id pub-id-type="doi">10.1038/sj.npp.1301164</pub-id> <pub-id pub-id-type="pmid">16855530</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arnsten</surname> <given-names>A. F.</given-names></name> <name><surname>Dudley</surname> <given-names>A. G.</given-names></name></person-group> (<year>2005</year>). <article-title>Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in attention deficit hyperactivity disorder.</article-title> <source><italic>Behav. Brain Funct.</italic></source> <volume>1</volume>:<issue>2</issue>. <pub-id pub-id-type="doi">10.1186/1744-9081-1-2</pub-id> <pub-id pub-id-type="pmid">15916700</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arnsten</surname> <given-names>A. F.</given-names></name> <name><surname>Li</surname> <given-names>B. M.</given-names></name></person-group> (<year>2005</year>). <article-title>Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions.</article-title> <source><italic>Biol. Psychiatry</italic></source> <volume>57</volume> <fpage>1377</fpage>&#x2013;<lpage>1384</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2004.08.019</pub-id> <pub-id pub-id-type="pmid">15950011</pub-id></citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aydar</surname> <given-names>E.</given-names></name> <name><surname>Palmer</surname> <given-names>C. P.</given-names></name> <name><surname>Klyachko</surname> <given-names>V. A.</given-names></name> <name><surname>Jackson</surname> <given-names>M. B.</given-names></name></person-group> (<year>2002</year>). <article-title>The sigma receptor as a ligand-regulated auxiliary potassium channel subunit.</article-title> <source><italic>Neuron</italic></source> <volume>34</volume> <fpage>399</fpage>&#x2013;<lpage>410</lpage>. <pub-id pub-id-type="doi">10.1016/s0896-6273(02)00677-3</pub-id></citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>B&#x0103;descu</surname> <given-names>G. M.</given-names></name> <name><surname>F&#x00EE;lfan</surname> <given-names>M.</given-names></name> <name><surname>Sandu</surname> <given-names>R. E.</given-names></name> <name><surname>Surugiu</surname> <given-names>R.</given-names></name> <name><surname>Ciobanu</surname> <given-names>O.</given-names></name> <name><surname>Popa-Wagner</surname> <given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Molecular mechanisms underlying neurodevelopmental disorders, ADHD and autism.</article-title> <source><italic>Rom. J. Morphol. Embryol.</italic></source> <volume>57</volume> <fpage>361</fpage>&#x2013;<lpage>366</lpage>.</citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bagni</surname> <given-names>C.</given-names></name> <name><surname>Zukin</surname> <given-names>R. S.</given-names></name></person-group> (<year>2019</year>). <article-title>A synaptic perspective of fragile X syndrome and autism spectrum disorders.</article-title> <source><italic>Neuron</italic></source> <volume>101</volume> <fpage>1070</fpage>&#x2013;<lpage>1088</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2019.02.041</pub-id> <pub-id pub-id-type="pmid">30897358</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bakker</surname> <given-names>C. E.</given-names></name> <name><surname>Verheij</surname> <given-names>C.</given-names></name> <name><surname>Willemsen</surname> <given-names>R.</given-names></name> <name><surname>van der Helm</surname> <given-names>R.</given-names></name> <name><surname>Oerlemans</surname> <given-names>F.</given-names></name> <name><surname>Vermey</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>1994</year>). <article-title>Fmr1 knockout mice: A model to study fragile X mental retardation. The dutch-belgian fragile X consortium.</article-title> <source><italic>Cell</italic></source> <volume>78</volume> <fpage>23</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="pmid">8033209</pub-id></citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barkley</surname> <given-names>R. A.</given-names></name> <name><surname>Grodzinsky</surname> <given-names>G.</given-names></name> <name><surname>DuPaul</surname> <given-names>G. J.</given-names></name></person-group> (<year>1992</year>). <article-title>Frontal lobe functions in attention deficit disorder with and without hyperactivity: A review and research report.</article-title> <source><italic>J. Abnorm. Child Psychol.</italic></source> <volume>20</volume> <fpage>163</fpage>&#x2013;<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1007/BF00916547</pub-id> <pub-id pub-id-type="pmid">1593025</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bartholomeusz</surname> <given-names>H. H.</given-names></name> <name><surname>Courchesne</surname> <given-names>E.</given-names></name> <name><surname>Karns</surname> <given-names>C. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Relationship between head circumference and brain volume in healthy normal toddlers, children, and adults.</article-title> <source><italic>Neuropediatrics</italic></source> <volume>33</volume> <fpage>239</fpage>&#x2013;<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1055/s-2002-36735</pub-id> <pub-id pub-id-type="pmid">12536365</pub-id></citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baxter</surname> <given-names>A. J.</given-names></name> <name><surname>Brugha</surname> <given-names>T. S.</given-names></name> <name><surname>Erskine</surname> <given-names>H. E.</given-names></name> <name><surname>Scheurer</surname> <given-names>R. W.</given-names></name> <name><surname>Vos</surname> <given-names>T.</given-names></name> <name><surname>Scott</surname> <given-names>J. G.</given-names></name></person-group> (<year>2015</year>). <article-title>The epidemiology and global burden of autism spectrum disorders.</article-title> <source><italic>Psychol. Med.</italic></source> <volume>45</volume> <fpage>601</fpage>&#x2013;<lpage>613</lpage>. <pub-id pub-id-type="doi">10.1017/S003329171400172X</pub-id> <pub-id pub-id-type="pmid">25108395</pub-id></citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beghi</surname> <given-names>E.</given-names></name> <name><surname>Chi&#x00F2;</surname> <given-names>A.</given-names></name> <name><surname>Couratier</surname> <given-names>P.</given-names></name> <name><surname>Esteban</surname> <given-names>J.</given-names></name> <name><surname>Hardiman</surname> <given-names>O.</given-names></name> <name><surname>Logroscino</surname> <given-names>G.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>The epidemiology and treatment of ALS: Focus on the heterogeneity of the disease and critical appraisal of therapeutic trials.</article-title> <source><italic>Amyotroph. Lateral Scler.</italic></source> <volume>12</volume> <fpage>1</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.3109/17482968.2010.502940</pub-id> <pub-id pub-id-type="pmid">20698807</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Belmonte-Mateos</surname> <given-names>C.</given-names></name> <name><surname>Pujades</surname> <given-names>C.</given-names></name></person-group> (<year>2022</year>). <article-title>From cell states to cell fates: How cell proliferation and neuronal differentiation are coordinated during embryonic development.</article-title> <source><italic>Front. Neurosci.</italic></source> <volume>15</volume>:<issue>781160</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2021.781160</pub-id> <pub-id pub-id-type="pmid">35046768</pub-id></citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bengesser</surname> <given-names>S. A.</given-names></name> <name><surname>Reininghaus</surname> <given-names>E. Z.</given-names></name> <name><surname>Dalkner</surname> <given-names>N.</given-names></name> <name><surname>Birner</surname> <given-names>A.</given-names></name> <name><surname>Hohenberger</surname> <given-names>H.</given-names></name> <name><surname>Queissner</surname> <given-names>R.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Endoplasmic reticulum stress in bipolar disorder? &#x2013; BiP and CHOP gene expression- and XBP1 splicing analysis in peripheral blood.</article-title> <source><italic>Psychoneuroendocrinology</italic></source> <volume>95</volume> <fpage>113</fpage>&#x2013;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2018.05.029</pub-id> <pub-id pub-id-type="pmid">29843019</pub-id></citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bertling</surname> <given-names>E.</given-names></name> <name><surname>Hotulainen</surname> <given-names>P.</given-names></name></person-group> (<year>2017</year>). <article-title>New waves in dendritic spine actin cytoskeleton: From branches and bundles to rings, from actin binding proteins to post-translational modifications.</article-title> <source><italic>Mol. Cell. Neurosci.</italic></source> <volume>84</volume> <fpage>77</fpage>&#x2013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2017.05.002</pub-id> <pub-id pub-id-type="pmid">28479292</pub-id></citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bilches Medinas</surname> <given-names>D.</given-names></name> <name><surname>Malik</surname> <given-names>S.</given-names></name> <name><surname>Y&#x0131;ld&#x0131;z-B&#x00F6;l&#x00FC;kba&#x015F;&#x0131;</surname> <given-names>E.</given-names></name> <name><surname>Borgonovo</surname> <given-names>J.</given-names></name> <name><surname>Saaranen</surname> <given-names>M. J.</given-names></name> <name><surname>Urra</surname> <given-names>H.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Mutation in protein disulfide isomerase A3 causes neurodevelopmental defects by disturbing endoplasmic reticulum proteostasis.</article-title> <source><italic>EMBO J.</italic></source> <volume>41</volume>:<issue>e105531</issue>. <pub-id pub-id-type="doi">10.15252/embj.2020105531</pub-id> <pub-id pub-id-type="pmid">34904718</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bocchi</surname> <given-names>R.</given-names></name> <name><surname>Egervari</surname> <given-names>K.</given-names></name> <name><surname>Carol-Perdiguer</surname> <given-names>L.</given-names></name> <name><surname>Viale</surname> <given-names>B.</given-names></name> <name><surname>Quairiaux</surname> <given-names>C.</given-names></name> <name><surname>De Roo</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Perturbed Wnt signaling leads to neuronal migration delay, altered interhemispheric connections and impaired social behavior.</article-title> <source><italic>Nat. Commun.</italic></source> <volume>8</volume>:<issue>1158</issue>. <pub-id pub-id-type="doi">10.1038/s41467-017-01046-w</pub-id> <pub-id pub-id-type="pmid">29079819</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bose</surname> <given-names>D.</given-names></name> <name><surname>Chakrabarti</surname> <given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Substrate specificity in the context of molecular chaperones.</article-title> <source><italic>IUBMB Life</italic></source> <volume>69</volume> <fpage>647</fpage>&#x2013;<lpage>659</lpage>. <pub-id pub-id-type="doi">10.1002/iub.1656</pub-id> <pub-id pub-id-type="pmid">28748601</pub-id></citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bostan</surname> <given-names>A. C.</given-names></name> <name><surname>Dum</surname> <given-names>R. P.</given-names></name> <name><surname>Strick</surname> <given-names>P. L.</given-names></name></person-group> (<year>2018</year>). <article-title>Functional anatomy of basal ganglia circuits with the cerebral cortex and the cerebellum.</article-title> <source><italic>Prog. Neurol. Surg.</italic></source> <volume>33</volume> <fpage>50</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1159/000480748</pub-id> <pub-id pub-id-type="pmid">29332073</pub-id></citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bown</surname> <given-names>C. D.</given-names></name> <name><surname>Wang</surname> <given-names>J. F.</given-names></name> <name><surname>Chen</surname> <given-names>B.</given-names></name> <name><surname>Young</surname> <given-names>L. T.</given-names></name></person-group> (<year>2002</year>). <article-title>Regulation of ER stress proteins by valproate: Therapeutic implications.</article-title> <source><italic>Bipolar Disord.</italic></source> <volume>4</volume> <fpage>145</fpage>&#x2013;<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1034/j.1399-5618.2002.t01-1-40201.x</pub-id> <pub-id pub-id-type="pmid">12071512</pub-id></citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boyle</surname> <given-names>L.</given-names></name> <name><surname>Kaufmann</surname> <given-names>W. E.</given-names></name></person-group> (<year>2010</year>). <article-title>The behavioral phenotype of FMR1 mutations.</article-title> <source><italic>Am. J. Med. Genet. C Semin. Med. Genet.</italic></source> <volume>154C</volume> <fpage>469</fpage>&#x2013;<lpage>476</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.c.30277</pub-id> <pub-id pub-id-type="pmid">20981777</pub-id></citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bradke</surname> <given-names>F.</given-names></name> <name><surname>Fawcett</surname> <given-names>J. W.</given-names></name> <name><surname>Spira</surname> <given-names>M. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Assembly of a new growth cone after axotomy: The precursor to axon regeneration.</article-title> <source><italic>Nat. Rev. Neurosci.</italic></source> <volume>13</volume> <fpage>183</fpage>&#x2013;<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3176</pub-id> <pub-id pub-id-type="pmid">22334213</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bramham</surname> <given-names>C. R.</given-names></name> <name><surname>Alme</surname> <given-names>M. N.</given-names></name> <name><surname>Bittins</surname> <given-names>M.</given-names></name> <name><surname>Kuipers</surname> <given-names>S. D.</given-names></name> <name><surname>Nair</surname> <given-names>R. R.</given-names></name> <name><surname>Pai</surname> <given-names>B.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>The Arc of synaptic memory.</article-title> <source><italic>Exp. Brain Res.</italic></source> <volume>200</volume> <fpage>125</fpage>&#x2013;<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1007/s00221-009-1959-2</pub-id> <pub-id pub-id-type="pmid">19690847</pub-id></citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Budimirovic</surname> <given-names>D. B.</given-names></name> <name><surname>Kaufmann</surname> <given-names>W. E.</given-names></name></person-group> (<year>2011</year>). <article-title>What can we learn about autism from studying fragile X syndrome?</article-title> <source><italic>Dev. Neurosci.</italic></source> <volume>33</volume> <fpage>379</fpage>&#x2013;<lpage>394</lpage>. <pub-id pub-id-type="doi">10.1159/000330213</pub-id> <pub-id pub-id-type="pmid">21893949</pub-id></citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buffington</surname> <given-names>S. A.</given-names></name> <name><surname>Huang</surname> <given-names>W.</given-names></name> <name><surname>Costa-Mattioli</surname> <given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Translational control in synaptic plasticity and cognitive dysfunction.</article-title> <source><italic>Annu. Rev. Neurosci.</italic></source> <volume>37</volume> <fpage>17</fpage>&#x2013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-neuro-071013-014100</pub-id> <pub-id pub-id-type="pmid">25032491</pub-id></citation></ref>
<ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname> <given-names>S.</given-names></name> <name><surname>Carlesso</surname> <given-names>G.</given-names></name> <name><surname>Osipovich</surname> <given-names>A. B.</given-names></name> <name><surname>Llanes</surname> <given-names>J.</given-names></name> <name><surname>Lin</surname> <given-names>Q.</given-names></name> <name><surname>Hoek</surname> <given-names>K. L.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Subunit 1 of the prefoldin chaperone complex is required for lymphocyte development and function.</article-title> <source><italic>J. Immunol.</italic></source> <volume>181</volume> <fpage>476</fpage>&#x2013;<lpage>484</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.181.1.476</pub-id> <pub-id pub-id-type="pmid">18566413</pub-id></citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Capp</surname> <given-names>P. K.</given-names></name> <name><surname>Pearl</surname> <given-names>P. L.</given-names></name> <name><surname>Conlon</surname> <given-names>C.</given-names></name></person-group> (<year>2005</year>). <article-title>Methylphenidate HCl: Therapy for attention deficit hyperactivity disorder.</article-title> <source><italic>Expert Rev. Neurother.</italic></source> <volume>5</volume> <fpage>325</fpage>&#x2013;<lpage>331</lpage>. <pub-id pub-id-type="doi">10.1586/14737175.5.3.325</pub-id> <pub-id pub-id-type="pmid">15938665</pub-id></citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>C&#x00E1;rdenas</surname> <given-names>C.</given-names></name> <name><surname>Miller</surname> <given-names>R. A.</given-names></name> <name><surname>Smith</surname> <given-names>I.</given-names></name> <name><surname>Bui</surname> <given-names>T.</given-names></name> <name><surname>Molg&#x00F3;</surname> <given-names>J.</given-names></name> <name><surname>M&#x00FC;ller</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria.</article-title> <source><italic>Cell</italic></source> <volume>142</volume> <fpage>270</fpage>&#x2013;<lpage>283</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2010.06.007</pub-id> <pub-id pub-id-type="pmid">20655468</pub-id></citation></ref>
<ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carver</surname> <given-names>J. A.</given-names></name> <name><surname>Ecroyd</surname> <given-names>H.</given-names></name> <name><surname>Truscott</surname> <given-names>R.</given-names></name> <name><surname>Thorn</surname> <given-names>D. C.</given-names></name> <name><surname>Holt</surname> <given-names>C.</given-names></name></person-group> (<year>2018</year>). <article-title>Proteostasis and the regulation of intra- and extracellular protein aggregation by ATP-independent molecular chaperones: Lens &#x03B1;-crystallins and milk caseins.</article-title> <source><italic>Acc. Chem. Res.</italic></source> <volume>51</volume> <fpage>745</fpage>&#x2013;<lpage>752</lpage>. <pub-id pub-id-type="doi">10.1021/acs.accounts.7b00250</pub-id> <pub-id pub-id-type="pmid">29442498</pub-id></citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Castelo-Branco</surname> <given-names>G.</given-names></name> <name><surname>Wagner</surname> <given-names>J.</given-names></name> <name><surname>Rodriguez</surname> <given-names>F. J.</given-names></name> <name><surname>Kele</surname> <given-names>J.</given-names></name> <name><surname>Sousa</surname> <given-names>K.</given-names></name> <name><surname>Rawal</surname> <given-names>N.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a.</article-title> <source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source> <volume>100</volume> <fpage>12747</fpage>&#x2013;<lpage>12752</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1534900100</pub-id> <pub-id pub-id-type="pmid">14557550</pub-id></citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caviness</surname> <given-names>V. S.</given-names> <suffix>Jr.</suffix></name></person-group> (<year>1982</year>). <article-title>Neocortical histogenesis in normal and reeler mice: A developmental study based upon [3H]thymidine autoradiography.</article-title> <source><italic>Brain Res.</italic></source> <volume>256</volume> <fpage>293</fpage>&#x2013;<lpage>302</lpage>. <pub-id pub-id-type="doi">10.1016/0165-3806(82)90141-9</pub-id></citation></ref>
<ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname> <given-names>M. V.</given-names></name></person-group> (<year>2003</year>). <article-title>Neurotrophins and their receptors: A convergence point for many signalling pathways.</article-title> <source><italic>Nat. Rev. Neurosci.</italic></source> <volume>4</volume> <fpage>299</fpage>&#x2013;<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1078</pub-id> <pub-id pub-id-type="pmid">12671646</pub-id></citation></ref>
<ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>B.</given-names></name> <name><surname>Wang</surname> <given-names>J. F.</given-names></name> <name><surname>Young</surname> <given-names>L. T.</given-names></name></person-group> (<year>2000</year>). <article-title>Chronic valproate treatment increases expression of endoplasmic reticulum stress proteins in the rat cerebral cortex and hippocampus.</article-title> <source><italic>Biol. Psychiatry</italic></source> <volume>48</volume> <fpage>658</fpage>&#x2013;<lpage>664</lpage>. <pub-id pub-id-type="doi">10.1016/s0006-3223(00)00878-7</pub-id></citation></ref>
<ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>B.</given-names></name> <name><surname>Wu</surname> <given-names>Z.</given-names></name> <name><surname>Xu</surname> <given-names>J.</given-names></name> <name><surname>Xu</surname> <given-names>Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Calreticulin binds to fas ligand and inhibits neuronal cell apoptosis induced by ischemia-reperfusion injury.</article-title> <source><italic>Biomed Res. Int.</italic></source> <volume>2015</volume>:<issue>895284</issue>. <pub-id pub-id-type="doi">10.1155/2015/895284</pub-id> <pub-id pub-id-type="pmid">26583143</pub-id></citation></ref>
<ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chiarlone</surname> <given-names>A.</given-names></name> <name><surname>Bellocchio</surname> <given-names>L.</given-names></name> <name><surname>Bl&#x00E1;zquez</surname> <given-names>C.</given-names></name> <name><surname>Resel</surname> <given-names>E.</given-names></name> <name><surname>Soria-G&#x00F3;mez</surname> <given-names>E.</given-names></name> <name><surname>Cannich</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>A restricted population of CB1 cannabinoid receptors with neuroprotective activity.</article-title> <source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source> <volume>111</volume> <fpage>8257</fpage>&#x2013;<lpage>8262</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1400988111</pub-id> <pub-id pub-id-type="pmid">24843137</pub-id></citation></ref>
<ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coe</surname> <given-names>H.</given-names></name> <name><surname>Bedard</surname> <given-names>K.</given-names></name> <name><surname>Groenendyk</surname> <given-names>J.</given-names></name> <name><surname>Jung</surname> <given-names>J.</given-names></name> <name><surname>Michalak</surname> <given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Endoplasmic reticulum stress in the absence of calnexin.</article-title> <source><italic>Cell Stress Chaperones</italic></source> <volume>13</volume> <fpage>497</fpage>&#x2013;<lpage>507</lpage>. <pub-id pub-id-type="doi">10.1007/s12192-008-0049-x</pub-id> <pub-id pub-id-type="pmid">18528784</pub-id></citation></ref>
<ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Correll</surname> <given-names>R. N.</given-names></name> <name><surname>Grimes</surname> <given-names>K. M.</given-names></name> <name><surname>Prasad</surname> <given-names>V.</given-names></name> <name><surname>Lynch</surname> <given-names>J. M.</given-names></name> <name><surname>Khalil</surname> <given-names>H.</given-names></name> <name><surname>Molkentin</surname> <given-names>J. D.</given-names></name></person-group> (<year>2019</year>). <article-title>Overlapping and differential functions of ATF6&#x03B1; versus ATF6&#x03B2; in the mouse heart.</article-title> <source><italic>Sci. Rep.</italic></source> <volume>9</volume>:<issue>2059</issue>. <pub-id pub-id-type="doi">10.1038/s41598-019-39515-5</pub-id> <pub-id pub-id-type="pmid">30765833</pub-id></citation></ref>
<ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coudreuse</surname> <given-names>D. Y.</given-names></name> <name><surname>Ro&#x00EB;l</surname> <given-names>G.</given-names></name> <name><surname>Betist</surname> <given-names>M. C.</given-names></name> <name><surname>Destr&#x00E9;e</surname> <given-names>O.</given-names></name> <name><surname>Korswagen</surname> <given-names>H. C.</given-names></name></person-group> (<year>2006</year>). <article-title>Wnt gradient formation requires retromer function in Wnt-producing cells.</article-title> <source><italic>Science</italic></source> <volume>312</volume> <fpage>921</fpage>&#x2013;<lpage>924</lpage>. <pub-id pub-id-type="doi">10.1126/science.1124856</pub-id> <pub-id pub-id-type="pmid">16645052</pub-id></citation></ref>
<ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crelin</surname> <given-names>E. S.</given-names></name></person-group> (<year>1974</year>). <article-title>Development of the nervous system. A logical approach to neuroanatomy.</article-title> <source><italic>Clin. Symposia</italic></source> <volume>26</volume> <fpage>1</fpage>&#x2013;<lpage>32</lpage>.</citation></ref>
<ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Csord&#x00E1;s</surname> <given-names>G.</given-names></name> <name><surname>Renken</surname> <given-names>C.</given-names></name> <name><surname>V&#x00E1;rnai</surname> <given-names>P.</given-names></name> <name><surname>Walter</surname> <given-names>L.</given-names></name> <name><surname>Weaver</surname> <given-names>D.</given-names></name> <name><surname>Buttle</surname> <given-names>K. F.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Structural and functional features and significance of the physical linkage between ER and mitochondria.</article-title> <source><italic>J. Cell Biol.</italic></source> <volume>174</volume> <fpage>915</fpage>&#x2013;<lpage>921</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200604016</pub-id> <pub-id pub-id-type="pmid">16982799</pub-id></citation></ref>
<ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cull-Candy</surname> <given-names>S.</given-names></name> <name><surname>Brickley</surname> <given-names>S.</given-names></name> <name><surname>Farrant</surname> <given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>NMDA receptor subunits: Diversity, development and disease.</article-title> <source><italic>Curr. Opin. Neurobiol.</italic></source> <volume>11</volume> <fpage>327</fpage>&#x2013;<lpage>335</lpage>. <pub-id pub-id-type="doi">10.1016/s0959-4388(00)00215-4</pub-id></citation></ref>
<ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dahlhaus</surname> <given-names>R.</given-names></name></person-group> (<year>2018</year>). <article-title>Of men and mice: Modeling the fragile X syndrome.</article-title> <source><italic>Front. Mol. Neurosci.</italic></source> <volume>11</volume>:<issue>41</issue>. <pub-id pub-id-type="doi">10.3389/fnmol.2018.00041</pub-id> <pub-id pub-id-type="pmid">29599705</pub-id></citation></ref>
<ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dalwadi</surname> <given-names>D. A.</given-names></name> <name><surname>Kim</surname> <given-names>S.</given-names></name> <name><surname>Schetz</surname> <given-names>J.</given-names></name> <name><surname>Schreihofer</surname> <given-names>D. A.</given-names></name> <name><surname>Kim</surname> <given-names>S.</given-names></name></person-group> (<year>2022</year>). <article-title>Brain-derived neurotrophic factor for high-throughput evaluation of selective sigma-1 receptor ligands.</article-title> <source><italic>J. Pharmacol. Toxicol. Methods</italic></source> <volume>113</volume>:<issue>107129</issue>. <pub-id pub-id-type="doi">10.1016/j.vascn.2021.107129</pub-id> <pub-id pub-id-type="pmid">34678430</pub-id></citation></ref>
<ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>DaSilva</surname> <given-names>L. L.</given-names></name> <name><surname>Wall</surname> <given-names>M. J.</given-names></name> <name><surname>P de Almeida</surname> <given-names>L.</given-names></name> <name><surname>Wauters</surname> <given-names>S. C.</given-names></name> <name><surname>Janu&#x00E1;rio</surname> <given-names>Y. C.</given-names></name> <name><surname>M&#x00FC;ller</surname> <given-names>J.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Activity-regulated cytoskeleton-associated protein controls AMPAR endocytosis through a direct interaction with clathrin-adaptor protein 2.</article-title> <source><italic>eNeuro</italic></source> <volume>3</volume> <fpage>1</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1523/ENEURO.0144-15.2016</pub-id> <pub-id pub-id-type="pmid">27257628</pub-id></citation></ref>
<ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Montigny</surname> <given-names>C.</given-names></name> <name><surname>Monnet</surname> <given-names>F. P.</given-names></name> <name><surname>Fournier</surname> <given-names>A.</given-names></name> <name><surname>Debonnel</surname> <given-names>G.</given-names></name></person-group> (<year>1992</year>). <article-title>Sigma ligands and neuropeptide Y selectively potentiate the NMDA response in the rat CA3 dorsal hippocampus: In vivo electrophysiological studies.</article-title> <source><italic>Clin. Neuropharmacol.</italic></source> <volume>15(Suppl. 1)</volume> <fpage>145A</fpage>&#x2013;<lpage>146A</lpage>. <pub-id pub-id-type="doi">10.1097/00002826-199201001-00078</pub-id> <pub-id pub-id-type="pmid">1323387</pub-id></citation></ref>
<ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delgehyr</surname> <given-names>N.</given-names></name> <name><surname>Wieland</surname> <given-names>U.</given-names></name> <name><surname>Rangone</surname> <given-names>H.</given-names></name> <name><surname>Pinson</surname> <given-names>X.</given-names></name> <name><surname>Mao</surname> <given-names>G.</given-names></name> <name><surname>Dzhindzhev</surname> <given-names>N. S.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title><italic>Drosophila</italic> Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability.</article-title> <source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source> <volume>109</volume> <fpage>5729</fpage>&#x2013;<lpage>5734</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1108537109</pub-id> <pub-id pub-id-type="pmid">22451918</pub-id></citation></ref>
<ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Denzel</surname> <given-names>A.</given-names></name> <name><surname>Molinari</surname> <given-names>M.</given-names></name> <name><surname>Trigueros</surname> <given-names>C.</given-names></name> <name><surname>Martin</surname> <given-names>J. E.</given-names></name> <name><surname>Velmurgan</surname> <given-names>S.</given-names></name> <name><surname>Brown</surname> <given-names>S.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Early postnatal death and motor disorders in mice congenitally deficient in calnexin expression.</article-title> <source><italic>Mol. Cell. Biol.</italic></source> <volume>22</volume> <fpage>7398</fpage>&#x2013;<lpage>7404</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.22.21.7398-7404.2002</pub-id> <pub-id pub-id-type="pmid">12370287</pub-id></citation></ref>
<ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Desai</surname> <given-names>C.</given-names></name> <name><surname>Garriga</surname> <given-names>G.</given-names></name> <name><surname>McIntire</surname> <given-names>S. L.</given-names></name> <name><surname>Horvitz</surname> <given-names>H. R.</given-names></name></person-group> (<year>1988</year>). <article-title>A genetic pathway for the development of the <italic>Caenorhabditis elegans</italic> HSN motor neurons.</article-title> <source><italic>Nature</italic></source> <volume>336</volume> <fpage>638</fpage>&#x2013;<lpage>646</lpage>. <pub-id pub-id-type="doi">10.1038/336638a0</pub-id> <pub-id pub-id-type="pmid">3200316</pub-id></citation></ref>
<ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Devakumar</surname> <given-names>D.</given-names></name> <name><surname>Bamford</surname> <given-names>A.</given-names></name> <name><surname>Ferreira</surname> <given-names>M. U.</given-names></name> <name><surname>Broad</surname> <given-names>J.</given-names></name> <name><surname>Rosch</surname> <given-names>R. E.</given-names></name> <name><surname>Groce</surname> <given-names>N.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Infectious causes of microcephaly: Epidemiology, pathogenesis, diagnosis, and management.</article-title> <source><italic>Lancet Infect. Dis.</italic></source> <volume>18</volume> <fpage>e1</fpage>&#x2013;<lpage>e13</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(17)30398-5</pub-id></citation></ref>
<ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Doyle</surname> <given-names>S. M.</given-names></name> <name><surname>Genest</surname> <given-names>O.</given-names></name> <name><surname>Wickner</surname> <given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Protein rescue from aggregates by powerful molecular chaperone machines.</article-title> <source><italic>Nat. Rev. Mol. Cell Biol.</italic></source> <volume>14</volume> <fpage>617</fpage>&#x2013;<lpage>629</lpage>. <pub-id pub-id-type="doi">10.1038/nrm3660</pub-id> <pub-id pub-id-type="pmid">24061228</pub-id></citation></ref>
<ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ehlers</surname> <given-names>M. D.</given-names></name></person-group> (<year>2000</year>). <article-title>Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting.</article-title> <source><italic>Neuron</italic></source> <volume>28</volume> <fpage>511</fpage>&#x2013;<lpage>525</lpage>. <pub-id pub-id-type="doi">10.1016/s0896-6273(00)00129-x</pub-id></citation></ref>
<ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ellgaard</surname> <given-names>L.</given-names></name> <name><surname>Ruddock</surname> <given-names>L. W.</given-names></name></person-group> (<year>2005</year>). <article-title>The human protein disulphide isomerase family: Substrate interactions and functional properties.</article-title> <source><italic>EMBO Rep.</italic></source> <volume>6</volume> <fpage>28</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1038/sj.embor.7400311</pub-id> <pub-id pub-id-type="pmid">15643448</pub-id></citation></ref>
<ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eyre</surname> <given-names>O.</given-names></name> <name><surname>Hughes</surname> <given-names>R. A.</given-names></name> <name><surname>Thapar</surname> <given-names>A. K.</given-names></name> <name><surname>Leibenluft</surname> <given-names>E.</given-names></name> <name><surname>Stringaris</surname> <given-names>A.</given-names></name> <name><surname>Davey Smith</surname> <given-names>G.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Childhood neurodevelopmental difficulties and risk of adolescent depression: The role of irritability.</article-title> <source><italic>J. Child Psychol. Psychiatry</italic></source> <volume>60</volume> <fpage>866</fpage>&#x2013;<lpage>874</lpage>. <pub-id pub-id-type="doi">10.1111/jcpp.13053</pub-id> <pub-id pub-id-type="pmid">30908655</pub-id></citation></ref>
<ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fatemi</surname> <given-names>S. H.</given-names></name> <name><surname>Snow</surname> <given-names>A. V.</given-names></name> <name><surname>Stary</surname> <given-names>J. M.</given-names></name> <name><surname>Araghi-Niknam</surname> <given-names>M.</given-names></name> <name><surname>Reutiman</surname> <given-names>T. J.</given-names></name> <name><surname>Lee</surname> <given-names>S.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Reelin signaling is impaired in autism.</article-title> <source><italic>Biol. Psychiatry</italic></source> <volume>57</volume> <fpage>777</fpage>&#x2013;<lpage>787</lpage>.</citation></ref>
<ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x00E1;ndez-Fern&#x00E1;ndez</surname> <given-names>M. R.</given-names></name> <name><surname>Valpuesta</surname> <given-names>J. M.</given-names></name></person-group> (<year>2018</year>). <article-title>Hsp70 chaperone: A master player in protein homeostasis.</article-title> <source><italic>F1000Res.</italic></source> <volume>7</volume> <fpage>1</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.12688/f1000research.15528.1</pub-id> <pub-id pub-id-type="pmid">30338057</pub-id></citation></ref>
<ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ficicioglu</surname> <given-names>C.</given-names></name> <name><surname>Giugliani</surname> <given-names>R.</given-names></name> <name><surname>Harmatz</surname> <given-names>P.</given-names></name> <name><surname>Mendelsohn</surname> <given-names>N. J.</given-names></name> <name><surname>Jego</surname> <given-names>V.</given-names></name> <name><surname>Parini</surname> <given-names>R.</given-names></name></person-group> (<year>2018</year>). <article-title>Intrafamilial variability in the clinical manifestations of mucopolysaccharidosis type II: Data from the hunter outcome survey (HOS).</article-title> <source><italic>Am. J. Med. Genet. A</italic></source> <volume>176</volume> <fpage>301</fpage>&#x2013;<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.38551</pub-id> <pub-id pub-id-type="pmid">29210515</pub-id></citation></ref>
<ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Filareti</surname> <given-names>M.</given-names></name> <name><surname>Luotti</surname> <given-names>S.</given-names></name> <name><surname>Pasetto</surname> <given-names>L.</given-names></name> <name><surname>Pignataro</surname> <given-names>M.</given-names></name> <name><surname>Paolella</surname> <given-names>K.</given-names></name> <name><surname>Messina</surname> <given-names>P.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Decreased levels of foldase and chaperone proteins are associated with an early-onset amyotrophic lateral sclerosis.</article-title> <source><italic>Front. Mol. Neurosci.</italic></source> <volume>10</volume>:<issue>99</issue>. <pub-id pub-id-type="doi">10.3389/fnmol.2017.00099</pub-id> <pub-id pub-id-type="pmid">28428745</pub-id></citation></ref>
<ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fontanilla</surname> <given-names>D.</given-names></name> <name><surname>Johannessen</surname> <given-names>M.</given-names></name> <name><surname>Hajipour</surname> <given-names>A. R.</given-names></name> <name><surname>Cozzi</surname> <given-names>N. V.</given-names></name> <name><surname>Jackson</surname> <given-names>M. B.</given-names></name> <name><surname>Ruoho</surname> <given-names>A. E.</given-names></name></person-group> (<year>2009</year>). <article-title>The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator.</article-title> <source><italic>Science</italic></source> <volume>323</volume> <fpage>934</fpage>&#x2013;<lpage>937</lpage>. <pub-id pub-id-type="doi">10.1126/science.1166127</pub-id> <pub-id pub-id-type="pmid">19213917</pub-id></citation></ref>
<ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Freese</surname> <given-names>J. L.</given-names></name> <name><surname>Pino</surname> <given-names>D.</given-names></name> <name><surname>Pleasure</surname> <given-names>S. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Wnt signaling in development and disease.</article-title> <source><italic>Neurobiol. Dis.</italic></source> <volume>38</volume> <fpage>148</fpage>&#x2013;<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2009.09.003</pub-id> <pub-id pub-id-type="pmid">19765659</pub-id></citation></ref>
<ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Freilich</surname> <given-names>R.</given-names></name> <name><surname>Arhar</surname> <given-names>T.</given-names></name> <name><surname>Abrams</surname> <given-names>J. L.</given-names></name> <name><surname>Gestwicki</surname> <given-names>J. E.</given-names></name></person-group> (<year>2018</year>). <article-title>Protein-protein interactions in the molecular chaperone network.</article-title> <source><italic>Acc. Chem. Res.</italic></source> <volume>51</volume> <fpage>940</fpage>&#x2013;<lpage>949</lpage>. <pub-id pub-id-type="doi">10.1021/acs.accounts.8b00036</pub-id> <pub-id pub-id-type="pmid">29613769</pub-id></citation></ref>
<ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname> <given-names>Y.</given-names></name> <name><surname>Lee</surname> <given-names>A. S.</given-names></name></person-group> (<year>2006</year>). <article-title>Glucose regulated proteins in cancer progression, drug resistance and immunotherapy.</article-title> <source><italic>Cancer Biol. Ther.</italic></source> <volume>5</volume> <fpage>741</fpage>&#x2013;<lpage>744</lpage>. <pub-id pub-id-type="doi">10.4161/cbt.5.7.2970</pub-id> <pub-id pub-id-type="pmid">16861902</pub-id></citation></ref>
<ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fucikova</surname> <given-names>J.</given-names></name> <name><surname>Spisek</surname> <given-names>R.</given-names></name> <name><surname>Kroemer</surname> <given-names>G.</given-names></name> <name><surname>Galluzzi</surname> <given-names>L.</given-names></name></person-group> (<year>2021</year>). <article-title>Calreticulin and cancer.</article-title> <source><italic>Cell Res.</italic></source> <volume>31</volume> <fpage>5</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1038/s41422-020-0383-9</pub-id> <pub-id pub-id-type="pmid">32733014</pub-id></citation></ref>
<ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fukunaga</surname> <given-names>K.</given-names></name> <name><surname>Moriguchi</surname> <given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Stimulation of the sigma-1 receptor and the effects on neurogenesis and depressive behaviors in mice.</article-title> <source><italic>Adv. Exp. Med. Biol.</italic></source> <volume>964</volume> <fpage>201</fpage>&#x2013;<lpage>211</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-319-50174-1_14</pub-id></citation></ref>
<ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galligan</surname> <given-names>J. J.</given-names></name> <name><surname>Petersen</surname> <given-names>D. R.</given-names></name></person-group> (<year>2012</year>). <article-title>The human protein disulfide isomerase gene family.</article-title> <source><italic>Hum. Genomics</italic></source> <volume>6</volume>:<issue>6</issue>. <pub-id pub-id-type="doi">10.1186/1479-7364-6-6</pub-id> <pub-id pub-id-type="pmid">23245351</pub-id></citation></ref>
<ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gerrow</surname> <given-names>K.</given-names></name> <name><surname>Triller</surname> <given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Synaptic stability and plasticity in a floating world.</article-title> <source><italic>Curr. Opin. Neurobiol.</italic></source> <volume>20</volume> <fpage>631</fpage>&#x2013;<lpage>639</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2010.06.010</pub-id> <pub-id pub-id-type="pmid">20655734</pub-id></citation></ref>
<ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gewirth</surname> <given-names>D. T.</given-names></name></person-group> (<year>2016</year>). <article-title>Paralog specific Hsp90 inhibitors &#x2013; a brief history and a bright future.</article-title> <source><italic>Curr. Top. Med. Chem.</italic></source> <volume>16</volume> <fpage>2779</fpage>&#x2013;<lpage>2791</lpage>. <pub-id pub-id-type="doi">10.2174/1568026616666160413141154</pub-id> <pub-id pub-id-type="pmid">27072700</pub-id></citation></ref>
<ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ghashghaei</surname> <given-names>H. T.</given-names></name> <name><surname>Lai</surname> <given-names>C.</given-names></name> <name><surname>Anton</surname> <given-names>E. S.</given-names></name></person-group> (<year>2007</year>). <article-title>Neuronal migration in the adult brain: Are we there yet?</article-title> <source><italic>Nat. Rev. Neurosci.</italic></source> <volume>8</volume> <fpage>141</fpage>&#x2013;<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2074</pub-id> <pub-id pub-id-type="pmid">17237805</pub-id></citation></ref>
<ref id="B73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gibbons</surname> <given-names>R. J.</given-names></name> <name><surname>Picketts</surname> <given-names>D. J.</given-names></name> <name><surname>Villard</surname> <given-names>L.</given-names></name> <name><surname>Higgs</surname> <given-names>D. R.</given-names></name></person-group> (<year>1995</year>). <article-title>Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome).</article-title> <source><italic>Cell</italic></source> <volume>80</volume> <fpage>837</fpage>&#x2013;<lpage>845</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(95)90287-2</pub-id></citation></ref>
<ref id="B74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gibbons</surname> <given-names>R. J.</given-names></name> <name><surname>Suthers</surname> <given-names>G. K.</given-names></name> <name><surname>Wilkie</surname> <given-names>A. O.</given-names></name> <name><surname>Buckle</surname> <given-names>V. J.</given-names></name> <name><surname>Higgs</surname> <given-names>D. R.</given-names></name></person-group> (<year>1992</year>). <article-title>X-linked alpha-thalassemia/mental retardation (ATR-X) syndrome: Localization to Xq12-q21.31 by X inactivation and linkage analysis.</article-title> <source><italic>Am. J. Hum. Genet.</italic></source> <volume>51</volume> <fpage>1136</fpage>&#x2013;<lpage>1149</lpage>. <pub-id pub-id-type="pmid">1415255</pub-id></citation></ref>
<ref id="B75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gibbons</surname> <given-names>R. J.</given-names></name> <name><surname>Wada</surname> <given-names>T.</given-names></name> <name><surname>Fisher</surname> <given-names>C. A.</given-names></name> <name><surname>Malik</surname> <given-names>N.</given-names></name> <name><surname>Mitson</surname> <given-names>M. J.</given-names></name> <name><surname>Steensma</surname> <given-names>D. P.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Mutations in the chromatin-associated protein ATRX.</article-title> <source><italic>Hum. Mutat.</italic></source> <volume>29</volume> <fpage>796</fpage>&#x2013;<lpage>802</lpage>. <pub-id pub-id-type="doi">10.1002/humu.20734</pub-id> <pub-id pub-id-type="pmid">18409179</pub-id></citation></ref>
<ref id="B76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gloor</surname> <given-names>S. M.</given-names></name> <name><surname>Wachtel</surname> <given-names>M.</given-names></name> <name><surname>Bolliger</surname> <given-names>M. F.</given-names></name> <name><surname>Ishihara</surname> <given-names>H.</given-names></name> <name><surname>Landmann</surname> <given-names>R.</given-names></name> <name><surname>Frei</surname> <given-names>K.</given-names></name></person-group> (<year>2001</year>). <article-title>Molecular and cellular permeability control at the blood-brain barrier.</article-title> <source><italic>Brain Res.</italic></source> <volume>36</volume> <fpage>258</fpage>&#x2013;<lpage>264</lpage>. <pub-id pub-id-type="doi">10.1016/s0165-0173(01)00102-3</pub-id></citation></ref>
<ref id="B77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Glover</surname> <given-names>D. J.</given-names></name> <name><surname>Clark</surname> <given-names>D. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Oligomeric assembly is required for chaperone activity of the filamentous &#x03B3;-prefoldin.</article-title> <source><italic>FEBS J.</italic></source> <volume>282</volume> <fpage>2985</fpage>&#x2013;<lpage>2997</lpage>. <pub-id pub-id-type="doi">10.1111/febs.13341</pub-id> <pub-id pub-id-type="pmid">26096656</pub-id></citation></ref>
<ref id="B78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>G&#x00F3;mez-Almer&#x00ED;a</surname> <given-names>M.</given-names></name> <name><surname>Burgaz</surname> <given-names>S.</given-names></name> <name><surname>Costas-Insua</surname> <given-names>C.</given-names></name> <name><surname>Rodr&#x00ED;guez-Cueto</surname> <given-names>C.</given-names></name> <name><surname>Santos-Garc&#x00ED;a</surname> <given-names>I.</given-names></name> <name><surname>Rodr&#x00ED;guez-Crespo</surname> <given-names>I.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>BiP heterozigosity aggravates pathological deterioration in experimental amyotrophic lateral sclerosis.</article-title> <source><italic>Int. J. Mol. Sci.</italic></source> <volume>22</volume>:<issue>12533</issue>. <pub-id pub-id-type="doi">10.3390/ijms222212533</pub-id> <pub-id pub-id-type="pmid">34830414</pub-id></citation></ref>
<ref id="B79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guerrini</surname> <given-names>R.</given-names></name> <name><surname>Dobyns</surname> <given-names>W. B.</given-names></name></person-group> (<year>2014</year>). <article-title>Malformations of cortical development: Clinical features and genetic causes.</article-title> <source><italic>Lancet Neurol.</italic></source> <volume>13</volume> <fpage>710</fpage>&#x2013;<lpage>726</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(14)70040-7</pub-id></citation></ref>
<ref id="B80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>C.</given-names></name> <name><surname>Ma</surname> <given-names>Y. Y.</given-names></name></person-group> (<year>2021</year>). <article-title>Calcium permeable-AMPA receptors and excitotoxicity in neurological disorders.</article-title> <source><italic>Front. Neural Circuits</italic></source> <volume>15</volume>:<issue>711564</issue>. <pub-id pub-id-type="doi">10.3389/fncir.2021.711564</pub-id> <pub-id pub-id-type="pmid">34483848</pub-id></citation></ref>
<ref id="B81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hagerman</surname> <given-names>R. J.</given-names></name> <name><surname>Berry-Kravis</surname> <given-names>E.</given-names></name> <name><surname>Kaufmann</surname> <given-names>W. E.</given-names></name> <name><surname>Ono</surname> <given-names>M. Y.</given-names></name> <name><surname>Tartaglia</surname> <given-names>N.</given-names></name> <name><surname>Lachiewicz</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Advances in the treatment of fragile X syndrome.</article-title> <source><italic>Pediatrics</italic></source> <volume>123</volume> <fpage>378</fpage>&#x2013;<lpage>390</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2008-0317</pub-id> <pub-id pub-id-type="pmid">19117905</pub-id></citation></ref>
<ref id="B82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hampel</surname> <given-names>H.</given-names></name> <name><surname>Williams</surname> <given-names>C.</given-names></name> <name><surname>Etcheto</surname> <given-names>A.</given-names></name> <name><surname>Goodsaid</surname> <given-names>F.</given-names></name> <name><surname>Parmentier</surname> <given-names>F.</given-names></name> <name><surname>Sallantin</surname> <given-names>J.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer&#x2019;s disease therapy: Analysis of the blarcamesine (ANAVEX2-73) Phase 2a clinical study.</article-title> <source><italic>Alzheimers Dement.</italic></source> <volume>6</volume>:<issue>e12013</issue>. <pub-id pub-id-type="doi">10.1002/trc2.12013</pub-id> <pub-id pub-id-type="pmid">32318621</pub-id></citation></ref>
<ref id="B83"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hanner</surname> <given-names>M.</given-names></name> <name><surname>Moebius</surname> <given-names>F. F.</given-names></name> <name><surname>Flandorfer</surname> <given-names>A.</given-names></name> <name><surname>Knaus</surname> <given-names>H. G.</given-names></name> <name><surname>Striessnig</surname> <given-names>J.</given-names></name> <name><surname>Kempner</surname> <given-names>E.</given-names></name><etal/></person-group> (<year>1996</year>). <article-title>Purification, molecular cloning, and expression of the mammalian sigma1-binding site.</article-title> <source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source> <volume>93</volume> <fpage>8072</fpage>&#x2013;<lpage>8077</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.93.15.8072</pub-id> <pub-id pub-id-type="pmid">8755605</pub-id></citation></ref>
<ref id="B84"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname> <given-names>A.</given-names></name> <name><surname>Kasahara</surname> <given-names>T.</given-names></name> <name><surname>Kametani</surname> <given-names>M.</given-names></name> <name><surname>Toyota</surname> <given-names>T.</given-names></name> <name><surname>Yoshikawa</surname> <given-names>T.</given-names></name> <name><surname>Kato</surname> <given-names>T.</given-names></name></person-group> (<year>2009</year>). <article-title>Aberrant endoplasmic reticulum stress response in lymphoblastoid cells from patients with bipolar disorder.</article-title> <source><italic>Int. J. Neuropsychopharmacol.</italic></source> <volume>12</volume> <fpage>33</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1017/S1461145708009358</pub-id> <pub-id pub-id-type="pmid">18771604</pub-id></citation></ref>
<ref id="B85"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname> <given-names>T.</given-names></name> <name><surname>Su</surname> <given-names>T. P.</given-names></name></person-group> (<year>2004</year>). <article-title>Sigma-1 receptor ligands: Potential in the treatment of neuropsychiatric disorders.</article-title> <source><italic>CNS Drugs</italic></source> <volume>18</volume> <fpage>269</fpage>&#x2013;<lpage>284</lpage>. <pub-id pub-id-type="doi">10.2165/00023210-200418050-00001</pub-id> <pub-id pub-id-type="pmid">15089113</pub-id></citation></ref>
<ref id="B86"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname> <given-names>T.</given-names></name> <name><surname>Su</surname> <given-names>T. P.</given-names></name></person-group> (<year>2007</year>). <article-title>Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival.</article-title> <source><italic>Cell</italic></source> <volume>131</volume> <fpage>596</fpage>&#x2013;<lpage>610</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2007.08.036</pub-id> <pub-id pub-id-type="pmid">17981125</pub-id></citation></ref>
<ref id="B87"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hazlett</surname> <given-names>H. C.</given-names></name> <name><surname>Poe</surname> <given-names>M. D.</given-names></name> <name><surname>Gerig</surname> <given-names>G.</given-names></name> <name><surname>Styner</surname> <given-names>M.</given-names></name> <name><surname>Chappell</surname> <given-names>C.</given-names></name> <name><surname>Smith</surname> <given-names>R. G.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Early brain overgrowth in autism associated with an increase in cortical surface area before age 2 years.</article-title> <source><italic>Arch. Gen. Psychiatry</italic></source> <volume>68</volume> <fpage>467</fpage>&#x2013;<lpage>476</lpage>. <pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2011.39</pub-id> <pub-id pub-id-type="pmid">21536976</pub-id></citation></ref>
<ref id="B88"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Helenius</surname> <given-names>A.</given-names></name> <name><surname>Aebi</surname> <given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>Intracellular functions of N-linked glycans.</article-title> <source><italic>Science</italic></source> <volume>291</volume> <fpage>2364</fpage>&#x2013;<lpage>2369</lpage>. <pub-id pub-id-type="doi">10.1126/science.291.5512.2364</pub-id> <pub-id pub-id-type="pmid">11269317</pub-id></citation></ref>
<ref id="B89"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hendershot</surname> <given-names>L.</given-names></name> <name><surname>Wei</surname> <given-names>J.</given-names></name> <name><surname>Gaut</surname> <given-names>J.</given-names></name> <name><surname>Melnick</surname> <given-names>J.</given-names></name> <name><surname>Aviel</surname> <given-names>S.</given-names></name> <name><surname>Argon</surname> <given-names>Y.</given-names></name></person-group> (<year>1996</year>). <article-title>Inhibition of immunoglobulin folding and secretion by dominant negative BiP ATPase mutants.</article-title> <source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source> <volume>93</volume> <fpage>5269</fpage>&#x2013;<lpage>5274</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.93.11.5269</pub-id> <pub-id pub-id-type="pmid">8643565</pub-id></citation></ref>
<ref id="B90"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Henley</surname> <given-names>J. M.</given-names></name> <name><surname>Wilkinson</surname> <given-names>K. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Synaptic AMPA receptor composition in development, plasticity and disease.</article-title> <source><italic>Nat. Rev. Neurosci.</italic></source> <volume>17</volume> <fpage>337</fpage>&#x2013;<lpage>350</lpage>. <pub-id pub-id-type="doi">10.1038/nrn.2016.37</pub-id> <pub-id pub-id-type="pmid">27080385</pub-id></citation></ref>
<ref id="B91"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hilliard</surname> <given-names>M. A.</given-names></name> <name><surname>Bargmann</surname> <given-names>C. I.</given-names></name></person-group> (<year>2006</year>). <article-title>Wnt signals and frizzled activity orient anterior-posterior axon outgrowth in <italic>C. elegans</italic>.</article-title> <source><italic>Dev. Cell</italic></source> <volume>10</volume> <fpage>379</fpage>&#x2013;<lpage>390</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2006.01.013</pub-id> <pub-id pub-id-type="pmid">16516840</pub-id></citation></ref>
<ref id="B92"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hinata</surname> <given-names>M.</given-names></name> <name><surname>Matsuoka</surname> <given-names>I.</given-names></name> <name><surname>Iwamoto</surname> <given-names>T.</given-names></name> <name><surname>Watanabe</surname> <given-names>Y.</given-names></name> <name><surname>Kimura</surname> <given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>Mechanism of Na+/Ca2+ exchanger activation by hydrogen peroxide in guinea-pig ventricular myocytes.</article-title> <source><italic>J. Pharmacol. Sci.</italic></source> <volume>103</volume> <fpage>283</fpage>&#x2013;<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1254/jphs.fp0060015</pub-id> <pub-id pub-id-type="pmid">17332693</pub-id></citation></ref>
<ref id="B93"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoter</surname> <given-names>A.</given-names></name> <name><surname>El-Sabban</surname> <given-names>M. E.</given-names></name> <name><surname>Naim</surname> <given-names>H. Y.</given-names></name></person-group> (<year>2018</year>). <article-title>The HSP90 family: Structure, regulation, function, and implications in health and disease.</article-title> <source><italic>Int. J. Mol. Sci.</italic></source> <volume>19</volume>:<issue>2560</issue>. <pub-id pub-id-type="doi">10.3390/ijms19092560</pub-id> <pub-id pub-id-type="pmid">30158430</pub-id></citation></ref>
<ref id="B94"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ichhaporia</surname> <given-names>V. P.</given-names></name> <name><surname>Hendershot</surname> <given-names>L. M.</given-names></name></person-group> (<year>2021</year>). <article-title>Role of the HSP70 co-chaperone sil1 in health and disease</article-title>. <source><italic>Int. J. Mol. Sci.</italic></source> <volume>22</volume>:<fpage>1564</fpage>. <pub-id pub-id-type="doi">10.3390/ijms22041564</pub-id> <pub-id pub-id-type="pmid">33557244</pub-id></citation></ref>
<ref id="B95"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Inaguma</surname> <given-names>Y.</given-names></name> <name><surname>Hamada</surname> <given-names>N.</given-names></name> <name><surname>Tabata</surname> <given-names>H.</given-names></name> <name><surname>Iwamoto</surname> <given-names>I.</given-names></name> <name><surname>Mizuno</surname> <given-names>M.</given-names></name> <name><surname>Nishimura</surname> <given-names>Y. V.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>SIL1, a causative cochaperone gene of marinesco-s&#x00F6;jgren syndrome, plays an essential role in establishing the architecture of the developing cerebral cortex.</article-title> <source><italic>EMBO Mol. Med.</italic></source> <volume>6</volume> <fpage>414</fpage>&#x2013;<lpage>429</lpage>. <pub-id pub-id-type="doi">10.1002/emmm.201303069</pub-id> <pub-id pub-id-type="pmid">24473200</pub-id></citation></ref>
<ref id="B96"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iossifov</surname> <given-names>I.</given-names></name> <name><surname>O&#x2019;Roak</surname> <given-names>B. J.</given-names></name> <name><surname>Sanders</surname> <given-names>S. J.</given-names></name> <name><surname>Ronemus</surname> <given-names>M.</given-names></name> <name><surname>Krumm</surname> <given-names>N.</given-names></name> <name><surname>Levy</surname> <given-names>D.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>The contribution of de novo coding mutations to autism spectrum disorder.</article-title> <source><italic>Nature</italic></source> <volume>515</volume> <fpage>216</fpage>&#x2013;<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1038/nature13908</pub-id> <pub-id pub-id-type="pmid">25363768</pub-id></citation></ref>
<ref id="B97"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ishima</surname> <given-names>T.</given-names></name> <name><surname>Hashimoto</surname> <given-names>K.</given-names></name></person-group> (<year>2012</year>). <article-title>Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by ifenprodil: The role of sigma-1 and IP3 receptors.</article-title> <source><italic>PLoS One</italic></source> <volume>7</volume>:<issue>e37989</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0037989</pub-id> <pub-id pub-id-type="pmid">22655093</pub-id></citation></ref>
<ref id="B98"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ishima</surname> <given-names>T.</given-names></name> <name><surname>Fujita</surname> <given-names>Y.</given-names></name> <name><surname>Hashimoto</surname> <given-names>K.</given-names></name></person-group> (<year>2014</year>). <article-title>Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells.</article-title> <source><italic>Eur. J. Pharmacol.</italic></source> <volume>727</volume> <fpage>167</fpage>&#x2013;<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2014.01.064</pub-id> <pub-id pub-id-type="pmid">24508523</pub-id></citation></ref>
<ref id="B99"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ismail</surname> <given-names>F. Y.</given-names></name> <name><surname>Shapiro</surname> <given-names>B. K.</given-names></name></person-group> (<year>2019</year>). <article-title>What are neurodevelopmental disorders?</article-title> <source><italic>Curr. Opin. Neurol.</italic></source> <volume>32</volume> <fpage>611</fpage>&#x2013;<lpage>616</lpage>. <pub-id pub-id-type="doi">10.1097/WCO.0000000000000710</pub-id> <pub-id pub-id-type="pmid">31116115</pub-id></citation></ref>
<ref id="B100"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Itakura</surname> <given-names>M.</given-names></name> <name><surname>Tsujimura</surname> <given-names>J.</given-names></name> <name><surname>Yamamori</surname> <given-names>S.</given-names></name> <name><surname>Ohkido</surname> <given-names>T.</given-names></name> <name><surname>Takahashi</surname> <given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>NMDA receptor-dependent recruitment of calnexin to the neuronal plasma membrane.</article-title> <source><italic>Neurosci. Lett.</italic></source> <volume>550</volume> <fpage>173</fpage>&#x2013;<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2013.06.064</pub-id> <pub-id pub-id-type="pmid">23851254</pub-id></citation></ref>
<ref id="B101"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>Y. S.</given-names></name> <name><surname>Xu</surname> <given-names>Z. H.</given-names></name></person-group> (<year>2019</year>). <article-title>Brain developmental diseases and pathogenic mechanisms.</article-title> <source><italic>Hereditas</italic></source> <volume>41</volume> <fpage>801</fpage>&#x2013;<lpage>815</lpage>. <pub-id pub-id-type="doi">10.16288/j.yczz.19-133</pub-id> <pub-id pub-id-type="pmid">31549679</pub-id></citation></ref>
<ref id="B102"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname> <given-names>H.</given-names></name> <name><surname>Komita</surname> <given-names>M.</given-names></name> <name><surname>Aoe</surname> <given-names>T.</given-names></name></person-group> (<year>2017</year>). <article-title>The role of BiP retrieval by the KDEL receptor in the early secretory pathway and its effect on protein quality control and neurodegeneration.</article-title> <source><italic>Front. Mol. Neurosci.</italic></source> <volume>10</volume>:<issue>222</issue>. <pub-id pub-id-type="doi">10.3389/fnmol.2017.00222</pub-id> <pub-id pub-id-type="pmid">28769758</pub-id></citation></ref>
<ref id="B103"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname> <given-names>H.</given-names></name> <name><surname>Mimura</surname> <given-names>N.</given-names></name> <name><surname>Kashio</surname> <given-names>M.</given-names></name> <name><surname>Koseki</surname> <given-names>H.</given-names></name> <name><surname>Aoe</surname> <given-names>T.</given-names></name></person-group> (<year>2014</year>). <article-title>Late-onset of spinal neurodegeneration in knock-in mice expressing a mutant BiP.</article-title> <source><italic>PLoS One</italic></source> <volume>9</volume>:<issue>e112837</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0112837</pub-id> <pub-id pub-id-type="pmid">25405877</pub-id></citation></ref>
<ref id="B104"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jossin</surname> <given-names>Y.</given-names></name> <name><surname>Goffinet</surname> <given-names>A. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Reelin signals through phosphatidylinositol 3-kinase and Akt to control cortical development and through mTor to regulate dendritic growth.</article-title> <source><italic>Mol. Cell. Biol.</italic></source> <volume>27</volume> <fpage>7113</fpage>&#x2013;<lpage>7124</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.00928-07</pub-id> <pub-id pub-id-type="pmid">17698586</pub-id></citation></ref>
<ref id="B105"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname> <given-names>J.</given-names></name> <name><surname>Eggleton</surname> <given-names>P.</given-names></name> <name><surname>Robinson</surname> <given-names>A.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Gutowski</surname> <given-names>N.</given-names></name> <name><surname>Holley</surname> <given-names>J.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Calnexin is necessary for T cell transmigration into the central nervous system.</article-title> <source><italic>JCI Insight</italic></source> <volume>3</volume>:<issue>e98410</issue>. <pub-id pub-id-type="doi">10.1172/jci.insight.98410</pub-id> <pub-id pub-id-type="pmid">29515033</pub-id></citation></ref>
<ref id="B106"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kadoyama</surname> <given-names>K.</given-names></name> <name><surname>Matsuura</surname> <given-names>K.</given-names></name> <name><surname>Takano</surname> <given-names>M.</given-names></name> <name><surname>Maekura</surname> <given-names>K.</given-names></name> <name><surname>Inoue</surname> <given-names>Y.</given-names></name> <name><surname>Matsuyama</surname> <given-names>S.</given-names></name></person-group> (<year>2019</year>). <article-title>Changes in the expression of prefoldin subunit 5 depending on synaptic plasticity in the mouse hippocampus.</article-title> <source><italic>Neurosci. Lett.</italic></source> <volume>712</volume>:<issue>134484</issue>. <pub-id pub-id-type="doi">10.1016/j.neulet.2019.134484</pub-id> <pub-id pub-id-type="pmid">31505240</pub-id></citation></ref>
<ref id="B107"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kann</surname> <given-names>O.</given-names></name> <name><surname>Kov&#x00E1;cs</surname> <given-names>R.</given-names></name></person-group> (<year>2007</year>). <article-title>Mitochondria and neuronal activity.</article-title> <source><italic>Am. J. Physiol. Cell Physiol.</italic></source> <volume>292</volume> <fpage>C641</fpage>&#x2013;<lpage>C657</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00222.2006</pub-id> <pub-id pub-id-type="pmid">17092996</pub-id></citation></ref>
<ref id="B108"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaufman</surname> <given-names>L.</given-names></name> <name><surname>Ayub</surname> <given-names>M.</given-names></name> <name><surname>Vincent</surname> <given-names>J. B.</given-names></name></person-group> (<year>2010</year>). <article-title>The genetic basis of non-syndromic intellectual disability: A review.</article-title> <source><italic>J. Neurodev. Disord.</italic></source> <volume>2</volume> <fpage>182</fpage>&#x2013;<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1007/s11689-010-9055-2</pub-id> <pub-id pub-id-type="pmid">21124998</pub-id></citation></ref>
<ref id="B109"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname> <given-names>W. E.</given-names></name> <name><surname>Moser</surname> <given-names>H. W.</given-names></name></person-group> (<year>2000</year>). <article-title>Dendritic anomalies in disorders associated with mental retardation.</article-title> <source><italic>Cereb. Cortex</italic></source> <volume>10</volume> <fpage>981</fpage>&#x2013;<lpage>991</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/10.10.981</pub-id> <pub-id pub-id-type="pmid">11007549</pub-id></citation></ref>
<ref id="B110"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname> <given-names>W. E.</given-names></name> <name><surname>Kidd</surname> <given-names>S. A.</given-names></name> <name><surname>Andrews</surname> <given-names>H. F.</given-names></name> <name><surname>Budimirovic</surname> <given-names>D. B.</given-names></name> <name><surname>Esler</surname> <given-names>A.</given-names></name> <name><surname>Haas-Givler</surname> <given-names>B.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Autism spectrum disorder in fragile X syndrome: Cooccurring conditions and current treatment.</article-title> <source><italic>Pediatrics</italic></source> <volume>139(Suppl. 3)</volume> <fpage>S194</fpage>&#x2013;<lpage>S206</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2016-1159F</pub-id> <pub-id pub-id-type="pmid">28814540</pub-id></citation></ref>
<ref id="B111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname> <given-names>W. E.</given-names></name> <name><surname>Sprouse</surname> <given-names>J.</given-names></name> <name><surname>Rebowe</surname> <given-names>N.</given-names></name> <name><surname>Hanania</surname> <given-names>T.</given-names></name> <name><surname>Klamer</surname> <given-names>D.</given-names></name> <name><surname>Missling</surname> <given-names>C. U.</given-names></name></person-group> (<year>2019</year>). <article-title>ANAVEX&#x00A7;2-73 (blarcamesine), a sigma-1 receptor agonist, ameliorates neurologic impairments in a mouse model of rett syndrome.</article-title> <source><italic>Pharmacol. Biochem. Behav.</italic></source> <volume>187</volume>:<issue>172796</issue>. <pub-id pub-id-type="doi">10.1016/j.pbb.2019.172796</pub-id> <pub-id pub-id-type="pmid">31704481</pub-id></citation></ref>
<ref id="B112"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname> <given-names>W. E.</given-names></name> <name><surname>Stallworth</surname> <given-names>J. L.</given-names></name> <name><surname>Everman</surname> <given-names>D. B.</given-names></name> <name><surname>Skinner</surname> <given-names>S. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Neurobiologically-based treatments in rett syndrome: Opportunities and challenges.</article-title> <source><italic>Expert Opin. Orphan Drugs</italic></source> <volume>4</volume> <fpage>1043</fpage>&#x2013;<lpage>1055</lpage>. <pub-id pub-id-type="doi">10.1080/21678707.2016.1229181</pub-id> <pub-id pub-id-type="pmid">28163986</pub-id></citation></ref>
<ref id="B113"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kessels</surname> <given-names>H. W.</given-names></name> <name><surname>Malinow</surname> <given-names>R.</given-names></name></person-group> (<year>2009</year>). <article-title>Synaptic AMPA receptor plasticity and behavior.</article-title> <source><italic>Neuron</italic></source> <volume>61</volume> <fpage>340</fpage>&#x2013;<lpage>350</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2009.01.015</pub-id> <pub-id pub-id-type="pmid">19217372</pub-id></citation></ref>
<ref id="B114"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>A. J.</given-names></name> <name><surname>Shi</surname> <given-names>Y.</given-names></name> <name><surname>Austin</surname> <given-names>R. C.</given-names></name> <name><surname>Werstuck</surname> <given-names>G. H.</given-names></name></person-group> (<year>2005</year>). <article-title>Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3.</article-title> <source><italic>J. Cell Sci.</italic></source> <volume>118(Pt 1)</volume> <fpage>89</fpage>&#x2013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.01562</pub-id> <pub-id pub-id-type="pmid">15585578</pub-id></citation></ref>
<ref id="B115"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname> <given-names>K.</given-names></name> <name><surname>Jin</surname> <given-names>H.</given-names></name> <name><surname>Ogawa</surname> <given-names>M.</given-names></name> <name><surname>Aoe</surname> <given-names>T.</given-names></name></person-group> (<year>2008</year>). <article-title>Dysfunction of the ER chaperone BiP accelerates the renal tubular injury.</article-title> <source><italic>Biochem. Biophys. Res. Commun.</italic></source> <volume>366</volume> <fpage>1048</fpage>&#x2013;<lpage>1053</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2007.12.098</pub-id> <pub-id pub-id-type="pmid">18158912</pub-id></citation></ref>
<ref id="B116"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Korb</surname> <given-names>E.</given-names></name> <name><surname>Finkbeiner</surname> <given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>Arc in synaptic plasticity: From gene to behavior.</article-title> <source><italic>Trends Neurosci.</italic></source> <volume>34</volume> <fpage>591</fpage>&#x2013;<lpage>598</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2011.08.007</pub-id> <pub-id pub-id-type="pmid">21963089</pub-id></citation></ref>
<ref id="B117"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kourrich</surname> <given-names>S.</given-names></name> <name><surname>Su</surname> <given-names>T. P.</given-names></name> <name><surname>Fujimoto</surname> <given-names>M.</given-names></name> <name><surname>Bonci</surname> <given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>The sigma-1 receptor: Roles in neuronal plasticity and disease.</article-title> <source><italic>Trends Neurosci.</italic></source> <volume>35</volume> <fpage>762</fpage>&#x2013;<lpage>771</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2012.09.007</pub-id> <pub-id pub-id-type="pmid">23102998</pub-id></citation></ref>
<ref id="B118"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kraus</surname> <given-names>A.</given-names></name> <name><surname>Groenendyk</surname> <given-names>J.</given-names></name> <name><surname>Bedard</surname> <given-names>K.</given-names></name> <name><surname>Baldwin</surname> <given-names>T. A.</given-names></name> <name><surname>Krause</surname> <given-names>K. H.</given-names></name> <name><surname>Dubois-Dauphin</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Calnexin deficiency leads to dysmyelination.</article-title> <source><italic>J. Biol. Chem.</italic></source> <volume>285</volume> <fpage>18928</fpage>&#x2013;<lpage>18938</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.107201</pub-id> <pub-id pub-id-type="pmid">20400506</pub-id></citation></ref>
<ref id="B119"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krieger</surname> <given-names>M.</given-names></name> <name><surname>Roos</surname> <given-names>A.</given-names></name> <name><surname>Stendel</surname> <given-names>C.</given-names></name> <name><surname>Claeys</surname> <given-names>K. G.</given-names></name> <name><surname>Sonmez</surname> <given-names>F. M.</given-names></name> <name><surname>Baudis</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>SIL1 mutations and clinical spectrum in patients with marinesco-sjogren syndrome.</article-title> <source><italic>Brain</italic></source> <volume>136(Pt 12)</volume> <fpage>3634</fpage>&#x2013;<lpage>3644</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awt283</pub-id> <pub-id pub-id-type="pmid">24176978</pub-id></citation></ref>
<ref id="B120"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname> <given-names>R. A.</given-names></name> <name><surname>KaraMohamed</surname> <given-names>S.</given-names></name> <name><surname>Sudi</surname> <given-names>J.</given-names></name> <name><surname>Conrad</surname> <given-names>D. F.</given-names></name> <name><surname>Brune</surname> <given-names>C.</given-names></name> <name><surname>Badner</surname> <given-names>J. A.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Recurrent 16p11.2 microdeletions in autism.</article-title> <source><italic>Hum. Mol. Genet.</italic></source> <volume>17</volume> <fpage>628</fpage>&#x2013;<lpage>638</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddm376</pub-id> <pub-id pub-id-type="pmid">18156158</pub-id></citation></ref>
<ref id="B121"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kwan</surname> <given-names>K. Y.</given-names></name> <name><surname>Sestan</surname> <given-names>N.</given-names></name> <name><surname>Anton</surname> <given-names>E. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Transcriptional co-regulation of neuronal migration and laminar identity in the neocortex.</article-title> <source><italic>Development</italic></source> <volume>139</volume> <fpage>1535</fpage>&#x2013;<lpage>1546</lpage>. <pub-id pub-id-type="doi">10.1242/dev.069963</pub-id> <pub-id pub-id-type="pmid">22492350</pub-id></citation></ref>
<ref id="B122"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname> <given-names>O. C.</given-names></name> <name><surname>Lee</surname> <given-names>E. J.</given-names></name> <name><surname>Lee</surname> <given-names>J. Y.</given-names></name> <name><surname>Youn</surname> <given-names>J.</given-names></name> <name><surname>Kim</surname> <given-names>T. H.</given-names></name> <name><surname>Hong</surname> <given-names>S.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Prefoldin 5 and anti-prefoldin 5 antibodies as biomarkers for uveitis in ankylosing spondylitis.</article-title> <source><italic>Front. Immunol.</italic></source> <volume>10</volume>:<issue>384</issue>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.00384</pub-id> <pub-id pub-id-type="pmid">30891043</pub-id></citation></ref>
<ref id="B123"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname> <given-names>M. C.</given-names></name> <name><surname>Lombardo</surname> <given-names>M. V.</given-names></name> <name><surname>Baron-Cohen</surname> <given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Autism.</article-title> <source><italic>Lancet</italic></source> <volume>383</volume> <fpage>896</fpage>&#x2013;<lpage>910</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(13)61539-1</pub-id></citation></ref>
<ref id="B124"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lammert</surname> <given-names>D. B.</given-names></name> <name><surname>Howell</surname> <given-names>B. W.</given-names></name></person-group> (<year>2016</year>). <article-title>RELN mutations in autism spectrum disorder.</article-title> <source><italic>Front. Cell. Neurosci.</italic></source> <volume>10</volume>:<issue>84</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2016.00084</pub-id> <pub-id pub-id-type="pmid">27064498</pub-id></citation></ref>
<ref id="B125"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lammert</surname> <given-names>D. B.</given-names></name> <name><surname>Middleton</surname> <given-names>F. A.</given-names></name> <name><surname>Pan</surname> <given-names>J.</given-names></name> <name><surname>Olson</surname> <given-names>E. C.</given-names></name> <name><surname>Howell</surname> <given-names>B. W.</given-names></name></person-group> (<year>2017</year>). <article-title>The de novo autism spectrum disorder RELN R2290C mutation reduces reelin secretion and increases protein disulfide isomerase expression.</article-title> <source><italic>J. Neurochem.</italic></source> <volume>142</volume> <fpage>89</fpage>&#x2013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.14045</pub-id> <pub-id pub-id-type="pmid">28419454</pub-id></citation></ref>
<ref id="B126"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laurvick</surname> <given-names>C. L.</given-names></name> <name><surname>de Klerk</surname> <given-names>N.</given-names></name> <name><surname>Bower</surname> <given-names>C.</given-names></name> <name><surname>Christodoulou</surname> <given-names>J.</given-names></name> <name><surname>Ravine</surname> <given-names>D.</given-names></name> <name><surname>Ellaway</surname> <given-names>C.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Rett syndrome in Australia: A review of the epidemiology.</article-title> <source><italic>J. Pediatr.</italic></source> <volume>148</volume> <fpage>347</fpage>&#x2013;<lpage>352</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2005.10.037</pub-id> <pub-id pub-id-type="pmid">16615965</pub-id></citation></ref>
<ref id="B127"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>A. C.</given-names></name> <name><surname>Shih</surname> <given-names>Y. Y.</given-names></name> <name><surname>Zhou</surname> <given-names>F.</given-names></name> <name><surname>Chao</surname> <given-names>T. C.</given-names></name> <name><surname>Lee</surname> <given-names>H.</given-names></name> <name><surname>Liao</surname> <given-names>Y. F.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Calreticulin regulates MYCN expression to control neuronal differentiation and stemness of neuroblastoma.</article-title> <source><italic>J. Mol. Med.</italic></source> <volume>97</volume> <fpage>325</fpage>&#x2013;<lpage>339</lpage>. <pub-id pub-id-type="doi">10.1007/s00109-018-1730-x</pub-id> <pub-id pub-id-type="pmid">30612140</pub-id></citation></ref>
<ref id="B128"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>Y.</given-names></name> <name><surname>Smith</surname> <given-names>R. S.</given-names></name> <name><surname>Jordan</surname> <given-names>W.</given-names></name> <name><surname>King</surname> <given-names>B. L.</given-names></name> <name><surname>Won</surname> <given-names>J.</given-names></name> <name><surname>Valpuesta</surname> <given-names>J. M.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Prefoldin 5 is required for normal sensory and neuronal development in a murine model.</article-title> <source><italic>J. Biol. Chem.</italic></source> <volume>286</volume> <fpage>726</fpage>&#x2013;<lpage>736</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.177352</pub-id> <pub-id pub-id-type="pmid">20956523</pub-id></citation></ref>
<ref id="B129"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leemhuis</surname> <given-names>J.</given-names></name> <name><surname>Bock</surname> <given-names>H. H.</given-names></name></person-group> (<year>2011</year>). <article-title>Reelin modulates cytoskeletal organization by regulating Rho GTPases.</article-title> <source><italic>Commun. Integr. Biol.</italic></source> <volume>4</volume> <fpage>254</fpage>&#x2013;<lpage>257</lpage>. <pub-id pub-id-type="doi">10.4161/cib.4.3.14890</pub-id> <pub-id pub-id-type="pmid">21980553</pub-id></citation></ref>
<ref id="B130"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levenga</surname> <given-names>J.</given-names></name> <name><surname>Willemsen</surname> <given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>Perturbation of dendritic protrusions in intellectual disability.</article-title> <source><italic>Prog. Brain Res.</italic></source> <volume>197</volume> <fpage>153</fpage>&#x2013;<lpage>168</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-444-54299-1.00008-X</pub-id> <pub-id pub-id-type="pmid">22541292</pub-id></citation></ref>
<ref id="B131"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>G.</given-names></name> <name><surname>Pleasure</surname> <given-names>S. J.</given-names></name></person-group> (<year>2014</year>). <article-title>The development of hippocampal cellular assemblies.</article-title> <source><italic>Wiley Interdiscip. Rev. Dev. Biol.</italic></source> <volume>3</volume> <fpage>165</fpage>&#x2013;<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1002/wdev.127</pub-id> <pub-id pub-id-type="pmid">24719288</pub-id></citation></ref>
<ref id="B132"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H. D.</given-names></name> <name><surname>Liu</surname> <given-names>W. X.</given-names></name> <name><surname>Michalak</surname> <given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Enhanced clathrin-dependent endocytosis in the absence of calnexin.</article-title> <source><italic>PLoS One</italic></source> <volume>6</volume>:<issue>e21678</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0021678</pub-id> <pub-id pub-id-type="pmid">21747946</pub-id></citation></ref>
<ref id="B133"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>J.</given-names></name> <name><surname>Brickler</surname> <given-names>T.</given-names></name> <name><surname>Banuelos</surname> <given-names>A.</given-names></name> <name><surname>Marjon</surname> <given-names>K.</given-names></name> <name><surname>Shcherbina</surname> <given-names>A.</given-names></name> <name><surname>Banerjee</surname> <given-names>S.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Overexpression of CD47 is associated with brain overgrowth and 16p11.2 deletion syndrome.</article-title> <source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source> <volume>118</volume>:<issue>e2005483118</issue>. <pub-id pub-id-type="doi">10.1073/pnas.2005483118</pub-id> <pub-id pub-id-type="pmid">33833053</pub-id></citation></ref>
<ref id="B134"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li&#x00E8;vremont</surname> <given-names>J. P.</given-names></name> <name><surname>Rizzuto</surname> <given-names>R.</given-names></name> <name><surname>Hendershot</surname> <given-names>L.</given-names></name> <name><surname>Meldolesi</surname> <given-names>J.</given-names></name></person-group> (<year>1997</year>). <article-title>BiP, a major chaperone protein of the endoplasmic reticulum lumen, plays a direct and important role in the storage of the rapidly exchanging pool of Ca2+.</article-title> <source><italic>J. Biol. Chem.</italic></source> <volume>272</volume> <fpage>30873</fpage>&#x2013;<lpage>30879</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.272.49.30873</pub-id> <pub-id pub-id-type="pmid">9388233</pub-id></citation></ref>
<ref id="B135"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>X. B.</given-names></name> <name><surname>Murray</surname> <given-names>K. D.</given-names></name> <name><surname>Jones</surname> <given-names>E. G.</given-names></name></person-group> (<year>2004</year>). <article-title>Switching of NMDA receptor 2A and 2B subunits at thalamic and cortical synapses during early postnatal development.</article-title> <source><italic>J. Neurosci.</italic></source> <volume>24</volume> <fpage>8885</fpage>&#x2013;<lpage>8895</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2476-04.2004</pub-id> <pub-id pub-id-type="pmid">15470155</pub-id></citation></ref>
<ref id="B136"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lombardi</surname> <given-names>L. M.</given-names></name> <name><surname>Baker</surname> <given-names>S. A.</given-names></name> <name><surname>Zoghbi</surname> <given-names>H. Y.</given-names></name></person-group> (<year>2015</year>). <article-title>MECP2 disorders: From the clinic to mice and back.</article-title> <source><italic>J. Clin. Investig.</italic></source> <volume>125</volume> <fpage>2914</fpage>&#x2013;<lpage>2923</lpage>. <pub-id pub-id-type="doi">10.1172/JCI78167</pub-id> <pub-id pub-id-type="pmid">26237041</pub-id></citation></ref>
<ref id="B137"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lopez de Armentia</surname> <given-names>M.</given-names></name> <name><surname>Sah</surname> <given-names>P.</given-names></name></person-group> (<year>2003</year>). <article-title>Development and subunit composition of synaptic NMDA receptors in the amygdala: NR2B synapses in the adult central amygdala.</article-title> <source><italic>J. Neurosci.</italic></source> <volume>23</volume> <fpage>6876</fpage>&#x2013;<lpage>6883</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-17-06876.2003</pub-id> <pub-id pub-id-type="pmid">12890782</pub-id></citation></ref>
<ref id="B138"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>S.</given-names></name> <name><surname>Mao</surname> <given-names>C.</given-names></name> <name><surname>Lee</surname> <given-names>B.</given-names></name> <name><surname>Lee</surname> <given-names>A. S.</given-names></name></person-group> (<year>2006</year>). <article-title>GRP78/BiP is required for cell proliferation and protecting the inner cell mass from apoptosis during early mouse embryonic development.</article-title> <source><italic>Mol. Cell. Biol.</italic></source> <volume>26</volume> <fpage>5688</fpage>&#x2013;<lpage>5697</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.00779-06</pub-id> <pub-id pub-id-type="pmid">16847323</pub-id></citation></ref>
<ref id="B139"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lynch</surname> <given-names>J. M.</given-names></name> <name><surname>Maillet</surname> <given-names>M.</given-names></name> <name><surname>Vanhoutte</surname> <given-names>D.</given-names></name> <name><surname>Schloemer</surname> <given-names>A.</given-names></name> <name><surname>Sargent</surname> <given-names>M. A.</given-names></name> <name><surname>Blair</surname> <given-names>N. S.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>A thrombospondin-dependent pathway for a protective ER stress response.</article-title> <source><italic>Cell</italic></source> <volume>149</volume> <fpage>1257</fpage>&#x2013;<lpage>1268</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.03.050</pub-id> <pub-id pub-id-type="pmid">22682248</pub-id></citation></ref>
<ref id="B140"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>F. H.</given-names></name> <name><surname>Li</surname> <given-names>C.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Shi</surname> <given-names>L.</given-names></name></person-group> (<year>2020</year>). <article-title>Mimicking molecular chaperones to regulate protein folding.</article-title> <source><italic>Adv. Mater.</italic></source> <volume>32</volume>:<issue>e1805945</issue>. <pub-id pub-id-type="doi">10.1002/adma.201805945</pub-id> <pub-id pub-id-type="pmid">31045287</pub-id></citation></ref>
<ref id="B141"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>MacDonald</surname> <given-names>B. T.</given-names></name> <name><surname>Hien</surname> <given-names>A.</given-names></name> <name><surname>Zhang</surname> <given-names>X.</given-names></name> <name><surname>Iranloye</surname> <given-names>O.</given-names></name> <name><surname>Virshup</surname> <given-names>D. M.</given-names></name> <name><surname>Waterman</surname> <given-names>M. L.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Disulfide bond requirements for active Wnt ligands.</article-title> <source><italic>J. Biol. Chem.</italic></source> <volume>289</volume> <fpage>18122</fpage>&#x2013;<lpage>18136</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M114.575027</pub-id> <pub-id pub-id-type="pmid">24841207</pub-id></citation></ref>
<ref id="B142"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maillard</surname> <given-names>A. M.</given-names></name> <name><surname>Ruef</surname> <given-names>A.</given-names></name> <name><surname>Pizzagalli</surname> <given-names>F.</given-names></name> <name><surname>Migliavacca</surname> <given-names>E.</given-names></name> <name><surname>Hippolyte</surname> <given-names>L.</given-names></name> <name><surname>Adaszewski</surname> <given-names>S.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>The 16p11.2 locus modulates brain structures common to autism, schizophrenia and obesity.</article-title> <source><italic>Mol. Psychiatry</italic></source> <volume>20</volume> <fpage>140</fpage>&#x2013;<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2014.145</pub-id> <pub-id pub-id-type="pmid">25421402</pub-id></citation></ref>
<ref id="B143"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mar&#x00ED;n</surname> <given-names>O.</given-names></name> <name><surname>Valiente</surname> <given-names>M.</given-names></name> <name><surname>Ge</surname> <given-names>X.</given-names></name> <name><surname>Tsai</surname> <given-names>L. H.</given-names></name></person-group> (<year>2010</year>). <article-title>Guiding neuronal cell migrations.</article-title> <source><italic>Cold Spring Harb. Perspect. Biol.</italic></source> <volume>2</volume>:<issue>a001834</issue>. <pub-id pub-id-type="doi">10.1101/cshperspect.a001834</pub-id> <pub-id pub-id-type="pmid">20182622</pub-id></citation></ref>
<ref id="B144"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname> <given-names>H. C.</given-names></name> <name><surname>Jones</surname> <given-names>W. D.</given-names></name> <name><surname>McIntyre</surname> <given-names>R.</given-names></name> <name><surname>Sanchez-Andrade</surname> <given-names>G.</given-names></name> <name><surname>Sanderson</surname> <given-names>M.</given-names></name> <name><surname>Stephenson</surname> <given-names>J. D.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Quantifying the contribution of recessive coding variation to developmental disorders.</article-title> <source><italic>Science</italic></source> <volume>362</volume> <fpage>1161</fpage>&#x2013;<lpage>1164</lpage>. <pub-id pub-id-type="doi">10.1126/science.aar6731</pub-id> <pub-id pub-id-type="pmid">30409806</pub-id></citation></ref>
<ref id="B145"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname> <given-names>R. R.</given-names></name> <name><surname>Bowen</surname> <given-names>W. D.</given-names></name> <name><surname>Tom</surname> <given-names>M. A.</given-names></name> <name><surname>Vo</surname> <given-names>V. N.</given-names></name> <name><surname>Truong</surname> <given-names>D. D.</given-names></name> <name><surname>De Costa</surname> <given-names>B. R.</given-names></name></person-group> (<year>1995</year>). <article-title>Characterization of two novel sigma receptor ligands: Antidystonic effects in rats suggest sigma receptor antagonism.</article-title> <source><italic>Eur. J. Pharmacol.</italic></source> <volume>280</volume> <fpage>301</fpage>&#x2013;<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1016/0014-2999(95)00208-3</pub-id></citation></ref>
<ref id="B146"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname> <given-names>R. R.</given-names></name> <name><surname>Hewett</surname> <given-names>K. L.</given-names></name> <name><surname>Pouw</surname> <given-names>B.</given-names></name> <name><surname>Bowen</surname> <given-names>W. D.</given-names></name> <name><surname>Husbands</surname> <given-names>S. M.</given-names></name> <name><surname>Cao</surname> <given-names>J. J.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Rimcazole analogs attenuate the convulsive effects of cocaine: Correlation with binding to sigma receptors rather than dopamine transporters.</article-title> <source><italic>Neuropharmacology</italic></source> <volume>41</volume> <fpage>878</fpage>&#x2013;<lpage>886</lpage>. <pub-id pub-id-type="doi">10.1016/s0028-3908(01)00116-2</pub-id></citation></ref>
<ref id="B147"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsuno</surname> <given-names>K.</given-names></name> <name><surname>Nakazawa</surname> <given-names>M.</given-names></name> <name><surname>Okamoto</surname> <given-names>K.</given-names></name> <name><surname>Kawashima</surname> <given-names>Y.</given-names></name> <name><surname>Mita</surname> <given-names>S.</given-names></name></person-group> (<year>1996</year>). <article-title>Binding properties of SA4503, a novel and selective sigma 1 receptor agonist.</article-title> <source><italic>Eur. J. Pharmacol.</italic></source> <volume>306</volume> <fpage>271</fpage>&#x2013;<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1016/0014-2999(96)00201-4</pub-id></citation></ref>
<ref id="B148"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maurice</surname> <given-names>T.</given-names></name> <name><surname>Martin-Fardon</surname> <given-names>R.</given-names></name> <name><surname>Romieu</surname> <given-names>P.</given-names></name> <name><surname>Matsumoto</surname> <given-names>R. R.</given-names></name></person-group> (<year>2002</year>). <article-title>Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity.</article-title> <source><italic>Neurosci. Biobehav. Rev.</italic></source> <volume>26</volume> <fpage>499</fpage>&#x2013;<lpage>527</lpage>. <pub-id pub-id-type="doi">10.1016/s0149-7634(02)00017-9</pub-id></citation></ref>
<ref id="B149"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname> <given-names>M. P.</given-names></name> <name><surname>Gierasch</surname> <given-names>L. M.</given-names></name></person-group> (<year>2019</year>). <article-title>Recent advances in the structural and mechanistic aspects of Hsp70 molecular chaperones.</article-title> <source><italic>J. Biol. Chem.</italic></source> <volume>294</volume> <fpage>2085</fpage>&#x2013;<lpage>2097</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.REV118.002810</pub-id> <pub-id pub-id-type="pmid">30455352</pub-id></citation></ref>
<ref id="B150"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname> <given-names>S. E.</given-names></name> <name><surname>Makarov</surname> <given-names>V.</given-names></name> <name><surname>Kirov</surname> <given-names>G.</given-names></name> <name><surname>Addington</surname> <given-names>A. M.</given-names></name> <name><surname>McClellan</surname> <given-names>J.</given-names></name> <name><surname>Yoon</surname> <given-names>S.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Microduplications of 16p11.2 are associated with schizophrenia.</article-title> <source><italic>Nat. Genet.</italic></source> <volume>41</volume> <fpage>1223</fpage>&#x2013;<lpage>1227</lpage>. <pub-id pub-id-type="doi">10.1038/ng.474</pub-id> <pub-id pub-id-type="pmid">19855392</pub-id></citation></ref>
<ref id="B151"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCracken</surname> <given-names>K. A.</given-names></name> <name><surname>Bowen</surname> <given-names>W. D.</given-names></name> <name><surname>de Costa</surname> <given-names>B. R.</given-names></name> <name><surname>Matsumoto</surname> <given-names>R. R.</given-names></name></person-group> (<year>1999</year>). <article-title>Two novel sigma receptor ligands, BD1047 and LR172, attenuate cocaine-induced toxicity and locomotor activity.</article-title> <source><italic>Eur. J. Pharmacol.</italic></source> <volume>370</volume> <fpage>225</fpage>&#x2013;<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1016/s0014-2999(99)00113-2</pub-id></citation></ref>
<ref id="B152"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mehregan</surname> <given-names>H.</given-names></name> <name><surname>Najmabadi</surname> <given-names>H.</given-names></name> <name><surname>Kahrizi</surname> <given-names>K.</given-names></name></person-group> (<year>2016</year>). <article-title>Genetic studies in intellectual disability and behavioral impairment.</article-title> <source><italic>Arch. Iran. Med.</italic></source> <volume>19</volume> <fpage>363</fpage>&#x2013;<lpage>375</lpage>.</citation></ref>
<ref id="B153"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Merikangas</surname> <given-names>K. R.</given-names></name> <name><surname>Jin</surname> <given-names>R.</given-names></name> <name><surname>He</surname> <given-names>J. P.</given-names></name> <name><surname>Kessler</surname> <given-names>R. C.</given-names></name> <name><surname>Lee</surname> <given-names>S.</given-names></name> <name><surname>Sampson</surname> <given-names>N. A.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative.</article-title> <source><italic>Arch. Gen. Psychiatry</italic></source> <volume>68</volume> <fpage>241</fpage>&#x2013;<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2011.12</pub-id> <pub-id pub-id-type="pmid">21383262</pub-id></citation></ref>
<ref id="B154"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Merlos</surname> <given-names>M.</given-names></name> <name><surname>Romero</surname> <given-names>L.</given-names></name> <name><surname>Zamanillo</surname> <given-names>D.</given-names></name> <name><surname>Plata-Salam&#x00E1;n</surname> <given-names>C.</given-names></name> <name><surname>Vela</surname> <given-names>J. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Sigma-1 receptor and pain.</article-title> <source><italic>Handb. Exp. Pharmacol.</italic></source> <volume>244</volume> <fpage>131</fpage>&#x2013;<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1007/164_2017_9</pub-id></citation></ref>
<ref id="B155"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mesaeli</surname> <given-names>N.</given-names></name> <name><surname>Nakamura</surname> <given-names>K.</given-names></name> <name><surname>Zvaritch</surname> <given-names>E.</given-names></name> <name><surname>Dickie</surname> <given-names>P.</given-names></name> <name><surname>Dziak</surname> <given-names>E.</given-names></name> <name><surname>Krause</surname> <given-names>K. H.</given-names></name><etal/></person-group> (<year>1999</year>). <article-title>Calreticulin is essential for cardiac development.</article-title> <source><italic>J. Cell Biol.</italic></source> <volume>144</volume> <fpage>857</fpage>&#x2013;<lpage>868</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.144.5.857</pub-id> <pub-id pub-id-type="pmid">10085286</pub-id></citation></ref>
<ref id="B156"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Michalak</surname> <given-names>M.</given-names></name> <name><surname>Corbett</surname> <given-names>E. F.</given-names></name> <name><surname>Mesaeli</surname> <given-names>N.</given-names></name> <name><surname>Nakamura</surname> <given-names>K.</given-names></name> <name><surname>Opas</surname> <given-names>M.</given-names></name></person-group> (<year>1999</year>). <article-title>Calreticulin: One protein, one gene, many functions.</article-title> <source><italic>Biochem. J.</italic></source> <volume>344(Pt 2)</volume> <fpage>281</fpage>&#x2013;<lpage>292</lpage>.</citation></ref>
<ref id="B157"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Michalak</surname> <given-names>M.</given-names></name> <name><surname>Milner</surname> <given-names>R. E.</given-names></name> <name><surname>Burns</surname> <given-names>K.</given-names></name> <name><surname>Opas</surname> <given-names>M.</given-names></name></person-group> (<year>1992</year>). <article-title>Calreticulin.</article-title> <source><italic>Biochem. J.</italic></source> <volume>285(Pt 3)</volume> <fpage>681</fpage>&#x2013;<lpage>692</lpage>. <pub-id pub-id-type="doi">10.1042/bj2850681</pub-id> <pub-id pub-id-type="pmid">1497605</pub-id></citation></ref>
<ref id="B158"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mientjes</surname> <given-names>E. J.</given-names></name> <name><surname>Nieuwenhuizen</surname> <given-names>I.</given-names></name> <name><surname>Kirkpatrick</surname> <given-names>L.</given-names></name> <name><surname>Zu</surname> <given-names>T.</given-names></name> <name><surname>Hoogeveen-Westerveld</surname> <given-names>M.</given-names></name> <name><surname>Severijnen</surname> <given-names>L.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo.</article-title> <source><italic>Neurobiol. Dis.</italic></source> <volume>21</volume> <fpage>549</fpage>&#x2013;<lpage>555</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2005.08.019</pub-id> <pub-id pub-id-type="pmid">16257225</pub-id></citation></ref>
<ref id="B159"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>D. J.</given-names></name> <name><surname>Fort</surname> <given-names>P. E.</given-names></name></person-group> (<year>2018</year>). <article-title>Heat shock proteins regulatory role in neurodevelopment.</article-title> <source><italic>Front. Neurosci.</italic></source> <volume>12</volume>:<issue>821</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2018.00821</pub-id> <pub-id pub-id-type="pmid">30483047</pub-id></citation></ref>
<ref id="B160"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mimura</surname> <given-names>N.</given-names></name> <name><surname>Yuasa</surname> <given-names>S.</given-names></name> <name><surname>Soma</surname> <given-names>M.</given-names></name> <name><surname>Jin</surname> <given-names>H.</given-names></name> <name><surname>Kimura</surname> <given-names>K.</given-names></name> <name><surname>Goto</surname> <given-names>S.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Altered quality control in the endoplasmic reticulum causes cortical dysplasia in knock-in mice expressing a mutant BiP.</article-title> <source><italic>Mol. Cell. Biol.</italic></source> <volume>28</volume> <fpage>293</fpage>&#x2013;<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.00473-07</pub-id> <pub-id pub-id-type="pmid">17954555</pub-id></citation></ref>
<ref id="B161"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monnet</surname> <given-names>F. P.</given-names></name> <name><surname>de Costa</surname> <given-names>B. R.</given-names></name> <name><surname>Bowen</surname> <given-names>W. D.</given-names></name></person-group> (<year>1996</year>). <article-title>Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.</article-title> <source><italic>Br. J. Pharmacol.</italic></source> <volume>119</volume> <fpage>65</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.1996.tb15678.x</pub-id> <pub-id pub-id-type="pmid">8872358</pub-id></citation></ref>
<ref id="B162"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monnet</surname> <given-names>F. P.</given-names></name> <name><surname>Debonnel</surname> <given-names>G.</given-names></name> <name><surname>Bergeron</surname> <given-names>R.</given-names></name> <name><surname>Gronier</surname> <given-names>B.</given-names></name> <name><surname>de Montigny</surname> <given-names>C.</given-names></name></person-group> (<year>1994</year>). <article-title>The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurons are differentially affected by pertussin toxin.</article-title> <source><italic>Br. J. Pharmacol.</italic></source> <volume>112</volume> <fpage>709</fpage>&#x2013;<lpage>715</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.1994.tb13134.x</pub-id> <pub-id pub-id-type="pmid">8075892</pub-id></citation></ref>
<ref id="B163"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monzo</surname> <given-names>K.</given-names></name> <name><surname>Dowd</surname> <given-names>S. R.</given-names></name> <name><surname>Minden</surname> <given-names>J. S.</given-names></name> <name><surname>Sisson</surname> <given-names>J. C.</given-names></name></person-group> (<year>2010</year>). <article-title>Proteomic analysis reveals CCT is a target of Fragile X mental retardation protein regulation in <italic>Drosophila</italic>.</article-title> <source><italic>Dev. Biol.</italic></source> <volume>340</volume> <fpage>408</fpage>&#x2013;<lpage>418</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2010.01.028</pub-id> <pub-id pub-id-type="pmid">20122915</pub-id></citation></ref>
<ref id="B164"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moon</surname> <given-names>L. D.</given-names></name> <name><surname>Xiong</surname> <given-names>F.</given-names></name></person-group> (<year>2022</year>). <article-title>Mechanics of neural tube morphogenesis.</article-title> <source><italic>Semin. Cell Dev. Biol.</italic></source> <volume>130</volume> <fpage>56</fpage>&#x2013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcdb.2021.09.009</pub-id> <pub-id pub-id-type="pmid">34561169</pub-id></citation></ref>
<ref id="B165"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname> <given-names>T.</given-names></name> <name><surname>Hayashi</surname> <given-names>T.</given-names></name> <name><surname>Hayashi</surname> <given-names>E.</given-names></name> <name><surname>Su</surname> <given-names>T. P.</given-names></name></person-group> (<year>2013</year>). <article-title>Sigma-1 receptor chaperone at the ER-mitochondrion interface mediates the mitochondrion-ER-nucleus signaling for cellular survival.</article-title> <source><italic>PLoS One</italic></source> <volume>8</volume>:<issue>e76941</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0076941</pub-id> <pub-id pub-id-type="pmid">24204710</pub-id></citation></ref>
<ref id="B166"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morris-Rosendahl</surname> <given-names>D. J.</given-names></name> <name><surname>Crocq</surname> <given-names>M. A.</given-names></name></person-group> (<year>2020</year>). <article-title>Neurodevelopmental disorders-the history and future of a diagnostic concept.</article-title> <source><italic>Dialogues Clin. Neurosci.</italic></source> <volume>22</volume> <fpage>65</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.31887/DCNS.2020.22.1/macrocq</pub-id> <pub-id pub-id-type="pmid">32699506</pub-id></citation></ref>
<ref id="B167"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Motawe</surname> <given-names>Z. Y.</given-names></name> <name><surname>Abdelmaboud</surname> <given-names>S. S.</given-names></name> <name><surname>Cuevas</surname> <given-names>J.</given-names></name> <name><surname>Breslin</surname> <given-names>J. W.</given-names></name></person-group> (<year>2020</year>). <article-title>PRE-084 as a tool to uncover potential therapeutic applications for selective sigma-1 receptor activation.</article-title> <source><italic>Int. J. Biochem. Cell Biol.</italic></source> <volume>126</volume>:<issue>105803</issue>. <pub-id pub-id-type="doi">10.1016/j.biocel.2020.105803</pub-id> <pub-id pub-id-type="pmid">32668330</pub-id></citation></ref>
<ref id="B168"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Munji</surname> <given-names>R. N.</given-names></name> <name><surname>Choe</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>G.</given-names></name> <name><surname>Siegenthaler</surname> <given-names>J. A.</given-names></name> <name><surname>Pleasure</surname> <given-names>S. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Wnt signaling regulates neuronal differentiation of cortical intermediate progenitors.</article-title> <source><italic>J. Neurosci.</italic></source> <volume>31</volume> <fpage>1676</fpage>&#x2013;<lpage>1687</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5404-10.2011</pub-id> <pub-id pub-id-type="pmid">21289176</pub-id></citation></ref>
<ref id="B169"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Myrum</surname> <given-names>C.</given-names></name> <name><surname>Soul&#x00E9;</surname> <given-names>J.</given-names></name> <name><surname>Bittins</surname> <given-names>M.</given-names></name> <name><surname>Cavagnini</surname> <given-names>K.</given-names></name> <name><surname>Goff</surname> <given-names>K.</given-names></name> <name><surname>Ziemek</surname> <given-names>S. K.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Arc Interacts with the integral endoplasmic reticulum protein, calnexin.</article-title> <source><italic>Front. Cell. Neurosci.</italic></source> <volume>11</volume>:<issue>294</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2017.00294</pub-id> <pub-id pub-id-type="pmid">28979192</pub-id></citation></ref>
<ref id="B170"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nadarajah</surname> <given-names>B.</given-names></name> <name><surname>Parnavelas</surname> <given-names>J. G.</given-names></name></person-group> (<year>2002</year>). <article-title>Modes of neuronal migration in the developing cerebral cortex.</article-title> <source><italic>Nat. Rev. Neurosci.</italic></source> <volume>3</volume> <fpage>423</fpage>&#x2013;<lpage>432</lpage>. <pub-id pub-id-type="doi">10.1038/nrn845</pub-id> <pub-id pub-id-type="pmid">12042877</pub-id></citation></ref>
<ref id="B171"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nase</surname> <given-names>G.</given-names></name> <name><surname>Weishaupt</surname> <given-names>J.</given-names></name> <name><surname>Stern</surname> <given-names>P.</given-names></name> <name><surname>Singer</surname> <given-names>W.</given-names></name> <name><surname>Monyer</surname> <given-names>H.</given-names></name></person-group> (<year>1999</year>). <article-title>Genetic and epigenetic regulation of NMDA receptor expression in the rat visual cortex.</article-title> <source><italic>Eur. J. Neurosci.</italic></source> <volume>11</volume> <fpage>4320</fpage>&#x2013;<lpage>4326</lpage>. <pub-id pub-id-type="doi">10.1046/j.1460-9568.1999.00859.x</pub-id> <pub-id pub-id-type="pmid">10594657</pub-id></citation></ref>
<ref id="B172"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neul</surname> <given-names>J. L.</given-names></name> <name><surname>Kaufmann</surname> <given-names>W. E.</given-names></name> <name><surname>Glaze</surname> <given-names>D. G.</given-names></name> <name><surname>Christodoulou</surname> <given-names>J.</given-names></name> <name><surname>Clarke</surname> <given-names>A. J.</given-names></name> <name><surname>Bahi-Buisson</surname> <given-names>N.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Rett syndrome: Revised diagnostic criteria and nomenclature.</article-title> <source><italic>Ann. Neurol.</italic></source> <volume>68</volume> <fpage>944</fpage>&#x2013;<lpage>950</lpage>. <pub-id pub-id-type="doi">10.1002/ana.22124</pub-id> <pub-id pub-id-type="pmid">21154482</pub-id></citation></ref>
<ref id="B173"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neul</surname> <given-names>J. L.</given-names></name> <name><surname>Lane</surname> <given-names>J. B.</given-names></name> <name><surname>Lee</surname> <given-names>H. S.</given-names></name> <name><surname>Geerts</surname> <given-names>S.</given-names></name> <name><surname>Barrish</surname> <given-names>J. O.</given-names></name> <name><surname>Annese</surname> <given-names>F.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Developmental delay in Rett syndrome: Data from the natural history study.</article-title> <source><italic>J. Neurodev. Disord.</italic></source> <volume>6</volume>:<issue>20</issue>. <pub-id pub-id-type="doi">10.1186/1866-1955-6-20</pub-id> <pub-id pub-id-type="pmid">25071871</pub-id></citation></ref>
<ref id="B174"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Newpher</surname> <given-names>T. M.</given-names></name> <name><surname>Ehlers</surname> <given-names>M. D.</given-names></name></person-group> (<year>2008</year>). <article-title>Glutamate receptor dynamics in dendritic microdomains.</article-title> <source><italic>Neuron</italic></source> <volume>58</volume> <fpage>472</fpage>&#x2013;<lpage>497</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2008.04.030</pub-id> <pub-id pub-id-type="pmid">18498731</pub-id></citation></ref>
<ref id="B175"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname> <given-names>M.</given-names></name> <name><surname>Lee</surname> <given-names>A. S.</given-names></name></person-group> (<year>2007</year>). <article-title>ER chaperones in mammalian development and human diseases.</article-title> <source><italic>FEBS Lett.</italic></source> <volume>581</volume> <fpage>3641</fpage>&#x2013;<lpage>3651</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2007.04.045</pub-id> <pub-id pub-id-type="pmid">17481612</pub-id></citation></ref>
<ref id="B176"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nikolaienko</surname> <given-names>O.</given-names></name> <name><surname>Eriksen</surname> <given-names>M. S.</given-names></name> <name><surname>Patil</surname> <given-names>S.</given-names></name> <name><surname>Bito</surname> <given-names>H.</given-names></name> <name><surname>Bramham</surname> <given-names>C. R.</given-names></name></person-group> (<year>2017</year>). <article-title>Stimulus-evoked ERK-dependent phosphorylation of activity-regulated cytoskeleton-associated protein (Arc) regulates its neuronal subcellular localization.</article-title> <source><italic>Neuroscience</italic></source> <volume>360</volume> <fpage>68</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2017.07.026</pub-id> <pub-id pub-id-type="pmid">28736134</pub-id></citation></ref>
<ref id="B177"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nimchinsky</surname> <given-names>E. A.</given-names></name> <name><surname>Sabatini</surname> <given-names>B. L.</given-names></name> <name><surname>Svoboda</surname> <given-names>K.</given-names></name></person-group> (<year>2002</year>). <article-title>Structure and function of dendritic spines.</article-title> <source><italic>Annu. Rev. Physiol.</italic></source> <volume>64</volume> <fpage>313</fpage>&#x2013;<lpage>353</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.physiol.64.081501.160008</pub-id> <pub-id pub-id-type="pmid">11826272</pub-id></citation></ref>
<ref id="B178"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nishimura</surname> <given-names>Y. V.</given-names></name> <name><surname>Shinoda</surname> <given-names>T.</given-names></name> <name><surname>Inaguma</surname> <given-names>Y.</given-names></name> <name><surname>Ito</surname> <given-names>H.</given-names></name> <name><surname>Nagata</surname> <given-names>K.</given-names></name></person-group> (<year>2012</year>). <article-title>Application of in utero electroporation and live imaging in the analyses of neuronal migration during mouse brain development.</article-title> <source><italic>Med. Mol. Morphol.</italic></source> <volume>45</volume> <fpage>1</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1007/s00795-011-0557-0</pub-id> <pub-id pub-id-type="pmid">22431177</pub-id></citation></ref>
<ref id="B179"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname> <given-names>S.</given-names></name> <name><surname>Renfro</surname> <given-names>A.</given-names></name> <name><surname>Quattrocchi</surname> <given-names>C. C.</given-names></name> <name><surname>Sheldon</surname> <given-names>M.</given-names></name> <name><surname>D&#x2019;Arcangelo</surname> <given-names>G.</given-names></name></person-group> (<year>2004</year>). <article-title>Reelin promotes hippocampal dendrite development through the VLDLR/ApoER2-Dab1 pathway.</article-title> <source><italic>Neuron</italic></source> <volume>41</volume> <fpage>71</fpage>&#x2013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/s0896-6273(03)00819-5</pub-id></citation></ref>
<ref id="B180"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname> <given-names>S.</given-names></name> <name><surname>Yabut</surname> <given-names>O.</given-names></name> <name><surname>D&#x2019;Arcangelo</surname> <given-names>G.</given-names></name></person-group> (<year>2008</year>). <article-title>The reelin signaling pathway promotes dendritic spine development in hippocampal neurons.</article-title> <source><italic>J. Neurosci.</italic></source> <volume>28</volume> <fpage>10339</fpage>&#x2013;<lpage>10348</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1917-08.2008</pub-id> <pub-id pub-id-type="pmid">18842893</pub-id></citation></ref>
<ref id="B181"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nogami</surname> <given-names>T.</given-names></name> <name><surname>Beppu</surname> <given-names>H.</given-names></name> <name><surname>Tokoro</surname> <given-names>T.</given-names></name> <name><surname>Moriguchi</surname> <given-names>S.</given-names></name> <name><surname>Shioda</surname> <given-names>N.</given-names></name> <name><surname>Fukunaga</surname> <given-names>K.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Reduced expression of the ATRX gene, a chromatin-remodeling factor, causes hippocampal dysfunction in mice.</article-title> <source><italic>Hippocampus</italic></source> <volume>21</volume> <fpage>678</fpage>&#x2013;<lpage>687</lpage>. <pub-id pub-id-type="doi">10.1002/hipo.20782</pub-id> <pub-id pub-id-type="pmid">20865721</pub-id></citation></ref>
<ref id="B182"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oldenborg</surname> <given-names>P. A.</given-names></name> <name><surname>Zheleznyak</surname> <given-names>A.</given-names></name> <name><surname>Fang</surname> <given-names>Y. F.</given-names></name> <name><surname>Lagenaur</surname> <given-names>C. F.</given-names></name> <name><surname>Gresham</surname> <given-names>H. D.</given-names></name> <name><surname>Lindberg</surname> <given-names>F. P.</given-names></name></person-group> (<year>2000</year>). <article-title>Role of CD47 as a marker of self on red blood cells.</article-title> <source><italic>Science</italic></source> <volume>288</volume> <fpage>2051</fpage>&#x2013;<lpage>2054</lpage>. <pub-id pub-id-type="doi">10.1126/science.288.5473.2051</pub-id> <pub-id pub-id-type="pmid">10856220</pub-id></citation></ref>
<ref id="B183"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olusanya</surname> <given-names>B. O.</given-names></name> <name><surname>Wright</surname> <given-names>S. M.</given-names></name> <name><surname>Nair</surname> <given-names>M.</given-names></name> <name><surname>Boo</surname> <given-names>N. Y.</given-names></name> <name><surname>Halpern</surname> <given-names>R.</given-names></name> <name><surname>Kuper</surname> <given-names>H.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Global burden of childhood epilepsy, intellectual disability, and sensory impairments.</article-title> <source><italic>Pediatrics</italic></source> <volume>146</volume>:<issue>e20192623</issue>. <pub-id pub-id-type="doi">10.1542/peds.2019-2623</pub-id> <pub-id pub-id-type="pmid">32554521</pub-id></citation></ref>
<ref id="B184"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Omotade</surname> <given-names>O. F.</given-names></name> <name><surname>Rui</surname> <given-names>Y.</given-names></name> <name><surname>Lei</surname> <given-names>W.</given-names></name> <name><surname>Yu</surname> <given-names>K.</given-names></name> <name><surname>Hartzell</surname> <given-names>H. C.</given-names></name> <name><surname>Fowler</surname> <given-names>V. M.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Tropomodulin Isoform-specific regulation of dendrite development and synapse formation.</article-title> <source><italic>J. Neurosci.</italic></source> <volume>38</volume> <fpage>10271</fpage>&#x2013;<lpage>10285</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3325-17.2018</pub-id> <pub-id pub-id-type="pmid">30301754</pub-id></citation></ref>
<ref id="B185"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Osaki</surname> <given-names>Y.</given-names></name> <name><surname>Matsuhisa</surname> <given-names>K.</given-names></name> <name><surname>Che</surname> <given-names>W.</given-names></name> <name><surname>Kaneko</surname> <given-names>M.</given-names></name> <name><surname>Asada</surname> <given-names>R.</given-names></name> <name><surname>Masaki</surname> <given-names>T.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Calnexin promotes the folding of mutant iduronate 2-sulfatase related to mucopolysaccharidosis type II.</article-title> <source><italic>Biochem. Biophys. Res. Commun.</italic></source> <volume>514</volume> <fpage>217</fpage>&#x2013;<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2019.04.115</pub-id> <pub-id pub-id-type="pmid">31029429</pub-id></citation></ref>
<ref id="B186"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Osborn</surname> <given-names>D.</given-names></name> <name><surname>Pond</surname> <given-names>H. L.</given-names></name> <name><surname>Mazaheri</surname> <given-names>N.</given-names></name> <name><surname>Dejardin</surname> <given-names>J.</given-names></name> <name><surname>Munn</surname> <given-names>C. J.</given-names></name> <name><surname>Mushref</surname> <given-names>K.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Mutations in INPP5K cause a form of congenital muscular dystrophy overlapping marinesco-sj&#x00F6;gren syndrome and dystroglycanopathy.</article-title> <source><italic>Am. J. Hum. Genet.</italic></source> <volume>100</volume> <fpage>537</fpage>&#x2013;<lpage>545</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2017.01.019</pub-id> <pub-id pub-id-type="pmid">28190459</pub-id></citation></ref>
<ref id="B187"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Otero</surname> <given-names>J. H.</given-names></name> <name><surname>Liz&#x00E1;k</surname> <given-names>B.</given-names></name> <name><surname>Hendershot</surname> <given-names>L. M.</given-names></name></person-group> (<year>2010</year>). <article-title>Life and death of a BiP substrate.</article-title> <source><italic>Semin. Cell Dev. Biol.</italic></source> <volume>21</volume> <fpage>472</fpage>&#x2013;<lpage>478</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcdb.2009.12.008</pub-id> <pub-id pub-id-type="pmid">20026282</pub-id></citation></ref>
<ref id="B188"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pabba</surname> <given-names>M.</given-names></name> <name><surname>Wong</surname> <given-names>A. Y.</given-names></name> <name><surname>Ahlskog</surname> <given-names>N.</given-names></name> <name><surname>Hristova</surname> <given-names>E.</given-names></name> <name><surname>Biscaro</surname> <given-names>D.</given-names></name> <name><surname>Nassrallah</surname> <given-names>W.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>NMDA receptors are upregulated and trafficked to the plasma membrane after sigma-1 receptor activation in the rat hippocampus.</article-title> <source><italic>J. Neurosci.</italic></source> <volume>34</volume> <fpage>11325</fpage>&#x2013;<lpage>11338</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0458-14.2014</pub-id> <pub-id pub-id-type="pmid">25143613</pub-id></citation></ref>
<ref id="B189"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pacheco</surname> <given-names>A.</given-names></name> <name><surname>Merianda</surname> <given-names>T. T.</given-names></name> <name><surname>Twiss</surname> <given-names>J. L.</given-names></name> <name><surname>Gallo</surname> <given-names>G.</given-names></name></person-group> (<year>2020</year>). <article-title>Mechanism and role of the intra-axonal calreticulin translation in response to axonal injury.</article-title> <source><italic>Exp. Neurol.</italic></source> <volume>323</volume>:<issue>113072</issue>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2019.113072</pub-id> <pub-id pub-id-type="pmid">31669485</pub-id></citation></ref>
<ref id="B190"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname> <given-names>C. L.</given-names></name> <name><surname>Howell</surname> <given-names>J. E.</given-names></name> <name><surname>Clark</surname> <given-names>S. G.</given-names></name> <name><surname>Hilliard</surname> <given-names>M.</given-names></name> <name><surname>Cordes</surname> <given-names>S.</given-names></name> <name><surname>Bargmann</surname> <given-names>C. I.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Multiple Wnts and frizzled receptors regulate anteriorly directed cell and growth cone migrations in <italic>Caenorhabditis elegans</italic>.</article-title> <source><italic>Dev. Cell</italic></source> <volume>10</volume> <fpage>367</fpage>&#x2013;<lpage>377</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2006.02.010</pub-id> <pub-id pub-id-type="pmid">16516839</pub-id></citation></ref>
<ref id="B191"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname> <given-names>Z.</given-names></name> <name><surname>Erkan</surname> <given-names>M.</given-names></name> <name><surname>Streit</surname> <given-names>S.</given-names></name> <name><surname>Friess</surname> <given-names>H.</given-names></name> <name><surname>Kleeff</surname> <given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>Silencing of GRP94 expression promotes apoptosis in pancreatic cancer cells.</article-title> <source><italic>Int. J. Oncol.</italic></source> <volume>35</volume> <fpage>823</fpage>&#x2013;<lpage>828</lpage>. <pub-id pub-id-type="doi">10.3892/ijo_00000395</pub-id></citation></ref>
<ref id="B192"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parakh</surname> <given-names>S.</given-names></name> <name><surname>Atkin</surname> <given-names>J. D.</given-names></name></person-group> (<year>2015</year>). <article-title>Novel roles for protein disulphide isomerase in disease states: A double edged sword?</article-title> <source><italic>Front. Cell Dev. Biol.</italic></source> <volume>3</volume>:<issue>30</issue>. <pub-id pub-id-type="doi">10.3389/fcell.2015.00030</pub-id> <pub-id pub-id-type="pmid">26052512</pub-id></citation></ref>
<ref id="B193"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Penke</surname> <given-names>B.</given-names></name> <name><surname>Fulop</surname> <given-names>L.</given-names></name> <name><surname>Szucs</surname> <given-names>M.</given-names></name> <name><surname>Frecska</surname> <given-names>E.</given-names></name></person-group> (<year>2018</year>). <article-title>The role of sigma-1 receptor, an intracellular chaperone in neurodegenerative diseases.</article-title> <source><italic>Curr. Neuropharmacol.</italic></source> <volume>16</volume> <fpage>97</fpage>&#x2013;<lpage>116</lpage>. <pub-id pub-id-type="doi">10.2174/1570159X15666170529104323</pub-id> <pub-id pub-id-type="pmid">28554311</pub-id></citation></ref>
<ref id="B194"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perri</surname> <given-names>E. R.</given-names></name> <name><surname>Thomas</surname> <given-names>C. J.</given-names></name> <name><surname>Parakh</surname> <given-names>S.</given-names></name> <name><surname>Spencer</surname> <given-names>D. M.</given-names></name> <name><surname>Atkin</surname> <given-names>J. D.</given-names></name></person-group> (<year>2016</year>). <article-title>The unfolded protein response and the role of protein disulfide isomerase in neurodegeneration.</article-title> <source><italic>Front. Cell Dev. Biol.</italic></source> <volume>3</volume>:<issue>80</issue>. <pub-id pub-id-type="doi">10.3389/fcell.2015.00080</pub-id> <pub-id pub-id-type="pmid">26779479</pub-id></citation></ref>
<ref id="B195"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peviani</surname> <given-names>M.</given-names></name> <name><surname>Salvaneschi</surname> <given-names>E.</given-names></name> <name><surname>Bontempi</surname> <given-names>L.</given-names></name> <name><surname>Petese</surname> <given-names>A.</given-names></name> <name><surname>Manzo</surname> <given-names>A.</given-names></name> <name><surname>Rossi</surname> <given-names>D.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Neuroprotective effects of the sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.</article-title> <source><italic>Neurobiol. Dis.</italic></source> <volume>62</volume> <fpage>218</fpage>&#x2013;<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2013.10.010</pub-id> <pub-id pub-id-type="pmid">24141020</pub-id></citation></ref>
<ref id="B196"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pfaffenseller</surname> <given-names>B.</given-names></name> <name><surname>Wollenhaupt-Aguiar</surname> <given-names>B.</given-names></name> <name><surname>Fries</surname> <given-names>G. R.</given-names></name> <name><surname>Colpo</surname> <given-names>G. D.</given-names></name> <name><surname>Burque</surname> <given-names>R. K.</given-names></name> <name><surname>Bristot</surname> <given-names>G.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Impaired endoplasmic reticulum stress response in bipolar disorder: Cellular evidence of illness progression.</article-title> <source><italic>Int. J. Neuropsychopharmacol.</italic></source> <volume>17</volume> <fpage>1453</fpage>&#x2013;<lpage>1463</lpage>. <pub-id pub-id-type="doi">10.1017/S1461145714000443</pub-id> <pub-id pub-id-type="pmid">24800824</pub-id></citation></ref>
<ref id="B197"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname> <given-names>M. J.</given-names></name> <name><surname>Voeltz</surname> <given-names>G. K.</given-names></name></person-group> (<year>2016</year>). <article-title>Structure and function of ER membrane contact sites with other organelles.</article-title> <source><italic>Nat. Rev. Mol. Cell Biol.</italic></source> <volume>17</volume> <fpage>69</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1038/nrm.2015.8</pub-id> <pub-id pub-id-type="pmid">26627931</pub-id></citation></ref>
<ref id="B198"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pick</surname> <given-names>J. E.</given-names></name> <name><surname>Ziff</surname> <given-names>E. B.</given-names></name></person-group> (<year>2018</year>). <article-title>Regulation of AMPA receptor trafficking and exit from the endoplasmic reticulum.</article-title> <source><italic>Mol. Cell. Neurosci.</italic></source> <volume>91</volume> <fpage>3</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2018.03.004</pub-id> <pub-id pub-id-type="pmid">29545119</pub-id></citation></ref>
<ref id="B199"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pilquil</surname> <given-names>C.</given-names></name> <name><surname>Alvandi</surname> <given-names>Z.</given-names></name> <name><surname>Opas</surname> <given-names>M.</given-names></name></person-group> (<year>2020</year>). <article-title>Calreticulin regulates a switch between osteoblast and chondrocyte lineages derived from murine embryonic stem cells.</article-title> <source><italic>J. Biol. Chem.</italic></source> <volume>295</volume> <fpage>6861</fpage>&#x2013;<lpage>6875</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.RA119.011029</pub-id> <pub-id pub-id-type="pmid">32220932</pub-id></citation></ref>
<ref id="B200"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pobre</surname> <given-names>K.</given-names></name> <name><surname>Poet</surname> <given-names>G. J.</given-names></name> <name><surname>Hendershot</surname> <given-names>L. M.</given-names></name></person-group> (<year>2019</year>). <article-title>The endoplasmic reticulum (ER) chaperone BiP is a master regulator of ER functions: Getting by with a little help from ERdj friends.</article-title> <source><italic>J. Biol. Chem.</italic></source> <volume>294</volume> <fpage>2098</fpage>&#x2013;<lpage>2108</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.REV118.002804</pub-id> <pub-id pub-id-type="pmid">30563838</pub-id></citation></ref>
<ref id="B201"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Polanczyk</surname> <given-names>G. V.</given-names></name> <name><surname>Willcutt</surname> <given-names>E. G.</given-names></name> <name><surname>Salum</surname> <given-names>G. A.</given-names></name> <name><surname>Kieling</surname> <given-names>C.</given-names></name> <name><surname>Rohde</surname> <given-names>L. A.</given-names></name></person-group> (<year>2014</year>). <article-title>ADHD prevalence estimates across three decades: An updated systematic review and meta-regression analysis.</article-title> <source><italic>Int. J. Epidemiol.</italic></source> <volume>43</volume> <fpage>434</fpage>&#x2013;<lpage>442</lpage>. <pub-id pub-id-type="doi">10.1093/ije/dyt261</pub-id> <pub-id pub-id-type="pmid">24464188</pub-id></citation></ref>
<ref id="B202"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Polanczyk</surname> <given-names>G.</given-names></name> <name><surname>de Lima</surname> <given-names>M. S.</given-names></name> <name><surname>Horta</surname> <given-names>B. L.</given-names></name> <name><surname>Biederman</surname> <given-names>J.</given-names></name> <name><surname>Rohde</surname> <given-names>L. A.</given-names></name></person-group> (<year>2007</year>). <article-title>The worldwide prevalence of ADHD: A systematic review and metaregression analysis.</article-title> <source><italic>Am. J. Psychiatry</italic></source> <volume>164</volume> <fpage>942</fpage>&#x2013;<lpage>948</lpage>. <pub-id pub-id-type="doi">10.1176/ajp.2007.164.6.942</pub-id> <pub-id pub-id-type="pmid">17541055</pub-id></citation></ref>
<ref id="B203"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prigge</surname> <given-names>C. L.</given-names></name> <name><surname>Kay</surname> <given-names>J. N.</given-names></name></person-group> (<year>2018</year>). <article-title>Dendrite morphogenesis from birth to adulthood.</article-title> <source><italic>Curr. Opin. Neurobiol.</italic></source> <volume>53</volume> <fpage>139</fpage>&#x2013;<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2018.07.007</pub-id> <pub-id pub-id-type="pmid">30092409</pub-id></citation></ref>
<ref id="B204"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rapoport</surname> <given-names>T. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Protein translocation across the eukaryotic endoplasmic reticulum and bacterial plasma membranes.</article-title> <source><italic>Nature</italic></source> <volume>450</volume> <fpage>663</fpage>&#x2013;<lpage>669</lpage>. <pub-id pub-id-type="doi">10.1038/nature06384</pub-id> <pub-id pub-id-type="pmid">18046402</pub-id></citation></ref>
<ref id="B205"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rauch</surname> <given-names>F.</given-names></name> <name><surname>Prud&#x2019;homme</surname> <given-names>J.</given-names></name> <name><surname>Arabian</surname> <given-names>A.</given-names></name> <name><surname>Dedhar</surname> <given-names>S.</given-names></name> <name><surname>St-Arnaud</surname> <given-names>R.</given-names></name></person-group> (<year>2000</year>). <article-title>Heart, brain, and body wall defects in mice lacking calreticulin.</article-title> <source><italic>Exp. Cell Res.</italic></source> <volume>256</volume> <fpage>105</fpage>&#x2013;<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1006/excr.2000.4818</pub-id> <pub-id pub-id-type="pmid">10739657</pub-id></citation></ref>
<ref id="B206"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reyes</surname> <given-names>S. T.</given-names></name> <name><surname>Deacon</surname> <given-names>R.</given-names></name> <name><surname>Guo</surname> <given-names>S. G.</given-names></name> <name><surname>Altimiras</surname> <given-names>F. J.</given-names></name> <name><surname>Castillo</surname> <given-names>J. B.</given-names></name> <name><surname>van der Wildt</surname> <given-names>B.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Effects of the sigma-1 receptor agonist blarcamesine in a murine model of fragile X syndrome: Neurobehavioral phenotypes and receptor occupancy.</article-title> <source><italic>Sci. Rep.</italic></source> <volume>11</volume>:<issue>17150</issue>. <pub-id pub-id-type="doi">10.1038/s41598-021-94079-7</pub-id> <pub-id pub-id-type="pmid">34433831</pub-id></citation></ref>
<ref id="B207"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Riquelme</surname> <given-names>P. A.</given-names></name> <name><surname>Drapeau</surname> <given-names>E.</given-names></name> <name><surname>Doetsch</surname> <given-names>F.</given-names></name></person-group> (<year>2008</year>). <article-title>Brain micro-ecologies: Neural stem cell niches in the adult mammalian brain.</article-title> <source><italic>Philos. Trans. R. Soc. Lond. B Biol. Sci.</italic></source> <volume>363</volume> <fpage>123</fpage>&#x2013;<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1098/rstb.2006.2016</pub-id> <pub-id pub-id-type="pmid">17322003</pub-id></citation></ref>
<ref id="B208"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rizzuto</surname> <given-names>R.</given-names></name> <name><surname>Duchen</surname> <given-names>M. R.</given-names></name> <name><surname>Pozzan</surname> <given-names>T.</given-names></name></person-group> (<year>2004</year>). <article-title>Flirting in little space: The ER/mitochondria Ca2+ liaison.</article-title> <source><italic>Sci. STKE</italic></source> <volume>2004</volume>:<issue>re1</issue>. <pub-id pub-id-type="doi">10.1126/stke.2152004re1</pub-id> <pub-id pub-id-type="pmid">14722345</pub-id></citation></ref>
<ref id="B209"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robson</surname> <given-names>M. J.</given-names></name> <name><surname>Turner</surname> <given-names>R. C.</given-names></name> <name><surname>Naser</surname> <given-names>Z. J.</given-names></name> <name><surname>McCurdy</surname> <given-names>C. R.</given-names></name> <name><surname>O&#x2019;Callaghan</surname> <given-names>J. P.</given-names></name> <name><surname>Huber</surname> <given-names>J. D.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation.</article-title> <source><italic>Exp. Neurol.</italic></source> <volume>254</volume> <fpage>180</fpage>&#x2013;<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2014.01.020</pub-id> <pub-id pub-id-type="pmid">24508558</pub-id></citation></ref>
<ref id="B210"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roderick</surname> <given-names>H. L.</given-names></name> <name><surname>Lechleiter</surname> <given-names>J. D.</given-names></name> <name><surname>Camacho</surname> <given-names>P.</given-names></name></person-group> (<year>2000</year>). <article-title>Cytosolic phosphorylation of calnexin controls intracellular Ca(2+) oscillations via an interaction with SERCA2b.</article-title> <source><italic>J. Cell Biol.</italic></source> <volume>149</volume> <fpage>1235</fpage>&#x2013;<lpage>1248</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.149.6.1235</pub-id> <pub-id pub-id-type="pmid">10851021</pub-id></citation></ref>
<ref id="B211"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roos</surname> <given-names>A.</given-names></name> <name><surname>Buchkremer</surname> <given-names>S.</given-names></name> <name><surname>Kollipara</surname> <given-names>L.</given-names></name> <name><surname>Labisch</surname> <given-names>T.</given-names></name> <name><surname>Gatz</surname> <given-names>C.</given-names></name> <name><surname>Zitzelsberger</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Myopathy in Marinesco-Sj&#x00F6;gren syndrome links endoplasmic reticulum chaperone dysfunction to nuclear envelope pathology.</article-title> <source><italic>Acta Neuropathol.</italic></source> <volume>127</volume> <fpage>761</fpage>&#x2013;<lpage>777</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-013-1224-4</pub-id> <pub-id pub-id-type="pmid">24362440</pub-id></citation></ref>
<ref id="B212"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ropers</surname> <given-names>H. H.</given-names></name></person-group> (<year>2010</year>). <article-title>Genetics of early onset cognitive impairment.</article-title> <source><italic>Annu. Rev. Genomics Hum. Genet.</italic></source> <volume>11</volume> <fpage>161</fpage>&#x2013;<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-genom-082509-141640</pub-id> <pub-id pub-id-type="pmid">20822471</pub-id></citation></ref>
<ref id="B213"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname> <given-names>S.</given-names></name> <name><surname>De Chiara</surname> <given-names>V.</given-names></name> <name><surname>Musella</surname> <given-names>A.</given-names></name> <name><surname>Cozzolino</surname> <given-names>M.</given-names></name> <name><surname>Bernardi</surname> <given-names>G.</given-names></name> <name><surname>Maccarrone</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis.</article-title> <source><italic>Amyotroph. Lateral</italic></source> <volume>11</volume> <fpage>83</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.3109/17482960902977954</pub-id> <pub-id pub-id-type="pmid">19452308</pub-id></citation></ref>
<ref id="B214"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosso</surname> <given-names>I. M.</given-names></name> <name><surname>Killgore</surname> <given-names>W. D.</given-names></name> <name><surname>Cintron</surname> <given-names>C. M.</given-names></name> <name><surname>Gruber</surname> <given-names>S. A.</given-names></name> <name><surname>Tohen</surname> <given-names>M.</given-names></name> <name><surname>Yurgelun-Todd</surname> <given-names>D. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Reduced amygdala volumes in first-episode bipolar disorder and correlation with cerebral white matter.</article-title> <source><italic>Biol. Psychiatry</italic></source> <volume>61</volume> <fpage>743</fpage>&#x2013;<lpage>749</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2006.07.035</pub-id> <pub-id pub-id-type="pmid">17123471</pub-id></citation></ref>
<ref id="B215"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rubio</surname> <given-names>M. E.</given-names></name> <name><surname>Wenthold</surname> <given-names>R. J.</given-names></name></person-group> (<year>1999</year>). <article-title>Calnexin and the immunoglobulin binding protein (BiP) coimmunoprecipitate with AMPA receptors.</article-title> <source><italic>J. Neurochem.</italic></source> <volume>73</volume> <fpage>942</fpage>&#x2013;<lpage>948</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.1999.0730942.x</pub-id> <pub-id pub-id-type="pmid">10461883</pub-id></citation></ref>
<ref id="B216"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruegsegger</surname> <given-names>C.</given-names></name> <name><surname>Saxena</surname> <given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Proteostasis impairment in ALS.</article-title> <source><italic>Brain Res.</italic></source> <volume>1648(Pt B)</volume> <fpage>571</fpage>&#x2013;<lpage>579</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2016.03.032</pub-id> <pub-id pub-id-type="pmid">27033833</pub-id></citation></ref>
<ref id="B217"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruscher</surname> <given-names>K.</given-names></name> <name><surname>In&#x00E1;cio</surname> <given-names>A. R.</given-names></name> <name><surname>Valind</surname> <given-names>K.</given-names></name> <name><surname>Rowshan Ravan</surname> <given-names>A.</given-names></name> <name><surname>Kuric</surname> <given-names>E.</given-names></name> <name><surname>Wieloch</surname> <given-names>T.</given-names></name></person-group> (<year>2012</year>). <article-title>Effects of the sigma-1 receptor agonist 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)-piperazine dihydro-chloride on inflammation after stroke.</article-title> <source><italic>PLoS One</italic></source> <volume>7</volume>:<issue>e45118</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0045118</pub-id> <pub-id pub-id-type="pmid">23028794</pub-id></citation></ref>
<ref id="B218"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruscher</surname> <given-names>K.</given-names></name> <name><surname>Shamloo</surname> <given-names>M.</given-names></name> <name><surname>Rickhag</surname> <given-names>M.</given-names></name> <name><surname>Ladunga</surname> <given-names>I.</given-names></name> <name><surname>Soriano</surname> <given-names>L.</given-names></name> <name><surname>Gisselsson</surname> <given-names>L.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke.</article-title> <source><italic>Brain</italic></source> <volume>134(Pt 3)</volume> <fpage>732</fpage>&#x2013;<lpage>746</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awq367</pub-id> <pub-id pub-id-type="pmid">21278085</pub-id></citation></ref>
<ref id="B219"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rutter</surname> <given-names>M.</given-names></name> <name><surname>Kim-Cohen</surname> <given-names>J.</given-names></name> <name><surname>Maughan</surname> <given-names>B.</given-names></name></person-group> (<year>2006</year>). <article-title>Continuities and discontinuities in psychopathology between childhood and adult life.</article-title> <source><italic>J. Child Psychol. Psychiatry</italic></source> <volume>47</volume> <fpage>276</fpage>&#x2013;<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7610.2006.01614.x</pub-id> <pub-id pub-id-type="pmid">16492260</pub-id></citation></ref>
<ref id="B220"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ryskamp</surname> <given-names>D. A.</given-names></name> <name><surname>Korban</surname> <given-names>S.</given-names></name> <name><surname>Zhemkov</surname> <given-names>V.</given-names></name> <name><surname>Kraskovskaya</surname> <given-names>N.</given-names></name> <name><surname>Bezprozvanny</surname> <given-names>I.</given-names></name></person-group> (<year>2019</year>). <article-title>Neuronal sigma-1 receptors: Signaling functions and protective roles in neurodegenerative diseases.</article-title> <source><italic>Front. Neurosci.</italic></source> <volume>13</volume>:<issue>862</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2019.00862</pub-id> <pub-id pub-id-type="pmid">31551669</pub-id></citation></ref>
<ref id="B221"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sacco</surname> <given-names>R.</given-names></name> <name><surname>Gabriele</surname> <given-names>S.</given-names></name> <name><surname>Persico</surname> <given-names>A. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Head circumference and brain size in autism spectrum disorder: A systematic review and meta-analysis.</article-title> <source><italic>Psychiatry Res.</italic></source> <volume>234</volume> <fpage>239</fpage>&#x2013;<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1016/j.pscychresns.2015.08.016</pub-id> <pub-id pub-id-type="pmid">26456415</pub-id></citation></ref>
<ref id="B222"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salinas</surname> <given-names>P. C.</given-names></name> <name><surname>Zou</surname> <given-names>Y.</given-names></name></person-group> (<year>2008</year>). <article-title>Wnt signaling in neural circuit assembly.</article-title> <source><italic>Annu. Rev. Neurosci.</italic></source> <volume>31</volume> <fpage>339</fpage>&#x2013;<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.neuro.31.060407.125649</pub-id> <pub-id pub-id-type="pmid">18558859</pub-id></citation></ref>
<ref id="B223"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Samaco</surname> <given-names>R. C.</given-names></name> <name><surname>McGraw</surname> <given-names>C. M.</given-names></name> <name><surname>Ward</surname> <given-names>C. S.</given-names></name> <name><surname>Sun</surname> <given-names>Y.</given-names></name> <name><surname>Neul</surname> <given-names>J. L.</given-names></name> <name><surname>Zoghbi</surname> <given-names>H. Y.</given-names></name></person-group> (<year>2013</year>). <article-title>Female Mecp2(+/-) mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies.</article-title> <source><italic>Hum. Mol. Genet.</italic></source> <volume>22</volume> <fpage>96</fpage>&#x2013;<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/dds406</pub-id> <pub-id pub-id-type="pmid">23026749</pub-id></citation></ref>
<ref id="B224"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname> <given-names>H. R.</given-names></name> <name><surname>Kruse</surname> <given-names>A. C.</given-names></name></person-group> (<year>2019</year>). <article-title>The molecular function of &#x03C3; receptors: Past, present, and future.</article-title> <source><italic>Trends Pharmacol. Sci.</italic></source> <volume>40</volume> <fpage>636</fpage>&#x2013;<lpage>654</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2019.07.006</pub-id> <pub-id pub-id-type="pmid">31387763</pub-id></citation></ref>
<ref id="B225"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname> <given-names>D. S.</given-names></name> <name><surname>Blower</surname> <given-names>M. D.</given-names></name></person-group> (<year>2016</year>). <article-title>The endoplasmic reticulum: Structure, function and response to cellular signaling.</article-title> <source><italic>Cell. Mol. Life Sci.</italic></source> <volume>73</volume> <fpage>79</fpage>&#x2013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-015-2052-6</pub-id> <pub-id pub-id-type="pmid">26433683</pub-id></citation></ref>
<ref id="B226"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shepherd</surname> <given-names>J. D.</given-names></name> <name><surname>Bear</surname> <given-names>M. F.</given-names></name></person-group> (<year>2011</year>). <article-title>New views of Arc, a master regulator of synaptic plasticity.</article-title> <source><italic>Nat. Neurosci.</italic></source> <volume>14</volume> <fpage>279</fpage>&#x2013;<lpage>284</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2708</pub-id> <pub-id pub-id-type="pmid">21278731</pub-id></citation></ref>
<ref id="B227"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shih</surname> <given-names>Y. Y.</given-names></name> <name><surname>Nakagawara</surname> <given-names>A.</given-names></name> <name><surname>Lee</surname> <given-names>H.</given-names></name> <name><surname>Juan</surname> <given-names>H. F.</given-names></name> <name><surname>Jeng</surname> <given-names>Y. M.</given-names></name> <name><surname>Lin</surname> <given-names>D. T.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Calreticulin mediates nerve growth factor-induced neuronal differentiation.</article-title> <source><italic>J. Mol. Neurosci.</italic></source> <volume>47</volume> <fpage>571</fpage>&#x2013;<lpage>581</lpage>. <pub-id pub-id-type="doi">10.1007/s12031-011-9683-3</pub-id> <pub-id pub-id-type="pmid">22147490</pub-id></citation></ref>
<ref id="B228"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shioda</surname> <given-names>N.</given-names></name> <name><surname>Beppu</surname> <given-names>H.</given-names></name> <name><surname>Fukuda</surname> <given-names>T.</given-names></name> <name><surname>Li</surname> <given-names>E.</given-names></name> <name><surname>Kitajima</surname> <given-names>I.</given-names></name> <name><surname>Fukunaga</surname> <given-names>K.</given-names></name></person-group> (<year>2011</year>). <article-title>Aberrant calcium/calmodulin-dependent protein kinase II (CaMKII) activity is associated with abnormal dendritic spine morphology in the ATRX mutant mouse brain.</article-title> <source><italic>J. Neurosci.</italic></source> <volume>31</volume> <fpage>346</fpage>&#x2013;<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4816-10.2011</pub-id> <pub-id pub-id-type="pmid">21209221</pub-id></citation></ref>
<ref id="B229"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Siegert</surname> <given-names>R.</given-names></name> <name><surname>Leroux</surname> <given-names>M. R.</given-names></name> <name><surname>Scheufler</surname> <given-names>C.</given-names></name> <name><surname>Hartl</surname> <given-names>F. U.</given-names></name> <name><surname>Moarefi</surname> <given-names>I.</given-names></name></person-group> (<year>2000</year>). <article-title>Structure of the molecular chaperone prefoldin: Unique interaction of multiple coiled coil tentacles with unfolded proteins.</article-title> <source><italic>Cell</italic></source> <volume>103</volume> <fpage>621</fpage>&#x2013;<lpage>632</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(00)00165-3</pub-id></citation></ref>
<ref id="B230"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>S. M.</given-names></name> <name><surname>Renden</surname> <given-names>R.</given-names></name> <name><surname>von Gersdorff</surname> <given-names>H.</given-names></name></person-group> (<year>2008</year>). <article-title>Synaptic vesicle endocytosis: Fast and slow modes of membrane retrieval.</article-title> <source><italic>Trends Neurosci.</italic></source> <volume>31</volume> <fpage>559</fpage>&#x2013;<lpage>568</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2008.08.005</pub-id> <pub-id pub-id-type="pmid">18817990</pub-id></citation></ref>
<ref id="B231"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>So</surname> <given-names>J.</given-names></name> <name><surname>Warsh</surname> <given-names>J. J.</given-names></name> <name><surname>Li</surname> <given-names>P. P.</given-names></name></person-group> (<year>2007</year>). <article-title>Impaired endoplasmic reticulum stress response in B-lymphoblasts from patients with bipolar-I disorder.</article-title> <source><italic>Biol. Psychiatry</italic></source> <volume>62</volume> <fpage>141</fpage>&#x2013;<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2006.10.014</pub-id> <pub-id pub-id-type="pmid">17217928</pub-id></citation></ref>
<ref id="B232"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sokolova</surname> <given-names>E.</given-names></name> <name><surname>Oerlemans</surname> <given-names>A. M.</given-names></name> <name><surname>Rommelse</surname> <given-names>N. N.</given-names></name> <name><surname>Groot</surname> <given-names>P.</given-names></name> <name><surname>Hartman</surname> <given-names>C. A.</given-names></name> <name><surname>Glennon</surname> <given-names>J. C.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>A causal and mediation analysis of the comorbidity between attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD).</article-title> <source><italic>J. Autism Dev. Disord.</italic></source> <volume>47</volume> <fpage>1595</fpage>&#x2013;<lpage>1604</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-017-3083-7</pub-id> <pub-id pub-id-type="pmid">28255761</pub-id></citation></ref>
<ref id="B233"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Solheim</surname> <given-names>J. C.</given-names></name> <name><surname>Harris</surname> <given-names>M. R.</given-names></name> <name><surname>Kindle</surname> <given-names>C. S.</given-names></name> <name><surname>Hansen</surname> <given-names>T. H.</given-names></name></person-group> (<year>1997</year>). <article-title>Prominence of beta 2-microglobulin, class I heavy chain conformation, and tapasin in the interactions of class I heavy chain with calreticulin and the transporter associated with antigen processing.</article-title> <source><italic>J. Immunol.</italic></source> <volume>158</volume> <fpage>2236</fpage>&#x2013;<lpage>2241</lpage>. <pub-id pub-id-type="pmid">9036970</pub-id></citation></ref>
<ref id="B234"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stapleton</surname> <given-names>M.</given-names></name> <name><surname>Arunkumar</surname> <given-names>N.</given-names></name> <name><surname>Kubaski</surname> <given-names>F.</given-names></name> <name><surname>Mason</surname> <given-names>R. W.</given-names></name> <name><surname>Tadao</surname> <given-names>O.</given-names></name> <name><surname>Tomatsu</surname> <given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>Clinical presentation and diagnosis of mucopolysaccharidoses.</article-title> <source><italic>Mol. Genet. Metab.</italic></source> <volume>125</volume> <fpage>4</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymgme.2018.01.003</pub-id> <pub-id pub-id-type="pmid">30057281</pub-id></citation></ref>
<ref id="B235"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stranahan</surname> <given-names>A. M.</given-names></name> <name><surname>Erion</surname> <given-names>J. R.</given-names></name> <name><surname>Wosiski-Kuhn</surname> <given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Reelin signaling in development, maintenance, and plasticity of neural networks.</article-title> <source><italic>Ageing Res. Rev.</italic></source> <volume>12</volume> <fpage>815</fpage>&#x2013;<lpage>822</lpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2013.01.005</pub-id> <pub-id pub-id-type="pmid">23352928</pub-id></citation></ref>
<ref id="B236"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Su</surname> <given-names>T. P.</given-names></name> <name><surname>Hayashi</surname> <given-names>T.</given-names></name> <name><surname>Maurice</surname> <given-names>T.</given-names></name> <name><surname>Buch</surname> <given-names>S.</given-names></name> <name><surname>Ruoho</surname> <given-names>A. E.</given-names></name></person-group> (<year>2010</year>). <article-title>The sigma-1 receptor chaperone as an inter-organelle signaling modulator.</article-title> <source><italic>Trends Pharmacol. Sci.</italic></source> <volume>31</volume> <fpage>557</fpage>&#x2013;<lpage>566</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2010.08.007</pub-id> <pub-id pub-id-type="pmid">20869780</pub-id></citation></ref>
<ref id="B237"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Su</surname> <given-names>T. P.</given-names></name> <name><surname>Su</surname> <given-names>T. C.</given-names></name> <name><surname>Nakamura</surname> <given-names>Y.</given-names></name> <name><surname>Tsai</surname> <given-names>S. Y.</given-names></name></person-group> (<year>2016</year>). <article-title>The sigma-1 receptor as a pluripotent modulator in living systems.</article-title> <source><italic>Trends Pharmacol. Sci.</italic></source> <volume>37</volume> <fpage>262</fpage>&#x2013;<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2016.01.003</pub-id> <pub-id pub-id-type="pmid">26869505</pub-id></citation></ref>
<ref id="B238"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sudhof</surname> <given-names>T. C.</given-names></name></person-group> (<year>2004</year>). <article-title>The synaptic vesicle cycle.</article-title> <source><italic>Annu. Rev. Neurosci.</italic></source> <volume>27</volume> <fpage>509</fpage>&#x2013;<lpage>547</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.neuro.26.041002.131412</pub-id> <pub-id pub-id-type="pmid">15217342</pub-id></citation></ref>
<ref id="B239"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Szabadkai</surname> <given-names>G.</given-names></name> <name><surname>Bianchi</surname> <given-names>K.</given-names></name> <name><surname>V&#x00E1;rnai</surname> <given-names>P.</given-names></name> <name><surname>De Stefani</surname> <given-names>D.</given-names></name> <name><surname>Wieckowski</surname> <given-names>M. R.</given-names></name> <name><surname>Cavagna</surname> <given-names>D.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels.</article-title> <source><italic>J. Cell Biol.</italic></source> <volume>175</volume> <fpage>901</fpage>&#x2013;<lpage>911</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200608073</pub-id> <pub-id pub-id-type="pmid">17178908</pub-id></citation></ref>
<ref id="B240"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tabata</surname> <given-names>H.</given-names></name> <name><surname>Nakajima</surname> <given-names>K.</given-names></name></person-group> (<year>2001</year>). <article-title>Efficient in utero gene transfer system to the developing mouse brain using electroporation: Visualization of neuronal migration in the developing cortex.</article-title> <source><italic>Neuroscience</italic></source> <volume>103</volume> <fpage>865</fpage>&#x2013;<lpage>872</lpage>. <pub-id pub-id-type="doi">10.1016/s0306-4522(01)00016-1</pub-id></citation></ref>
<ref id="B241"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tahmaz</surname> <given-names>I.</given-names></name> <name><surname>Shahmoradi Ghahe</surname> <given-names>S.</given-names></name> <name><surname>Topf</surname> <given-names>U.</given-names></name></person-group> (<year>2022</year>). <article-title>Prefoldin function in cellular protein homeostasis and human diseases.</article-title> <source><italic>Front. Cell Dev. Biol.</italic></source> <volume>9</volume>:<issue>816214</issue>. <pub-id pub-id-type="doi">10.3389/fcell.2021.816214</pub-id> <pub-id pub-id-type="pmid">35111762</pub-id></citation></ref>
<ref id="B242"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname> <given-names>T.</given-names></name></person-group> (<year>2018</year>). <article-title>Non-cell autonomous maintenance of proteostasis by molecular chaperones and its molecular mechanism.</article-title> <source><italic>Biol. Pharm. Bull.</italic></source> <volume>41</volume> <fpage>843</fpage>&#x2013;<lpage>849</lpage>. <pub-id pub-id-type="doi">10.1248/bpb.b18-00141</pub-id> <pub-id pub-id-type="pmid">29863073</pub-id></citation></ref>
<ref id="B243"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname> <given-names>Q.</given-names></name> <name><surname>Zoghbi</surname> <given-names>H. Y.</given-names></name></person-group> (<year>2019</year>). <article-title>Mouse models as a tool for discovering new neurological diseases.</article-title> <source><italic>Neurobiol. Learn. Mem.</italic></source> <volume>165</volume>:<issue>106902</issue>. <pub-id pub-id-type="doi">10.1016/j.nlm.2018.07.006</pub-id> <pub-id pub-id-type="pmid">30030131</pub-id></citation></ref>
<ref id="B244"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tashiro</surname> <given-names>E.</given-names></name> <name><surname>Zako</surname> <given-names>T.</given-names></name> <name><surname>Muto</surname> <given-names>H.</given-names></name> <name><surname>Itoo</surname> <given-names>Y.</given-names></name> <name><surname>S&#x00F6;rgjerd</surname> <given-names>K.</given-names></name> <name><surname>Terada</surname> <given-names>N.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Prefoldin protects neuronal cells from polyglutamine toxicity by preventing aggregation formation.</article-title> <source><italic>J. Biol. Chem.</italic></source> <volume>288</volume> <fpage>19958</fpage>&#x2013;<lpage>19972</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M113.477984</pub-id> <pub-id pub-id-type="pmid">23720755</pub-id></citation></ref>
<ref id="B245"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thapar</surname> <given-names>A.</given-names></name> <name><surname>Cooper</surname> <given-names>M.</given-names></name> <name><surname>Rutter</surname> <given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Neurodevelopmental disorders.</article-title> <source><italic>Lancet Psychiatry</italic></source> <volume>4</volume> <fpage>339</fpage>&#x2013;<lpage>346</lpage>. <pub-id pub-id-type="doi">10.1016/S2215-0366(16)30376-5</pub-id></citation></ref>
<ref id="B246"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tjoelker</surname> <given-names>L. W.</given-names></name> <name><surname>Seyfried</surname> <given-names>C. E.</given-names></name> <name><surname>Eddy</surname> <given-names>R. L.</given-names> <suffix>Jr.</suffix></name> <name><surname>Byers</surname> <given-names>M. G.</given-names></name> <name><surname>Shows</surname> <given-names>T. B.</given-names></name> <name><surname>Calderon</surname> <given-names>J.</given-names></name><etal/></person-group> (<year>1994</year>). <article-title>Human, mouse, and rat calnexin cDNA cloning: Identification of potential calcium binding motifs and gene localization to human chromosome 5.</article-title> <source><italic>Biochemistry</italic></source> <volume>33</volume> <fpage>3229</fpage>&#x2013;<lpage>3236</lpage>. <pub-id pub-id-type="doi">10.1021/bi00177a013</pub-id> <pub-id pub-id-type="pmid">8136357</pub-id></citation></ref>
<ref id="B247"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Torpe</surname> <given-names>N.</given-names></name> <name><surname>Gopal</surname> <given-names>S.</given-names></name> <name><surname>Baltaci</surname> <given-names>O.</given-names></name> <name><surname>Rella</surname> <given-names>L.</given-names></name> <name><surname>Handley</surname> <given-names>A.</given-names></name> <name><surname>Korswagen</surname> <given-names>H. C.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>A protein disulfide isomerase controls neuronal migration through regulation of Wnt secretion.</article-title> <source><italic>Cell Rep.</italic></source> <volume>26</volume> <fpage>3183</fpage>&#x2013;<lpage>3190.e5</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2019.02.072</pub-id> <pub-id pub-id-type="pmid">30893592</pub-id></citation></ref>
<ref id="B248"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tripp</surname> <given-names>G.</given-names></name> <name><surname>Wickens</surname> <given-names>J. R.</given-names></name></person-group> (<year>2009</year>). <article-title>Neurobiology of ADHD.</article-title> <source><italic>Neuropharmacology</italic></source> <volume>57</volume> <fpage>579</fpage>&#x2013;<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2009.07.026</pub-id> <pub-id pub-id-type="pmid">19627998</pub-id></citation></ref>
<ref id="B249"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trujillo</surname> <given-names>C. M.</given-names></name> <name><surname>Alonso</surname> <given-names>A.</given-names></name> <name><surname>Delgado</surname> <given-names>A. C.</given-names></name> <name><surname>Damas</surname> <given-names>C.</given-names></name></person-group> (<year>2005</year>). <article-title>The rostral and caudal boundaries of the diencephalon.</article-title> <source><italic>Brain Res. Brain Res. Rev.</italic></source> <volume>49</volume> <fpage>202</fpage>&#x2013;<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresrev.2005.01.002</pub-id> <pub-id pub-id-type="pmid">16111550</pub-id></citation></ref>
<ref id="B250"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname> <given-names>S. Y.</given-names></name> <name><surname>Hayashi</surname> <given-names>T.</given-names></name> <name><surname>Harvey</surname> <given-names>B. K.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Wu</surname> <given-names>W. W.</given-names></name> <name><surname>Shen</surname> <given-names>R. F.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Sigma-1 receptors regulate hippocampal dendritic spine formation via a free radical-sensitive mechanism involving Rac1xGTP pathway.</article-title> <source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source> <volume>106</volume> <fpage>22468</fpage>&#x2013;<lpage>22473</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0909089106</pub-id> <pub-id pub-id-type="pmid">20018732</pub-id></citation></ref>
<ref id="B251"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsuboyama</surname> <given-names>K.</given-names></name> <name><surname>Tadakuma</surname> <given-names>H.</given-names></name> <name><surname>Tomari</surname> <given-names>Y.</given-names></name></person-group> (<year>2018</year>). <article-title>Conformational activation of argonaute by distinct yet coordinated actions of the Hsp70 and Hsp90 chaperone systems.</article-title> <source><italic>Mol. Cell</italic></source> <volume>70</volume> <fpage>722</fpage>&#x2013;<lpage>729.e4</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2018.04.010</pub-id> <pub-id pub-id-type="pmid">29775584</pub-id></citation></ref>
<ref id="B252"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turano</surname> <given-names>C.</given-names></name> <name><surname>Coppari</surname> <given-names>S.</given-names></name> <name><surname>Altieri</surname> <given-names>F.</given-names></name> <name><surname>Ferraro</surname> <given-names>A.</given-names></name></person-group> (<year>2002</year>). <article-title>Proteins of the PDI family: Unpredicted non-ER locations and functions.</article-title> <source><italic>J. Cell. Physiol.</italic></source> <volume>193</volume> <fpage>154</fpage>&#x2013;<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.10172</pub-id> <pub-id pub-id-type="pmid">12384992</pub-id></citation></ref>
<ref id="B253"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turrero Garc&#x00ED;a</surname> <given-names>M.</given-names></name> <name><surname>Harwell</surname> <given-names>C. C.</given-names></name></person-group> (<year>2017</year>). <article-title>Radial glia in the ventral telencephalon.</article-title> <source><italic>FEBS Lett.</italic></source> <volume>591</volume> <fpage>3942</fpage>&#x2013;<lpage>3959</lpage>. <pub-id pub-id-type="doi">10.1002/1873-3468.12829</pub-id> <pub-id pub-id-type="pmid">28862741</pub-id></citation></ref>
<ref id="B254"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turrigiano</surname> <given-names>G. G.</given-names></name></person-group> (<year>2008</year>). <article-title>The self-tuning neuron: Synaptic scaling of excitatory synapses.</article-title> <source><italic>Cell</italic></source> <volume>135</volume> <fpage>422</fpage>&#x2013;<lpage>435</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2008.10.008</pub-id> <pub-id pub-id-type="pmid">18984155</pub-id></citation></ref>
<ref id="B255"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tyson</surname> <given-names>J. R.</given-names></name> <name><surname>Stirling</surname> <given-names>C. J.</given-names></name></person-group> (<year>2000</year>). <article-title>LHS1 and SIL1 provide a lumenal function that is essential for protein translocation into the endoplasmic reticulum.</article-title> <source><italic>EMBO J.</italic></source> <volume>19</volume> <fpage>6440</fpage>&#x2013;<lpage>6452</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/19.23.6440</pub-id> <pub-id pub-id-type="pmid">11101517</pub-id></citation></ref>
<ref id="B256"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Schadewijk</surname> <given-names>A.</given-names></name> <name><surname>van&#x2019;t Wout</surname> <given-names>E. F.</given-names></name> <name><surname>Stolk</surname> <given-names>J.</given-names></name> <name><surname>Hiemstra</surname> <given-names>P. S.</given-names></name></person-group> (<year>2012</year>). <article-title>A quantitative method for detection of spliced X-box binding protein-1 (XBP1) mRNA as a measure of endoplasmic reticulum (ER) stress.</article-title> <source><italic>Cell Stress Chaperones</italic></source> <volume>17</volume> <fpage>275</fpage>&#x2013;<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1007/s12192-011-0306-2</pub-id> <pub-id pub-id-type="pmid">22038282</pub-id></citation></ref>
<ref id="B257"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Villard</surname> <given-names>V.</given-names></name> <name><surname>Espallergues</surname> <given-names>J.</given-names></name> <name><surname>Keller</surname> <given-names>E.</given-names></name> <name><surname>Vamvakides</surname> <given-names>A.</given-names></name> <name><surname>Maurice</surname> <given-names>T.</given-names></name></person-group> (<year>2011</year>). <article-title>Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma 1 (&#x03C3;1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative.</article-title> <source><italic>J. Psychopharmacol.</italic></source> <volume>25</volume> <fpage>1101</fpage>&#x2013;<lpage>1117</lpage>. <pub-id pub-id-type="doi">10.1177/0269881110379286</pub-id> <pub-id pub-id-type="pmid">20829307</pub-id></citation></ref>
<ref id="B258"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vuppalanchi</surname> <given-names>D.</given-names></name> <name><surname>Coleman</surname> <given-names>J.</given-names></name> <name><surname>Yoo</surname> <given-names>S.</given-names></name> <name><surname>Merianda</surname> <given-names>T. T.</given-names></name> <name><surname>Yadhati</surname> <given-names>A. G.</given-names></name> <name><surname>Hossain</surname> <given-names>J.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Conserved 3&#x2019;-untranslated region sequences direct subcellular localization of chaperone protein mRNAs in neurons.</article-title> <source><italic>J. Biol. Chem.</italic></source> <volume>285</volume> <fpage>18025</fpage>&#x2013;<lpage>18038</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109.061333</pub-id> <pub-id pub-id-type="pmid">20308067</pub-id></citation></ref>
<ref id="B259"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Lee</surname> <given-names>J.</given-names></name> <name><surname>Liem</surname> <given-names>D.</given-names></name> <name><surname>Ping</surname> <given-names>P.</given-names></name></person-group> (<year>2017</year>). <article-title>HSPA5 gene encoding Hsp70 chaperone BiP in the endoplasmic reticulum.</article-title> <source><italic>Gene</italic></source> <volume>618</volume> <fpage>14</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2017.03.005</pub-id> <pub-id pub-id-type="pmid">28286085</pub-id></citation></ref>
<ref id="B260"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>M.</given-names></name> <name><surname>Wey</surname> <given-names>S.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Ye</surname> <given-names>R.</given-names></name> <name><surname>Lee</surname> <given-names>A. S.</given-names></name></person-group> (<year>2009</year>). <article-title>Role of the unfolded protein response regulator GRP78/BiP in development, cancer, and neurological disorders.</article-title> <source><italic>Antioxid. Redox Signal.</italic></source> <volume>11</volume> <fpage>2307</fpage>&#x2013;<lpage>2316</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2009.2485</pub-id> <pub-id pub-id-type="pmid">19309259</pub-id></citation></ref>
<ref id="B261"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>T.</given-names></name> <name><surname>Liu</surname> <given-names>K.</given-names></name> <name><surname>Li</surname> <given-names>Z.</given-names></name> <name><surname>Xu</surname> <given-names>Y.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Shi</surname> <given-names>W.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Prevalence of attention deficit/hyperactivity disorder among children and adolescents in China: A systematic review and meta-analysis.</article-title> <source><italic>BMC Psychiatry</italic></source> <volume>17</volume>:<issue>32</issue>. <pub-id pub-id-type="doi">10.1186/s12888-016-1187-9</pub-id> <pub-id pub-id-type="pmid">28103833</pub-id></citation></ref>
<ref id="B262"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Z. H.</given-names></name> <name><surname>Chen</surname> <given-names>Y. X.</given-names></name> <name><surname>Zhang</surname> <given-names>C. M.</given-names></name> <name><surname>Wu</surname> <given-names>L.</given-names></name> <name><surname>Yu</surname> <given-names>Z.</given-names></name> <name><surname>Cai</surname> <given-names>X. L.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Intermittent hypobaric hypoxia improves postischemic recovery of myocardial contractile function via redox signaling during early reperfusion.</article-title> <source><italic>Am. J. Physiol. Heart Circ. Physiol.</italic></source> <volume>301</volume> <fpage>H1695</fpage>&#x2013;<lpage>H1705</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00276.2011</pub-id> <pub-id pub-id-type="pmid">21821784</pub-id></citation></ref>
<ref id="B263"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Z.</given-names></name> <name><surname>Hong</surname> <given-names>Y.</given-names></name> <name><surname>Zou</surname> <given-names>L.</given-names></name> <name><surname>Zhong</surname> <given-names>R.</given-names></name> <name><surname>Zhu</surname> <given-names>B.</given-names></name> <name><surname>Shen</surname> <given-names>N.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Reelin gene variants and risk of autism spectrum disorders: An integrated meta-analysis.</article-title> <source><italic>Am. J. Med. Genet. B Neuropsychiatr. Genet.</italic></source> <volume>165B</volume> <fpage>192</fpage>&#x2013;<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.32222</pub-id> <pub-id pub-id-type="pmid">24453138</pub-id></citation></ref>
<ref id="B264"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname> <given-names>L. A.</given-names></name> <name><surname>Shen</surname> <given-names>Y.</given-names></name> <name><surname>Korn</surname> <given-names>J. M.</given-names></name> <name><surname>Arking</surname> <given-names>D. E.</given-names></name> <name><surname>Miller</surname> <given-names>D. T.</given-names></name> <name><surname>Fossdal</surname> <given-names>R.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Association between microdeletion and microduplication at 16p11.2 and autism.</article-title> <source><italic>N. Engl. J. Med.</italic></source> <volume>358</volume> <fpage>667</fpage>&#x2013;<lpage>675</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa075974</pub-id> <pub-id pub-id-type="pmid">18184952</pub-id></citation></ref>
<ref id="B265"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Whangbo</surname> <given-names>J.</given-names></name> <name><surname>Kenyon</surname> <given-names>C.</given-names></name></person-group> (<year>1999</year>). <article-title>A Wnt signaling system that specifies two patterns of cell migration in <italic>C. elegans</italic>.</article-title> <source><italic>Mol. Cell</italic></source> <volume>4</volume> <fpage>851</fpage>&#x2013;<lpage>858</lpage>. <pub-id pub-id-type="doi">10.1016/s1097-2765(00)80394-9</pub-id></citation></ref>
<ref id="B266"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname> <given-names>B.</given-names></name> <name><surname>Gilbert</surname> <given-names>H. F.</given-names></name></person-group> (<year>2004</year>). <article-title>Protein disulfide isomerase.</article-title> <source><italic>Biochim. Biophys. Acta</italic></source> <volume>1699</volume> <fpage>35</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbapap.2004.02.017</pub-id> <pub-id pub-id-type="pmid">15158710</pub-id></citation></ref>
<ref id="B267"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Willert</surname> <given-names>K.</given-names></name> <name><surname>Nusse</surname> <given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>Wnt proteins.</article-title> <source><italic>Cold Spring Harb. Perspect. Biol.</italic></source> <volume>4</volume>:<issue>a007864</issue>. <pub-id pub-id-type="doi">10.1101/cshperspect.a007864</pub-id> <pub-id pub-id-type="pmid">22952392</pub-id></citation></ref>
<ref id="B268"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Willis</surname> <given-names>D.</given-names></name> <name><surname>Li</surname> <given-names>K. W.</given-names></name> <name><surname>Zheng</surname> <given-names>J. Q.</given-names></name> <name><surname>Chang</surname> <given-names>J. H.</given-names></name> <name><surname>Smit</surname> <given-names>A. B.</given-names></name> <name><surname>Kelly</surname> <given-names>T.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Differential transport and local translation of cytoskeletal, injury-response, and neurodegeneration protein mRNAs in axons.</article-title> <source><italic>J. Neurosci.</italic></source> <volume>25</volume> <fpage>778</fpage>&#x2013;<lpage>791</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4235-04.2005</pub-id> <pub-id pub-id-type="pmid">15673657</pub-id></citation></ref>
<ref id="B269"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname> <given-names>P. J.</given-names></name> <name><surname>Morris</surname> <given-names>C. P.</given-names></name> <name><surname>Anson</surname> <given-names>D. S.</given-names></name> <name><surname>Occhiodoro</surname> <given-names>T.</given-names></name> <name><surname>Bielicki</surname> <given-names>J.</given-names></name> <name><surname>Clements</surname> <given-names>P. R.</given-names></name><etal/></person-group> (<year>1990</year>). <article-title>Hunter syndrome: Isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA.</article-title> <source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source> <volume>87</volume> <fpage>8531</fpage>&#x2013;<lpage>8535</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.87.21.8531</pub-id> <pub-id pub-id-type="pmid">2122463</pub-id></citation></ref>
<ref id="B270"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wraith</surname> <given-names>J. E.</given-names></name> <name><surname>Rogers</surname> <given-names>J. G.</given-names></name> <name><surname>Danks</surname> <given-names>D. M.</given-names></name></person-group> (<year>1987</year>). <article-title>The mucopolysaccharidoses.</article-title> <source><italic>Aust. Paediatr. J.</italic></source> <volume>23</volume> <fpage>329</fpage>&#x2013;<lpage>334</lpage>. <pub-id pub-id-type="doi">10.1111/j.1440-1754.1987.tb00284.x</pub-id> <pub-id pub-id-type="pmid">3124802</pub-id></citation></ref>
<ref id="B271"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xavier</surname> <given-names>J. M.</given-names></name> <name><surname>Rodrigues</surname> <given-names>C. M.</given-names></name> <name><surname>Sol&#x00E1;</surname> <given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Mitochondria: Major regulators of neural development.</article-title> <source><italic>Neuroscientist</italic></source> <volume>22</volume> <fpage>346</fpage>&#x2013;<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1177/1073858415585472</pub-id> <pub-id pub-id-type="pmid">25948649</pub-id></citation></ref>
<ref id="B272"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname> <given-names>K.</given-names></name> <name><surname>Shioda</surname> <given-names>N.</given-names></name> <name><surname>Yabuki</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>C.</given-names></name> <name><surname>Han</surname> <given-names>F.</given-names></name> <name><surname>Fukunaga</surname> <given-names>K.</given-names></name></person-group> (<year>2018</year>). <article-title>SA4503, a potent sigma-1 receptor ligand, ameliorates synaptic abnormalities and cognitive dysfunction in a mouse model of ATR-X syndrome.</article-title> <source><italic>Int. J. Mol. Sci.</italic></source> <volume>19</volume>:<issue>2811</issue>. <pub-id pub-id-type="doi">10.3390/ijms19092811</pub-id> <pub-id pub-id-type="pmid">30231518</pub-id></citation></ref>
<ref id="B273"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname> <given-names>M.</given-names></name> <name><surname>Li</surname> <given-names>J.</given-names></name> <name><surname>Sha</surname> <given-names>B.</given-names></name></person-group> (<year>2011</year>). <article-title>Structural analysis of the sil1-bip complex reveals the mechanism for sil1 to function as a nucleotide-exchange factor.</article-title> <source><italic>Biochem. J.</italic></source> <volume>438</volume> <fpage>447</fpage>&#x2013;<lpage>455</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20110500</pub-id> <pub-id pub-id-type="pmid">21675960</pub-id></citation></ref>
<ref id="B274"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yashiro</surname> <given-names>K.</given-names></name> <name><surname>Philpot</surname> <given-names>B. D.</given-names></name></person-group> (<year>2008</year>). <article-title>Regulation of NMDA receptor subunit expression and its implications for LTD, LTP, and metaplasticity.</article-title> <source><italic>Neuropharmacology</italic></source> <volume>55</volume> <fpage>1081</fpage>&#x2013;<lpage>1094</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2008.07.046</pub-id> <pub-id pub-id-type="pmid">18755202</pub-id></citation></ref>
<ref id="B275"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshikawa</surname> <given-names>S.</given-names></name> <name><surname>McKinnon</surname> <given-names>R. D.</given-names></name> <name><surname>Kokel</surname> <given-names>M.</given-names></name> <name><surname>Thomas</surname> <given-names>J. B.</given-names></name></person-group> (<year>2003</year>). <article-title>Wnt-mediated axon guidance via the <italic>Drosophila</italic> derailed receptor.</article-title> <source><italic>Nature</italic></source> <volume>422</volume> <fpage>583</fpage>&#x2013;<lpage>588</lpage>. <pub-id pub-id-type="doi">10.1038/nature01522</pub-id> <pub-id pub-id-type="pmid">12660735</pub-id></citation></ref>
<ref id="B276"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zablotsky</surname> <given-names>B.</given-names></name> <name><surname>Black</surname> <given-names>L. I.</given-names></name> <name><surname>Maenner</surname> <given-names>M. J.</given-names></name> <name><surname>Schieve</surname> <given-names>L. A.</given-names></name> <name><surname>Blumberg</surname> <given-names>S. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Estimated prevalence of autism and other developmental disabilities following questionnaire changes in the 2014 national health interview survey.</article-title> <source><italic>Natl. Health Stat. Rep.</italic></source> <volume>87</volume> <fpage>1</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="pmid">26632847</pub-id></citation></ref>
<ref id="B277"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zarrei</surname> <given-names>M.</given-names></name> <name><surname>Burton</surname> <given-names>C. L.</given-names></name> <name><surname>Engchuan</surname> <given-names>W.</given-names></name> <name><surname>Young</surname> <given-names>E. J.</given-names></name> <name><surname>Higginbotham</surname> <given-names>E. J.</given-names></name> <name><surname>MacDonald</surname> <given-names>J. R.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>A large data resource of genomic copy number variation across neurodevelopmental disorders.</article-title> <source><italic>NPJ Genom. Med.</italic></source> <volume>4</volume>:<issue>26</issue>. <pub-id pub-id-type="doi">10.1038/s41525-019-0098-3</pub-id> <pub-id pub-id-type="pmid">31602316</pub-id></citation></ref>
<ref id="B278"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zeeshan</surname> <given-names>H. M.</given-names></name> <name><surname>Lee</surname> <given-names>G. H.</given-names></name> <name><surname>Kim</surname> <given-names>H. R.</given-names></name> <name><surname>Chae</surname> <given-names>H. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Endoplasmic reticulum stress and associated ROS.</article-title> <source><italic>Int. J. Mol. Sci.</italic></source> <volume>17</volume>:<issue>327</issue>. <pub-id pub-id-type="doi">10.3390/ijms17030327</pub-id> <pub-id pub-id-type="pmid">26950115</pub-id></citation></ref>
<ref id="B279"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>X.</given-names></name> <name><surname>Abreu</surname> <given-names>J. G.</given-names></name> <name><surname>Yokota</surname> <given-names>C.</given-names></name> <name><surname>MacDonald</surname> <given-names>B. T.</given-names></name> <name><surname>Singh</surname> <given-names>S.</given-names></name> <name><surname>Coburn</surname> <given-names>K. L.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Tiki1 is required for head formation via Wnt cleavage-oxidation and inactivation.</article-title> <source><italic>Cell</italic></source> <volume>149</volume> <fpage>1565</fpage>&#x2013;<lpage>1577</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.04.039</pub-id> <pub-id pub-id-type="pmid">22726442</pub-id></citation></ref>
<ref id="B280"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>C. L.</given-names></name> <name><surname>Feng</surname> <given-names>Z. J.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Ji</surname> <given-names>X. H.</given-names></name> <name><surname>Peng</surname> <given-names>J. Y.</given-names></name> <name><surname>Zhang</surname> <given-names>X. H.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: A novel mechanism for methylphenidate action.</article-title> <source><italic>PLoS One</italic></source> <volume>7</volume>:<issue>e51910</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0051910</pub-id> <pub-id pub-id-type="pmid">23284812</pub-id></citation></ref>
<ref id="B281"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>K.</given-names></name> <name><surname>Kaufman</surname> <given-names>R. J.</given-names></name></person-group> (<year>2008</year>). <article-title>From endoplasmic-reticulum stress to the inflammatory response.</article-title> <source><italic>Nature</italic></source> <volume>454</volume> <fpage>455</fpage>&#x2013;<lpage>462</lpage>. <pub-id pub-id-type="doi">10.1038/nature07203</pub-id> <pub-id pub-id-type="pmid">18650916</pub-id></citation></ref>
<ref id="B282"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>X. M.</given-names></name> <name><surname>Yan</surname> <given-names>X. Y.</given-names></name> <name><surname>Zhang</surname> <given-names>B.</given-names></name> <name><surname>Yang</surname> <given-names>Q.</given-names></name> <name><surname>Ye</surname> <given-names>M.</given-names></name> <name><surname>Cao</surname> <given-names>W.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Activity-induced synaptic delivery of the GluN2A-containing NMDA receptor is dependent on endoplasmic reticulum chaperone bip and involved in fear memory.</article-title> <source><italic>Cell Res.</italic></source> <volume>25</volume> <fpage>818</fpage>&#x2013;<lpage>836</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2015.75</pub-id> <pub-id pub-id-type="pmid">26088419</pub-id></citation></ref>
<ref id="B283"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>P.</given-names></name> <name><surname>Ignacio</surname> <given-names>S.</given-names></name> <name><surname>Beattie</surname> <given-names>E. C.</given-names></name> <name><surname>Abood</surname> <given-names>M. E.</given-names></name></person-group> (<year>2008</year>). <article-title>Altered presymptomatic AMPA and cannabinoid receptor trafficking in motor neurons of ALS model mice: Implications for excitotoxicity.</article-title> <source><italic>Eur. J. Neurosci.</italic></source> <volume>27</volume> <fpage>572</fpage>&#x2013;<lpage>579</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2008.06041.x</pub-id> <pub-id pub-id-type="pmid">18279310</pub-id></citation></ref>
<ref id="B284"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhemkov</surname> <given-names>V.</given-names></name> <name><surname>Geva</surname> <given-names>M.</given-names></name> <name><surname>Hayden</surname> <given-names>M. R.</given-names></name> <name><surname>Bezprozvanny</surname> <given-names>I.</given-names></name></person-group> (<year>2021</year>). <article-title>Sigma-1 receptor (S1R) interaction with cholesterol: Mechanisms of S1R activation and its role in neurodegenerative diseases.</article-title> <source><italic>Int. J. Mol. Sci.</italic></source> <volume>22</volume>:<issue>4082</issue>. <pub-id pub-id-type="doi">10.3390/ijms22084082</pub-id> <pub-id pub-id-type="pmid">33920913</pub-id></citation></ref>
<ref id="B285"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>P.</given-names></name></person-group> (<year>2009</year>). <article-title>Neuroactive steroid regulation of neurotransmitter release in the CNS: Action, mechanism and possible significance.</article-title> <source><italic>Prog. Neurobiol.</italic></source> <volume>89</volume> <fpage>134</fpage>&#x2013;<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2009.07.001</pub-id> <pub-id pub-id-type="pmid">19595736</pub-id></citation></ref>
</ref-list>
</back>
</article>